NHS North West Genomics
2.2.0 - ci-build United Kingdom flag

NHS North West Genomics - Local Development build (v2.2.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

CodeSystem: NHS England Genomic Test Code

Official URL: https://fhir.nhs.uk/CodeSystem/England-GenomicTestDirectory Version: 2.2.0
Active as of 2026-09-08 Computable Name: GenomicTestCode

  • Source: National genomic test directories - Rare & Inherited Disease v9 and Cancer (non-CNS) v16 checked/refreshed on 2026-09-08.
  • The M* codes for Haematological Oncology and Cancer CNS below predate those two directories' move to the digital TP/GT scheme and no longer appear in any live M*-coded master spreadsheet - preserved for backwards compatibility, not refreshable from a current source. See ConceptMap-GenomicTestCodeToDigitalGenomicTestServices for their DGTS GT-code replacements.
  • specialist-test-group is populated for R* codes only, from the Rare & Inherited Disease spreadsheet's own "Specialist test group" column - the Cancer directories have no equivalent column, so M* codes don't carry it.
  • test-method is populated for R* codes from that same spreadsheet's "Test Method" column, and for current (non-legacy) M* codes from the Cancer directory's "Technology" column (the same concept, differently named) - not populated for legacy M* codes, or the small number of current M* codes (M4.14, M119.5) whose source cell had no clean single value.

HL7 v2 CodeSystem : England-GenomicTestDirectory

This Code system is referenced in the definition of the following value sets:

Properties

This code system defines the following properties for its concepts

NameCodeURITypeDescription
category category https://fhir.nhs.uk/CodeSystem/England-GenomicTestDirectory#category code Which part of the National Genomic Test Directory this code belongs to: rare-and-inherited-disease, cancer, or haematological-oncology
specialist-test-group specialist-test-group https://fhir.nhs.uk/CodeSystem/England-GenomicTestDirectory#specialist-test-group string The Specialist test group column from the Rare & Inherited Disease National Genomic Test Directory master spreadsheet (R* codes only - the Cancer directories have no equivalent column)
test-method test-method https://fhir.nhs.uk/CodeSystem/England-GenomicTestDirectory#test-method string The test method/technology used - Test Method column (R* codes) or Technology column (current M* codes); not populated for legacy M* codes

Concepts

This case-sensitive code system https://fhir.nhs.uk/CodeSystem/England-GenomicTestDirectory provides a fragment that includes following codes:

CodeDisplaycategoryspecialist-test-grouptest-method
R14.1 Acutely unwell children with a likely monogenic disorder (WGS) rare-and-inherited-disease Multi specialty WGS
R15.4 Primary immunodeficiency or monogenic inflammatory bowel disease (WGS) rare-and-inherited-disease Immunology WGS
R15.5 Primary immunodeficiency or monogenic inflammatory bowel disease (WES) rare-and-inherited-disease Immunology WES
R16.1 Severe combined immunodeficiency with adenosine deaminase deficiency (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Immunology Single gene sequencing >=10 amplicons
R17.1 Lymphoproliferative syndrome with absent SAP expression (Single gene sequencing <10 amplicons) rare-and-inherited-disease Immunology Single gene sequencing <10 amplicons
R18.1 Haemophagocytic syndrome with absent XIAP expression (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Immunology Single gene sequencing >=10 amplicons
R19.1 Autoimmune lymphoproliferative syndrome with defective apoptosis (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Immunology Single gene sequencing >=10 amplicons
R20.1 Wiskott-Aldrich syndrome (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Immunology Single gene sequencing >=10 amplicons
R21.1 Fetal anomalies with a likely genetic cause (Common aneuploidy testing) rare-and-inherited-disease Prenatal Common aneuploidy testing
R21.2 Fetal anomalies with a likely genetic cause (Large Panel) rare-and-inherited-disease Prenatal Large Panel
R21.3 Fetal anomalies with a likely genetic cause (Microarray) rare-and-inherited-disease Prenatal Microarray
R22.1 Fetus with a likely chromosomal abnormality (Common aneuploidy testing) rare-and-inherited-disease Core Common aneuploidy testing
R22.2 Fetus with a likely chromosomal abnormality (Microarray) rare-and-inherited-disease Core Microarray
R23.1 Apert syndrome (Targeted variant testing) rare-and-inherited-disease Musculoskeletal Targeted variant testing
R24.1 Achondroplasia (Targeted variant testing) rare-and-inherited-disease Core Targeted variant testing
R25.1 Thanatophoric dysplasia (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Core Single gene sequencing >=10 amplicons
R26.1 Likely common aneuploidy (Common aneuploidy testing) rare-and-inherited-disease Core Common aneuploidy testing
R27.3 Paediatric disorders (WGS) rare-and-inherited-disease Core WGS
R28.1 Congenital malformation and dysmorphism syndromes (Microarray) rare-and-inherited-disease Core Microarray
R31.3 Bilateral congenital or childhood onset cataracts (WGS) rare-and-inherited-disease Ophthalmology WGS
R32.2 Retinal disorders (WGS) rare-and-inherited-disease Ophthalmology WGS
R33.1 Possible X-linked retinitis pigmentosa (Targeted variant testing) rare-and-inherited-disease Ophthalmology Targeted variant testing
R36.2 Structural eye disease (WGS) rare-and-inherited-disease Ophthalmology WGS
R38.2 Sporadic aniridia (Small panel) rare-and-inherited-disease Ophthalmology Small panel
R39.1 Albinism or congenital nystagmus (WES or Medium panel) rare-and-inherited-disease Ophthalmology WES or Medium panel
R41.1 Optic neuropathy (WES or Medium panel) rare-and-inherited-disease Ophthalmology WES or Medium panel
R41.3 Optic neuropathy (Targeted variant testing) rare-and-inherited-disease Ophthalmology Targeted variant testing
R42.1 Leber hereditary optic neuropathy (Targeted variant testing) rare-and-inherited-disease Mitochondrial Targeted variant testing
R42.2 Leber hereditary optic neuropathy (Other) rare-and-inherited-disease Mitochondrial Other
R43.1 Blepharophimosis ptosis and epicanthus inversus (Single gene sequencing <10 amplicons) rare-and-inherited-disease Ophthalmology Single gene sequencing <10 amplicons
R43.2 Blepharophimosis ptosis and epicanthus inversus (MLPA or equivalent) rare-and-inherited-disease Ophthalmology MLPA or equivalent
R43.3 Blepharophimosis ptosis and epicanthus inversus (STR testing) rare-and-inherited-disease Ophthalmology STR testing
R45.1 Stickler syndrome (Small panel) rare-and-inherited-disease Ophthalmology Small panel
R46.1 Congenital fibrosis of the extraocular muscles (Small panel) rare-and-inherited-disease Ophthalmology Small panel
R47.1 Angelman syndrome (Methylation testing) rare-and-inherited-disease Core Methylation testing
R48.1 Prader-Willi syndrome (Methylation testing) rare-and-inherited-disease Core Methylation testing
R49.1 Beckwith-Wiedemann syndrome (Methylation testing) rare-and-inherited-disease Endocrinology Methylation testing
R49.3 Beckwith-Wiedemann syndrome (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Endocrinology Single gene sequencing >=10 amplicons
R50.1 Isolated hemihypertrophy or macroglossia (Methylation testing) rare-and-inherited-disease Endocrinology Methylation testing
R52.1 Short stature - SHOX deficiency (MLPA or equivalent) rare-and-inherited-disease Musculoskeletal MLPA or equivalent
R52.2 Short stature - SHOX deficiency (Single gene sequencing <10 amplicons) rare-and-inherited-disease Musculoskeletal Single gene sequencing <10 amplicons
R54.3 Hereditary ataxia with onset in adulthood (WGS) rare-and-inherited-disease Neurology WGS
R54.4 Hereditary ataxia with onset in adulthood (STR testing) rare-and-inherited-disease Neurology STR testing
R55.4 Hereditary ataxia with onset in childhood (WGS) rare-and-inherited-disease Neurology WGS
R56.3 Adult onset dystonia, chorea or related movement disorder (WGS) rare-and-inherited-disease Neurology WGS
R57.5 Childhood onset dystonia, chorea or related movement disorder (WGS) rare-and-inherited-disease Neurology WGS
R60.3 Adult onset hereditary spastic paraplegia (WGS) rare-and-inherited-disease Neurology WGS
R61.4 Childhood onset hereditary spastic paraplegia (WGS) rare-and-inherited-disease Neurology WGS
R62.2 Adult onset leukodystrophy (WGS) rare-and-inherited-disease Neurology WGS
R63.1 Possible mitochondrial disorder - nuclear genes (WES or Large Panel) rare-and-inherited-disease Mitochondrial WES or Large Panel
R64.1 MELAS or MIDD (Targeted variant testing) rare-and-inherited-disease Mitochondrial Targeted variant testing
R65.1 Aminoglycoside exposure posing risk to hearing (Targeted variant testing) rare-and-inherited-disease Core Targeted variant testing
R66.1 Paroxysmal central nervous system disorders (WES or Medium Panel) rare-and-inherited-disease Neurology WES or Medium Panel
R67.1 Monogenic hearing loss (WES or Large Panel) rare-and-inherited-disease Audiology WES or Large Panel
R68.1 Huntington disease (STR testing) rare-and-inherited-disease Core STR testing
R69.5 Hypotonic infant (WGS) rare-and-inherited-disease Core WGS
R70.1 Spinal muscular atrophy type 1 diagnostic test (MLPA or equivalent) rare-and-inherited-disease Core MLPA or equivalent
R71.1 Spinal muscular atrophy type 1 rare variant testing (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Neurology Single gene sequencing >=10 amplicons
R72.1 Myotonic dystrophy type 1 (STR testing) rare-and-inherited-disease Core STR testing
R73.1 Duchenne or Becker muscular dystrophy (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Neurology Single gene sequencing >=10 amplicons
R73.2 Duchenne or Becker muscular dystrophy (MLPA or equivalent) rare-and-inherited-disease Neurology MLPA or equivalent
R74.1 Facioscapulohumeral muscular dystrophy (Other) rare-and-inherited-disease Neurology Other
R75.1 Oculopharyngeal muscular dystrophy (STR testing) rare-and-inherited-disease Neurology STR testing
R76.1 Skeletal muscle channelopathy (Small panel) rare-and-inherited-disease Neurology Small panel
R77.1 Hereditary neuropathy - PMP22 copy number (MLPA or equivalent) rare-and-inherited-disease Core MLPA or equivalent
R78.4 Hereditary neuropathy or pain disorder (WGS) rare-and-inherited-disease Neurology WGS
R78.5 Hereditary neuropathy or pain disorder (STR testing) rare-and-inherited-disease Neurology STR testing
R79.1 Congenital muscular dystrophy (WES or Medium Panel) rare-and-inherited-disease Neurology WES or Medium Panel
R80.1 Congenital myaesthenic syndrome (WES or Medium Panel) rare-and-inherited-disease Neurology WES or Medium Panel
R81.1 Congenital myopathy (WES or Medium Panel) rare-and-inherited-disease Neurology WES or Medium Panel
R82.1 Limb girdle muscular dystrophies, myofibrillar myopathies and distal myopathies (WES or Medium Panel) rare-and-inherited-disease Neurology WES or Medium Panel
R83.3 Arthrogryposis (WGS) rare-and-inherited-disease Neurology WGS
R84.4 Cerebellar anomalies (WGS) rare-and-inherited-disease Neurology WGS
R85.2 Holoprosencephaly - NOT chromosomal (WGS) rare-and-inherited-disease Neurology WGS
R86.3 Hydrocephalus (WGS) rare-and-inherited-disease Neurology WGS
R87.3 Cerebral malformation (WGS) rare-and-inherited-disease Neurology WGS
R88.3 Severe microcephaly (WGS) rare-and-inherited-disease Neurology WGS
R89.3 Ultra-rare and atypical monogenic disorders (WGS) rare-and-inherited-disease Core WGS
R90.1 Bleeding and platelet disorders (WES or Medium Panel) rare-and-inherited-disease Haematology WES or Medium Panel
R91.1 Cytopenia - NOT Fanconi anaemia (WES or Medium Panel) rare-and-inherited-disease Haematology WES or Medium Panel
R91.2 Cytopenia - NOT Fanconi anaemia (MLPA or equivalent) rare-and-inherited-disease Haematology MLPA or equivalent
R92.1 Rare anaemia (MLPA or equivalent) rare-and-inherited-disease Haematology MLPA or equivalent
R92.2 Rare anaemia (Small panel) rare-and-inherited-disease Haematology Small panel
R92.3 Rare anaemia (WES or Medium Panel) rare-and-inherited-disease Haematology WES or Medium Panel
R93.1 Sickle cell, thalassaemia and other haemoglobinopathies (MLPA or equivalent) rare-and-inherited-disease Haematology MLPA or equivalent
R93.2 Sickle cell, thalassaemia and other haemoglobinopathies (Small panel) rare-and-inherited-disease Haematology Small panel
R95.1 Iron overload - hereditary haemochromatosis testing (Targeted variant testing) rare-and-inherited-disease Core Targeted variant testing
R96.1 Iron metabolism disorders - NOT common HFE variants (Small panel) rare-and-inherited-disease Haematology Small panel
R97.1 Thrombophilia with a likely monogenic cause (WES or Small Panel) rare-and-inherited-disease Haematology WES or Small Panel
R98.2 Likely inborn error of metabolism (WGS) rare-and-inherited-disease Metabolic WGS
R98.3 Likely inborn error of metabolism (WES) rare-and-inherited-disease Metabolic WES
R99.1 Common craniosynostosis syndromes (Small panel) rare-and-inherited-disease Musculoskeletal Small panel
R99.2 Common craniosynostosis syndromes (Exon level CNV detection by MLPA or equivalent) rare-and-inherited-disease Musculoskeletal Exon level CNV detection by MLPA or equivalent
R100.3 Rare syndromic craniosynostosis or isolated multisuture synostosis (WGS) rare-and-inherited-disease Musculoskeletal WGS
R101.1 Ehlers Danlos syndrome with a likely monogenic cause (WES or Medium Panel) rare-and-inherited-disease Musculoskeletal WES or Medium Panel
R102.1 Osteogenesis imperfecta (WES or Medium Panel) rare-and-inherited-disease Musculoskeletal WES or Medium Panel
R104.3 Skeletal dysplasia (WGS) rare-and-inherited-disease Musculoskeletal WGS
R104.4 Skeletal dysplasia (Small panel) rare-and-inherited-disease Musculoskeletal Small panel
R105.1 MCADD - Medium-chain acyl-CoA dehydrogenase deficiency – common variant newborn screening follow up (Targeted variant testing) rare-and-inherited-disease Screening Targeted variant testing
R106.1 Alstrom syndrome (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Endocrinology Single gene sequencing >=10 amplicons
R107.1 Bardet Biedl syndrome (Small panel) rare-and-inherited-disease Ophthalmology Small panel
R109.3 Childhood onset leukodystrophy (WGS) rare-and-inherited-disease Neurology WGS
R110.1 Segmental overgrowth disorders - Deep sequencing (Small panel) rare-and-inherited-disease Dermatology Small panel
R111.1 X-inactivation testing (X-inactivation testing) rare-and-inherited-disease Core/Specialised X-inactivation testing
R112.1 Factor II deficiency (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Haematology Single gene sequencing >=10 amplicons
R115.1 Factor V deficiency (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Haematology Single gene sequencing >=10 amplicons
R115.2 Factor V deficiency (MLPA or equivalent) rare-and-inherited-disease Haematology MLPA or equivalent
R116.1 Factor VII deficiency (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Haematology Single gene sequencing >=10 amplicons
R116.2 Factor VII deficiency (MLPA or equivalent) rare-and-inherited-disease Haematology MLPA or equivalent
R117.1 Factor VIII deficiency (Targeted variant testing) rare-and-inherited-disease Haematology Targeted variant testing
R117.2 Factor VIII deficiency (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Haematology Single gene sequencing >=10 amplicons
R117.3 Factor VIII deficiency (MLPA or equivalent) rare-and-inherited-disease Haematology MLPA or equivalent
R118.1 Factor IX deficiency (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Haematology Single gene sequencing >=10 amplicons
R118.2 Factor IX deficiency (MLPA or equivalent) rare-and-inherited-disease Haematology MLPA or equivalent
R119.1 Factor X deficiency (Single gene sequencing <10 amplicons) rare-and-inherited-disease Haematology Single gene sequencing <10 amplicons
R119.2 Factor X deficiency (MLPA or equivalent) rare-and-inherited-disease Haematology MLPA or equivalent
R120.1 Factor XI deficiency (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Haematology Single gene sequencing >=10 amplicons
R120.2 Factor XI deficiency (MLPA or equivalent) rare-and-inherited-disease Haematology MLPA or equivalent
R121.1 von Willebrand disease (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Haematology Single gene sequencing >=10 amplicons
R121.2 von Willebrand disease (MLPA or equivalent) rare-and-inherited-disease Haematology MLPA or equivalent
R122.1 Factor XIII deficiency (Small panel) rare-and-inherited-disease Haematology Small panel
R123.1 Combined vitamin K-dependent clotting factor deficiency (Small panel) rare-and-inherited-disease Haematology Small panel
R124.1 Combined factor V and VIII deficiency (Small panel) rare-and-inherited-disease Haematology Small panel
R125.1 Thoracic aortic aneurysm or dissection (WES or Medium Panel) rare-and-inherited-disease Cardiology WES or Medium Panel
R127.1 Long QT syndrome (Small panel) rare-and-inherited-disease Cardiology Small panel
R128.1 Brugada syndrome and cardiac sodium channel disease (Small panel) rare-and-inherited-disease Cardiology Small panel
R129.1 Catecholaminergic polymorphic VT (Small panel) rare-and-inherited-disease Cardiology Small panel
R130.1 Short QT syndrome (Small panel) rare-and-inherited-disease Cardiology Small panel
R131.1 Hypertrophic cardiomyopathy (WES or Medium Panel) rare-and-inherited-disease Cardiology WES or Medium Panel
R132.1 Dilated and Arrhythmogenic cardiomyopathy (WES or Medium Panel) rare-and-inherited-disease Cardiology WES or Medium Panel
R133.1 Arrhythmogenic right ventricular cardiomyopathy (Small panel) rare-and-inherited-disease Cardiology Small panel
R134.1 Familial hypercholesterolaemia (Small panel) rare-and-inherited-disease Core Small panel
R135.2 Paediatric or syndromic cardiomyopathy (WGS) rare-and-inherited-disease Cardiology WGS
R135.3 Paediatric or syndromic cardiomyopathy (WES) rare-and-inherited-disease Cardiology WES
R136.1 Primary lymphoedema (WES or Medium Panel) rare-and-inherited-disease Cardiology WES or Medium Panel
R137.1 Congenital heart disease - microarray (Microarray) rare-and-inherited-disease Core Microarray
R138.1 Sudden unexplained death or survivors of a cardiac event (WES or Medium Panel) rare-and-inherited-disease Cardiology WES or Medium Panel
R139.1 Laterality disorders and isomerism (WES or Medium Panel) rare-and-inherited-disease Respiratory WES or Medium Panel
R140.1 Elastin-related phenotypes (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Cardiology Single gene sequencing >=10 amplicons
R141.1 Monogenic diabetes (WES or Medium Panel) rare-and-inherited-disease Endocrinology WES or Medium Panel
R142.1 Glucokinase-related fasting hyperglycaemia (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Endocrinology Single gene sequencing >=10 amplicons
R143.1 Neonatal diabetes (Small panel) rare-and-inherited-disease Endocrinology Small panel
R143.3 Neonatal diabetes (Methylation testing) rare-and-inherited-disease Endocrinology Methylation testing
R143.4 Neonatal diabetes (WGS) rare-and-inherited-disease Endocrinology WGS
R144.1 Congenital hyperinsulinism (Small panel) rare-and-inherited-disease Endocrinology Small panel
R144.2 Congenital hyperinsulinism (Small panel) rare-and-inherited-disease Endocrinology Small panel
R145.1 Congenital hypothyroidism (WES or Medium panel) rare-and-inherited-disease Endocrinology WES or Medium panel
R146.1 Differences in sex development (Microarray) rare-and-inherited-disease Endocrinology Microarray
R146.2 Differences in sex development (WES or Medium Panel) rare-and-inherited-disease Endocrinology WES or Medium Panel
R148.1 Hypogonadotropic hypogonadism (Medium panel) rare-and-inherited-disease Endocrinology Medium panel
R149.1 Severe early-onset obesity (WES or Medium panel) rare-and-inherited-disease Endocrinology WES or Medium panel
R150.1 Congenital adrenal hypoplasia (Small panel) rare-and-inherited-disease Endocrinology Small panel
R151.1 Familial hyperparathyroidism or Hypocalciuric hypercalcaemia (Small panel) rare-and-inherited-disease Endocrinology Small panel
R153.1 Familial hypoparathyroidism (Small panel) rare-and-inherited-disease Endocrinology Small panel
R154.1 Hypophosphataemia or rickets (Small panel) rare-and-inherited-disease Endocrinology Small panel
R155.1 Autoimmune Polyendocrine Syndrome (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Immunology Single gene sequencing >=10 amplicons
R156.1 Carney complex (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Endocrinology Single gene sequencing >=10 amplicons
R157.1 IPEX - Immunodysregulation Polyendocrinopathy and Enteropathy, X-Linked (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Endocrinology Single gene sequencing >=10 amplicons
R158.1 Severe insulin resistance and lipodystrophy syndromes (Medium panel) rare-and-inherited-disease Endocrinology Medium panel
R159.1 Pituitary hormone deficiency (WES or Medium panel) rare-and-inherited-disease Endocrinology WES or Medium panel
R160.1 Primary pigmented nodular adrenocortical disease (Small panel) rare-and-inherited-disease Endocrinology Small panel
R162.1 Familial tumoral calcinosis (Small panel) rare-and-inherited-disease Endocrinology Small panel
R163.1 Ectodermal dysplasia (WES or Medium panel) rare-and-inherited-disease Dermatology WES or Medium panel
R164.1 Epidermolysis bullosa and congenital skin fragility (WES or Medium Panel) rare-and-inherited-disease Dermatology WES or Medium Panel
R165.1 Ichthyosis and erythrokeratoderma (WES or Medium panel) rare-and-inherited-disease Dermatology WES or Medium panel
R166.1 Palmoplantar keratodermas (WES or Medium panel) rare-and-inherited-disease Dermatology WES or Medium panel
R167.1 Autosomal recessive primary hypertrophic osteoarthropathy (Small panel) rare-and-inherited-disease Dermatology Small panel
R168.1 Non-acute porphyrias (Small panel) rare-and-inherited-disease Gastrohepatology Small panel
R169.1 Acute intermittent porphyria (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Gastrohepatology Single gene sequencing >=10 amplicons
R170.1 Variegate porphyria (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Gastrohepatology Single gene sequencing >=10 amplicons
R171.1 Cholestasis (WES or Medium Panel) rare-and-inherited-disease Gastrohepatology WES or Medium Panel
R172.1 Wilson disease (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Gastrohepatology Single gene sequencing >=10 amplicons
R173.1 Polycystic liver disease (WES or Small Panel) rare-and-inherited-disease Gastrohepatology WES or Small Panel
R175.1 Pancreatitis (Small panel) rare-and-inherited-disease Gastrohepatology Small panel
R176.1 Gilbert syndrome (Targeted variant testing) rare-and-inherited-disease Gastrohepatology Targeted variant testing
R180.1 Congenital adrenal hyperplasia diagnostic test (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Endocrinology Single gene sequencing >=10 amplicons
R180.2 Congenital adrenal hyperplasia diagnostic test (MLPA or equivalent) rare-and-inherited-disease Endocrinology MLPA or equivalent
R181.1 Congenital adrenal hyperplasia carrier testing (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Endocrinology Single gene sequencing >=10 amplicons
R181.2 Congenital adrenal hyperplasia carrier testing (MLPA or equivalent) rare-and-inherited-disease Endocrinology MLPA or equivalent
R182.1 Hyperthyroidism (Small panel) rare-and-inherited-disease Endocrinology Small panel
R183.1 Glucocorticoid-remediable aldosteronism (GRA) (Targeted variant testing) rare-and-inherited-disease Endocrinology Targeted variant testing
R184.1 Cystic fibrosis diagnostic test (Targeted variant testing) rare-and-inherited-disease Core Targeted variant testing
R184.2 Cystic fibrosis diagnostic test (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Core Single gene sequencing >=10 amplicons
R184.3 Cystic fibrosis diagnostic test (MLPA or equivalent) rare-and-inherited-disease Core MLPA or equivalent
R185.1 Cystic fibrosis carrier testing (Targeted variant testing) rare-and-inherited-disease Core Targeted variant testing
R186.1 Hereditary haemorrhagic telangiectasia (Small panel) rare-and-inherited-disease Respiratory Small panel
R188.1 Pulmonary arterial hypertension (Small panel) rare-and-inherited-disease Respiratory Small panel
R189.1 Respiratory ciliopathies including non-CF bronchiectasis (WES or Medium Panel) rare-and-inherited-disease Respiratory WES or Medium Panel
R190.1 Pneumothorax - familial (Small panel) rare-and-inherited-disease Respiratory Small panel
R191.1 Alpha-1-antitrypsin deficiency (Targeted variant testing) rare-and-inherited-disease Respiratory Targeted variant testing
R193.4 Cystic renal disease (WGS) rare-and-inherited-disease Renal WGS
R194.1 Haematuria (Small panel) rare-and-inherited-disease Renal Small panel
R195.3 Proteinuric renal disease (WGS) rare-and-inherited-disease Renal WGS
R196.1 CFHR5 nephropathy (MLPA or equivalent) rare-and-inherited-disease Renal MLPA or equivalent
R197.1 Membranoproliferative glomerulonephritis including C3 glomerulopathy (Small panel) rare-and-inherited-disease Renal Small panel
R197.2 Membranoproliferative glomerulonephritis including C3 glomerulopathy (MLPA or equivalent) rare-and-inherited-disease Renal MLPA or equivalent
R198.1 Renal tubulopathies (WES or Medium Panel) rare-and-inherited-disease Renal WES or Medium Panel
R199.1 Congenital anomalies of the kidney and urinary tract - familial (Microarray) rare-and-inherited-disease Core Microarray
R201.1 Atypical haemolytic uraemic syndrome (Small panel) rare-and-inherited-disease Renal Small panel
R202.1 Tubulointerstitial kidney disease (Small panel) rare-and-inherited-disease Renal Small panel
R204.1 Hereditary Systemic Amyloidosis (Small panel) rare-and-inherited-disease Renal Small panel
R207.1 Inherited ovarian cancer (without breast cancer) (Small panel) rare-and-inherited-disease Core Small panel
R208.1 Inherited breast cancer and ovarian cancer (Small panel) rare-and-inherited-disease Core Small panel
R210.2 Inherited MMR deficiency (Lynch syndrome) (Small panel) rare-and-inherited-disease Core Small panel
R210.4 Inherited MMR deficiency (Lynch syndrome) (Methylation testing) rare-and-inherited-disease Core Methylation testing
R210.6 Inherited MMR deficiency (Lynch syndrome) (MLPA or equivalent) rare-and-inherited-disease Core MLPA or equivalent
R211.1 Inherited polyposis and early onset colorectal cancer - germline testing (Small panel) rare-and-inherited-disease Core Small panel
R211.3 Inherited polyposis and early onset colorectal cancer - germline testing (MLPA or equivalent) rare-and-inherited-disease Core MLPA or equivalent
R212.1 Peutz Jeghers Syndrome (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Inherited cancer Single gene sequencing >=10 amplicons
R213.1 PTEN Hamartoma Tumor Syndrome (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Inherited cancer Single gene sequencing >=10 amplicons
R214.1 Nevoid Basal Cell Carcinoma Syndrome or Gorlin syndrome (Small panel) rare-and-inherited-disease Inherited cancer Small panel
R215.1 Hereditary diffuse gastric cancer (Small panel) rare-and-inherited-disease Inherited cancer Small panel
R216.1 Li Fraumeni Syndrome (Small panel) rare-and-inherited-disease Inherited cancer Small panel
R217.1 Endocrine neoplasia (Small panel) rare-and-inherited-disease Endocrinology Small panel
R218.1 Multiple endocrine neoplasia type 2 (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Endocrinology Single gene sequencing >=10 amplicons
R219.1 Retinoblastoma (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Inherited cancer Single gene sequencing >=10 amplicons
R219.2 Retinoblastoma (MLPA or equivalent) rare-and-inherited-disease Inherited cancer MLPA or equivalent
R221.1 Familial tumours of the nervous system (Small panel) rare-and-inherited-disease Neurology Small panel
R221.2 Familial tumours of the nervous system (MLPA or equivalent) rare-and-inherited-disease Neurology MLPA or equivalent
R222.1 Neurofibromatosis type 1 (Small panel) rare-and-inherited-disease Neurology Small panel
R222.2 Neurofibromatosis type 1 (MLPA or equivalent) rare-and-inherited-disease Neurology MLPA or equivalent
R223.1 Inherited phaeochromocytoma and paraganglioma excluding NF1 (Small panel) rare-and-inherited-disease Endocrinology Small panel
R224.1 Inherited renal cancer (Small panel) rare-and-inherited-disease Inherited cancer Small panel
R225.1 Von Hippel Lindau syndrome (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Inherited cancer Single gene sequencing >=10 amplicons
R226.1 Inherited parathyroid cancer (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Endocrinology Single gene sequencing >=10 amplicons
R227.1 Xeroderma pigmentosum, Trichothiodystrophy or Cockayne syndrome (Small panel) rare-and-inherited-disease Dermatology Small panel
R227.2 Xeroderma pigmentosum, Trichothiodystrophy or Cockayne syndrome (DNA repair defect testing) rare-and-inherited-disease Dermatology DNA repair defect testing
R228.1 Tuberous sclerosis (Small panel) rare-and-inherited-disease Neurology Small panel
R228.2 Tuberous sclerosis (MLPA or equivalent) rare-and-inherited-disease Neurology MLPA or equivalent
R228.3 Tuberous sclerosis (Small panel - deep sequencing) rare-and-inherited-disease Neurology Small panel - deep sequencing
R229.1 Confirmed Fanconi anaemia or Bloom syndrome - variant testing (Small panel) rare-and-inherited-disease Haematology Small panel
R230.1 Multiple monogenic benign skin tumours (Small panel) rare-and-inherited-disease Dermatology Small panel
R231.2 Neuronal ceroid lipofuscinosis (Small panel) rare-and-inherited-disease Metabolic Small panel
R232.1 Haemophagocytic syndrome with absent perforin expression (Single gene sequencing <10 amplicons) rare-and-inherited-disease Immunology Single gene sequencing <10 amplicons
R233.1 Agammaglobulinaemia with absent BTK expression (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Immunology Single gene sequencing >=10 amplicons
R234.1 Severe combined immunodeficiency with PNP deficiency (Single gene sequencing <10 amplicons) rare-and-inherited-disease Immunology Single gene sequencing <10 amplicons
R235.1 SCID with features of gamma chain deficiency (Single gene sequencing <10 amplicons) rare-and-inherited-disease Immunology Single gene sequencing <10 amplicons
R236.1 Pigmentary skin disorders (WES or Large panel) rare-and-inherited-disease Dermatology WES or Large panel
R236.2 Pigmentary skin disorders (MLPA or equivalent) rare-and-inherited-disease Dermatology MLPA or equivalent
R237.1 Cutaneous photosensitivity with a likely genetic cause (Small panel) rare-and-inherited-disease Dermatology Small panel
R239.1 Incontinentia pigmenti (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Dermatology Single gene sequencing >=10 amplicons
R239.2 Incontinentia pigmenti (Targeted variant testing) rare-and-inherited-disease Dermatology Targeted variant testing
R240.1 Diagnostic testing for known variant(s) (Targeted variant testing) rare-and-inherited-disease Core/Specialised Targeted variant testing
R242.1 Predictive testing for known familial variant(s) (Targeted variant testing) rare-and-inherited-disease Core/Specialised Targeted variant testing
R244.1 Carrier testing for known familial variant(s) (Targeted variant testing) rare-and-inherited-disease Core/Specialised Targeted variant testing
R246.1 Carrier testing at population risk for partners of known carriers of nationally agreed autosomal recessive disorders (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Core/Specialised Single gene sequencing >=10 amplicons
R249.1 NIPD using paternal exclusion testing for very rare conditions where familial variant is known (NIPD) rare-and-inherited-disease Prenatal NIPD
R250.1 NIPD for congenital adrenal hyperplasia - CYP21A2 haplotype testing (NIPD) rare-and-inherited-disease Prenatal NIPD
R251.1 Non-invasive prenatal sexing (NIPD) rare-and-inherited-disease Prenatal NIPD
R252.1 SMA carrier testing at population risk for partners of known carriers (MLPA or equivalent) rare-and-inherited-disease Core MLPA or equivalent
R253.1 Cystic fibrosis newborn screening follow-up (Targeted variant testing) rare-and-inherited-disease Screening Targeted variant testing
R254.1 Familial melanoma (Small panel) rare-and-inherited-disease Inherited cancer Small panel
R255.1 Epidermodysplasia verruciformis (Small panel) rare-and-inherited-disease Dermatology Small panel
R256.1 Nephrocalcinosis or nephrolithiasis (WES or Medium Panel) rare-and-inherited-disease Renal WES or Medium Panel
R257.2 Unexplained young onset end-stage renal disease (WGS) rare-and-inherited-disease Renal WGS
R257.3 Unexplained young onset end-stage renal disease (WES) rare-and-inherited-disease Renal WES
R258.1 Cytopenia - Fanconi breakage testing indicated (DNA repair defect testing) rare-and-inherited-disease Haematology DNA repair defect testing
R258.2 Cytopenia - Fanconi breakage testing indicated (Small Panel) rare-and-inherited-disease Haematology Small Panel
R259.1 Nijmegen breakage syndrome (DNA repair defect testing) rare-and-inherited-disease Haematology DNA repair defect testing
R259.2 Nijmegen breakage syndrome (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Haematology Single gene sequencing >=10 amplicons
R260.1 Fanconi anaemia or Bloom syndrome - chromosome breakage testing (DNA repair defect testing) rare-and-inherited-disease Haematology DNA repair defect testing
R262.1 Corneal dystrophy (WES or Medium panel) rare-and-inherited-disease Ophthalmology WES or Medium panel
R263.1 Confirmation of uniparental disomy (UPD testing) rare-and-inherited-disease Core/Specialised UPD testing
R264.1 Identity testing (Identity testing) rare-and-inherited-disease Core Identity testing
R265.1 Chromosomal mosaicism - karyotype (Karyotype) rare-and-inherited-disease Core Karyotype
R268.1 Kagami-Ogata syndrome - paternal uniparental disomy 14 (Methylation testing) rare-and-inherited-disease Endocrinology Methylation testing
R270.1 Smith-Lemli-Opitz syndrome (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R270.2 Smith-Lemli-Opitz syndrome (MLPA or equivalent) rare-and-inherited-disease Metabolic MLPA or equivalent
R271.1 Neuronal ceroid lipofuscinosis type 2 (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R272.1 Gaucher disease (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R273.1 Glycogen storage disease V (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R274.1 Glycogen storage disease (WES or Medium Panel) rare-and-inherited-disease Metabolic WES or Medium Panel
R275.1 Glutaric acidaemia I newborn screening follow up (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Screening Single gene sequencing >=10 amplicons
R276.1 Lysosomal storage disorder (WES or Medium Panel) rare-and-inherited-disease Metabolic WES or Medium Panel
R277.1 Mucopolysaccharidosis type IH/S (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R278.1 Mucopolysaccharidosis type II (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R278.2 Mucopolysaccharidosis type II (Targeted variant testing) rare-and-inherited-disease Metabolic Targeted variant testing
R279.1 Isovaleric acidaemia newborn screening follow up (Targeted variant testing) rare-and-inherited-disease Screening Targeted variant testing
R280.1 Krabbe disease – GALC deficiency (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R280.2 Krabbe disease – GALC deficiency (MLPA or equivalent) rare-and-inherited-disease Metabolic MLPA or equivalent
R281.1 Krabbe disease - Saposin A deficiency (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R282.1 Niemann-Pick disease type A or B (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R283.1 Phenylketonuria (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R285.1 Sandhoff disease (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R286.1 Tay-Sachs disease (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R287.1 Mucopolysaccharidosis type IVA (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R288.1 GM1 Gangliosidosis and Mucopolysaccharidosis Type IVB (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R289.1 Mucolipidosis II and III Alpha/Beta (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R290.1 Mucopolysaccharidosis type VI (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R291.1 Mucopolysaccharidosis type IIIA (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R292.1 Mucopolysaccharidosis type IIIB (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R293.1 Albright hereditary osteodystrophy, pseudohypoparathyroidism, pseudopseudohypoparathyroidism, acrodysostosis and osteoma cutis (Small panel) rare-and-inherited-disease Endocrinology Small panel
R293.2 Albright hereditary osteodystrophy, pseudohypoparathyroidism, pseudopseudohypoparathyroidism, acrodysostosis and osteoma cutis (Methylation testing) rare-and-inherited-disease Endocrinology Methylation testing
R294.1 Ataxia telangiectasia - DNA repair testing (DNA repair defect testing) rare-and-inherited-disease Neurology DNA repair defect testing
R295.1 Ataxia telangiectasia - variant testing (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Neurology Single gene sequencing >=10 amplicons
R296.1 RNA analysis of variants (Other) rare-and-inherited-disease Core/Specialised Other
R298.1 Possible structural or mosaic chromosomal abnormality - FISH (FISH) rare-and-inherited-disease Core FISH
R299.1 Possible mitochondrial disorder - mitochondrial DNA rearrangement testing (Other) rare-and-inherited-disease Mitochondrial Other
R299.2 Possible mitochondrial disorder - mitochondrial DNA rearrangement testing (Other) rare-and-inherited-disease Mitochondrial Other
R299.3 Possible mitochondrial disorder - mitochondrial DNA rearrangement testing (Other) rare-and-inherited-disease Mitochondrial Other
R300.1 Possible mitochondrial disorder - whole mitochondrial genome sequencing (Other) rare-and-inherited-disease Mitochondrial Other
R301.1 Possible mitochondrial disorder - mitochondrial DNA depletion testing (Other) rare-and-inherited-disease Mitochondrial Other
R304.1 NIPD for cystic fibrosis - haplotype testing (NIPD) rare-and-inherited-disease Prenatal NIPD
R305.1 NIPD for cystic fibrosis - variant testing (NIPD) rare-and-inherited-disease Prenatal NIPD
R306.1 NIPD for Apert syndrome - variant testing (NIPD) rare-and-inherited-disease Prenatal NIPD
R307.1 NIPD for Crouzon syndrome with acanthosis nigricans - variant testing (NIPD) rare-and-inherited-disease Prenatal NIPD
R308.1 NIPD for FGFR2-related craniosynostosis syndromes - variant testing (NIPD) rare-and-inherited-disease Prenatal NIPD
R309.1 NIPD for FGFR3-related skeletal dysplasias - variant testing (NIPD) rare-and-inherited-disease Prenatal NIPD
R310.1 NIPD for Duchenne and Becker muscular dystrophy - haplotype testing (NIPD) rare-and-inherited-disease Prenatal NIPD
R311.1 NIPD for spinal muscular atrophy - variant testing (NIPD) rare-and-inherited-disease Prenatal NIPD
R312.1 Parental sequencing for lethal autosomal recessive disorders (WES or Large panel) rare-and-inherited-disease Other WES or Large panel
R313.1 Neutropaenia consistent with ELANE variants (Single gene sequencing <10 amplicons) rare-and-inherited-disease Haematology Single gene sequencing <10 amplicons
R314.1 Ambiguous genitalia (Common aneuploidy testing) rare-and-inherited-disease Core Common aneuploidy testing
R314.2 Ambiguous genitalia (Karyotype) rare-and-inherited-disease Core Karyotype
R315.1 POLG-related disorder (Targeted variant testing) rare-and-inherited-disease Mitochondrial Targeted variant testing
R315.2 POLG-related disorder (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Mitochondrial Single gene sequencing >=10 amplicons
R316.1 Pyruvate dehydrogenase (PDH) deficiency (WES or Medium panel) rare-and-inherited-disease Mitochondrial WES or Medium panel
R317.1 Mitochondrial liver disease, including transient infantile liver failure (Small panel) rare-and-inherited-disease Mitochondrial Small panel
R318.1 Recurrent miscarriage with products of conception available for testing (Common aneuploidy testing) rare-and-inherited-disease Core Common aneuploidy testing
R318.2 Recurrent miscarriage with products of conception available for testing (Microarray) rare-and-inherited-disease Core Microarray
R319.1 Calcium-sensing receptor phenotypes (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Endocrinology Single gene sequencing >=10 amplicons
R320.1 Invasive prenatal diagnosis requiring fetal sexing (Common aneuploidy testing) rare-and-inherited-disease Core Common aneuploidy testing
R321.1 Maternal cell contamination testing (Identity testing) rare-and-inherited-disease Core/Specialised Identity testing
R322.1 Skin fibroblasts to be cultured and stored (Other) rare-and-inherited-disease Core Other
R323.1 Sitosterolaemia (Small panel) rare-and-inherited-disease Metabolic Small panel
R324.1 Familial Chylomicronaemia Syndrome (FCS) (Small panel) rare-and-inherited-disease Metabolic Small panel
R325.1 Lysosomal acid lipase deficiency (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R326.1 Vascular skin disorders (WES or Medium panel) rare-and-inherited-disease Dermatology WES or Medium panel
R327.1 Mosaic skin disorders - deep sequencing (Medium panel) rare-and-inherited-disease Dermatology Medium panel
R328.1 Progressive cardiac conduction disease (WES or Small Panel) rare-and-inherited-disease Cardiology WES or Small Panel
R329.1 Familial dysalbuminaemic hyperthyroxinaemia (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Endocrinology Single gene sequencing >=10 amplicons
R330.1 Alveolar capillary dysplasia with misalignment of pulmonary veins (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Respiratory Single gene sequencing >=10 amplicons
R331.1 Intestinal failure or congenital diarrhoea (WES or Small Panel) rare-and-inherited-disease Gastrohepatology WES or Small Panel
R332.1 Rare genetic inflammatory skin disorders (WES or Medium panel) rare-and-inherited-disease Dermatology WES or Medium panel
R333.1 Central congenital hypoventilation (STR testing) rare-and-inherited-disease Respiratory STR testing
R333.2 Central congenital hypoventilation (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Respiratory Single gene sequencing >=10 amplicons
R334.1 Cystinosis (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R335.1 Fabry disease (Single gene sequencing <10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing <10 amplicons
R335.2 Fabry disease (MLPA or equivalent) rare-and-inherited-disease Metabolic MLPA or equivalent
R336.1 Cerebral vascular malformations (WES or Medium Panel) rare-and-inherited-disease Neurology WES or Medium Panel
R337.1 CADASIL (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Neurology Single gene sequencing >=10 amplicons
R338.1 Monitoring for G(M)CSF escape variants (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Haematology Single gene sequencing >=10 amplicons
R340.1 Amelogenesis imperfecta (WES or Medium panel) rare-and-inherited-disease Musculoskeletal WES or Medium panel
R341.1 Hereditary angioedema types I and II (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Immunology Single gene sequencing >=10 amplicons
R343.1 Chromosomal mosaicism - microarray (Microarray) rare-and-inherited-disease Core Microarray
R344.1 Primary hyperaldosteronism - KCNJ5 (Single gene sequencing <10 amplicons) rare-and-inherited-disease Endocrinology Single gene sequencing <10 amplicons
R345.1 Facioscapulohumeral muscular dystrophy - extended testing (Methylation testing) rare-and-inherited-disease Neurology Methylation testing
R345.2 Facioscapulohumeral muscular dystrophy - extended testing (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Neurology Single gene sequencing >=10 amplicons
R345.3 Facioscapulohumeral muscular dystrophy - extended testing (Other) rare-and-inherited-disease Neurology Other
R346.1 DNA to be stored (Other) rare-and-inherited-disease Core Other
R347.1 Inherited predisposition to acute myeloid leukaemia (AML) (Small panel) rare-and-inherited-disease Haematology Small panel
R350.1 MERRF syndrome (Targeted variant testing) rare-and-inherited-disease Mitochondrial Targeted variant testing
R351.1 NARP syndrome or maternally inherited Leigh syndrome (Single gene sequencing <10 amplicons) rare-and-inherited-disease Mitochondrial Single gene sequencing <10 amplicons
R351.2 NARP syndrome or maternally inherited Leigh syndrome (Targeted variant testing) rare-and-inherited-disease Mitochondrial Targeted variant testing
R352.1 Mitochondrial DNA maintenance disorder (WES or Medium Panel) rare-and-inherited-disease Mitochondrial WES or Medium Panel
R353.1 Mitochondrial disorder with complex I deficiency (WES or Medium Panel) rare-and-inherited-disease Mitochondrial WES or Medium Panel
R354.1 Mitochondrial disorder with complex II deficiency (WES or Small Panel) rare-and-inherited-disease Mitochondrial WES or Small Panel
R355.1 Mitochondrial disorder with complex III deficiency (WES or Small Panel) rare-and-inherited-disease Mitochondrial WES or Small Panel
R356.1 Mitochondrial disorder with complex IV deficiency (WES or Medium Panel) rare-and-inherited-disease Mitochondrial WES or Medium Panel
R357.1 Mitochondrial disorder with complex V deficiency (WES or Small Panel) rare-and-inherited-disease Mitochondrial WES or Small Panel
R361.1 Sickle cell, thalassaemia and other haemoglobinopathies trait or carrier testing (Small panel) rare-and-inherited-disease Haematology Small panel
R361.2 Sickle cell, thalassaemia and other haemoglobinopathies trait or carrier testing (MLPA or equivalent) rare-and-inherited-disease Haematology MLPA or equivalent
R363.1 Inherited predisposition to GIST (Small panel) rare-and-inherited-disease Inherited cancer Small panel
R364.1 DICER1-related cancer predisposition (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Inherited cancer Single gene sequencing >=10 amplicons
R365.1 Fumarate hydratase-related tumour syndromes (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Inherited cancer Single gene sequencing >=10 amplicons
R366.1 Inherited susceptibility to acute lymphoblastoid leukaemia (ALL) (Small panel) rare-and-inherited-disease Haematology Small panel
R367.1 Inherited pancreatic cancer (Small panel) rare-and-inherited-disease Inherited cancer Small panel
R368.1 Hereditary angioedema type III (Targeted variant testing) rare-and-inherited-disease Immunology Targeted variant testing
R370.1 Validation of unaccredited findings (Targeted variant testing) rare-and-inherited-disease Core/Specialised Targeted variant testing
R371.1 Malignant hyperthermia (small panel) rare-and-inherited-disease Neurology small panel
R372.1 Newborn screening for sickle cell disease in a transfused baby (Targeted variant testing) rare-and-inherited-disease Screening Targeted variant testing
R373.1 RNA to be stored (Other) rare-and-inherited-disease Core Other
R374.1 Other sample to be stored (Other) rare-and-inherited-disease Core Other
R375.1 Family follow-up testing to aid variant interpretation (Targeted variant testing) rare-and-inherited-disease Core/Specialised Targeted variant testing
R376.1 Segmental or atypical neurofibromatosis type 1 testing (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Neurology Single gene sequencing >=10 amplicons
R376.2 Segmental or atypical neurofibromatosis type 1 testing (MLPA or equivalent) rare-and-inherited-disease Neurology MLPA or equivalent
R380.1 Niemann Pick disease type C (Small panel) rare-and-inherited-disease Metabolic Small panel
R380.2 Niemann Pick disease type C (MLPA or equivalent) rare-and-inherited-disease Metabolic MLPA or equivalent
R381.2 Other rare neuromuscular disorders (WGS) rare-and-inherited-disease Neurology WGS
R382.1 Hypochondroplasia (Targeted variant testing) rare-and-inherited-disease Core Targeted variant testing
R383.1 Linkage testing for Huntington disease (Other) rare-and-inherited-disease Neurology Other
R384.1 Generalised arterial calcification in infancy (Small panel) rare-and-inherited-disease Cardiology Small panel
R387.1 Reanalysis of existing data (Other) rare-and-inherited-disease Core/Specialised Other
R389.1 NIPD - pre-pregnancy test work-up (NIPD) rare-and-inherited-disease Prenatal NIPD
R390.1 Multiple exostoses (Small panel) rare-and-inherited-disease Musculoskeletal Small panel
R390.2 Multiple exostoses (MLPA or equivalent) rare-and-inherited-disease Musculoskeletal MLPA or equivalent
R391.1 Barth syndrome (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Cardiology Single gene sequencing >=10 amplicons
R394.1 Mitochondrial neurogastrointestinal encephalopathy (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Mitochondrial Single gene sequencing >=10 amplicons
R395.1 Thiamine metabolism dysfunction syndrome 2 (Single gene sequencing <10 amplicons) rare-and-inherited-disease Mitochondrial Single gene sequencing <10 amplicons
R396.1 Mitochondrial Complex V deficiency, TMEM70 type (Single gene sequencing <10 amplicons) rare-and-inherited-disease Mitochondrial Single gene sequencing <10 amplicons
R397.1 Maternally inherited cardiomyopathy (Targeted variant testing) rare-and-inherited-disease Mitochondrial Targeted variant testing
R401.1 Common aneuploidy testing - prenatal (Common aneuploidy testing) rare-and-inherited-disease Core Common aneuploidy testing
R402.1 Premature ovarian insufficiency (Karyotype or equivalent) rare-and-inherited-disease Core Karyotype or equivalent
R402.2 Premature ovarian insufficiency (STR testing) rare-and-inherited-disease Core STR testing
R403.1 MCADD - Medium-chain acyl-CoA dehydrogenase deficiency – full ACADM sequencing newborn screening follow up (Single gene sequencing <10 amplicons) rare-and-inherited-disease Screening Single gene sequencing <10 amplicons
R404.1 Testing of unaffected individuals for inherited cancer predisposition syndromes (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Inherited cancer Single gene sequencing >=10 amplicons
R404.3 Testing of unaffected individuals for inherited cancer predisposition syndromes (Small panel) rare-and-inherited-disease Inherited cancer Small panel
R405.1 Hereditary Erythrocytosis (Small panel) rare-and-inherited-disease Haematology Small panel
R406.1 Thrombocythaemia (Small panel) rare-and-inherited-disease Haematology Small panel
R409.1 Linkage testing for other recognisable Mendelian disorders (Linkage analysis) rare-and-inherited-disease Core/Specialised Linkage analysis
R410.1 Myotonic dystrophy type 2 (DM2) (STR testing) rare-and-inherited-disease Neurology STR testing
R411.1 Y chromosome microdeletion (Targeted variant testing or equivalent) rare-and-inherited-disease Core Targeted variant testing or equivalent
R412.1 Fetal anomalies with a likely genetic cause - non urgent (WES or Large Panel) rare-and-inherited-disease Prenatal WES or Large Panel
R413.1 Autoinflammatory Disorders (WES or Medium panel) rare-and-inherited-disease Immunology WES or Medium panel
R414.1 APC associated Polyposis (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Core Single gene sequencing >=10 amplicons
R416.1 Syndromic and non syndromic craniosynostosis involving midline sutures (Single gene sequencing <10 amplicons) rare-and-inherited-disease Musculoskeletal Single gene sequencing <10 amplicons
R417.1 Multi Locus Imprinting Disorder (MLID) (MLPA) rare-and-inherited-disease Endocrinology MLPA
R417.2 Multi Locus Imprinting Disorder (MLID) (Small panel) rare-and-inherited-disease Endocrinology Small panel
R419.1 Acute Rhabdomyolysis (Medium panel) rare-and-inherited-disease Neurology Medium panel
R420.1 Pseudoxanthoma elasticum (Small panel) rare-and-inherited-disease Ophthalmology Small panel
R421.1 Pulmonary Fibrosis, Familial (Medium panel) rare-and-inherited-disease Respiratory Medium panel
R422.1 BAP1 associated tumour predisposition syndrome (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Inherited cancer Single gene sequencing >=10 amplicons
R423.1 NIPD for Retinoblastoma - haplotype testing (NIPD) rare-and-inherited-disease Prenatal NIPD
R424.1 Subcutaneous panniculitis T-cell lymphoma (SPTCL) (Single gene sequencing <10 amplicons) rare-and-inherited-disease Dermatology Single gene sequencing <10 amplicons
R426.1 Pulmonary alveolar microlithiasis (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Respiratory Single gene sequencing >=10 amplicons
R428.1 Patient receiving solid organ transplantation (only in cases where passenger lymphocyte syndrome is suspected) (STR testing) rare-and-inherited-disease Core STR testing
R428.2 Patient receiving solid organ transplantation (only in cases where passenger lymphocyte syndrome is suspected) (FISH) rare-and-inherited-disease Core FISH
R430.1 Inherited prostate cancer (Small panel) rare-and-inherited-disease Core Small panel
R431.1 Genome-wide DNA Methylation Profiling to Aid Variant Interpretation (Methylation testing) rare-and-inherited-disease Multi specialty Methylation testing
R433.1 Monogenic diabetes, subtype glucokinase - NIPT (NIPD) rare-and-inherited-disease Prenatal NIPD
R436.1 Hereditary alpha tryptasaemia (Targeted variant testing) rare-and-inherited-disease Immunology Targeted variant testing
R438.1 Paediatric pseudo-obstruction syndrome (WES or Medium panel) rare-and-inherited-disease Gastrohepatology WES or Medium panel
R440.1 Hereditary isolated diabetes insipidus (Small panel) rare-and-inherited-disease Endocrinology Small panel
R441.1 Unexplained death in infancy and sudden unexplained death in childhood (WGS) rare-and-inherited-disease Multi specialty WGS
R442.1 Variant re-interpretation (Targeted variant testing) rare-and-inherited-disease Core/Specialised Targeted variant testing
R443.1 Confirmation test (Targeted variant testing) rare-and-inherited-disease Core/Specialised Targeted variant testing
R444.1 NICE approved PARP inhibitor treatment (Small panel) rare-and-inherited-disease Core Small panel
R444.2 NICE approved PARP inhibitor treatment (Small panel) rare-and-inherited-disease Core Small panel
R445.1 T21, T18 and T13 aneuploidy testing - NIPT (previous history) (NIPT) rare-and-inherited-disease Prenatal NIPT
R446.1 APOL1 kidney donor testing (Targeted variant testing) rare-and-inherited-disease Renal Targeted variant testing
R447.1 Validation of WGS Diagnostic discovery (Targeted variant testing) rare-and-inherited-disease Core Targeted variant testing
R448.1 Prenatal testing (Targeted variant testing) rare-and-inherited-disease Core Targeted variant testing
R449.1 Diagnostic testing for Glutaric acidaemia I (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R450.1 Diagnostic testing for Isovaleric acidaemia (Single gene sequencing >=10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing >=10 amplicons
R451.1 Diagnostic testing for MCADD - Medium-chain acyl-CoA dehydrogenase deficiency – full ACADM sequencing (Single gene sequencing <10 amplicons) rare-and-inherited-disease Metabolic Single gene sequencing <10 amplicons
R452.1 Silver russell syndrome and Temple Syndrome (Methylation testing) rare-and-inherited-disease Endocrinology Methylation testing
R453.1 Monogenic short stature (WES or Medium panel) rare-and-inherited-disease Endocrinology WES or Medium panel
R454.1 Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy (Targeted variant testing) rare-and-inherited-disease Cardiology Targeted variant testing
R456.1 Embryonal tumour of possible germline origin (WES or Medium Panel) rare-and-inherited-disease Inherited cancer WES or Medium Panel
R456.2 Embryonal tumour of possible germline origin (Methylation testing) rare-and-inherited-disease Inherited cancer Methylation testing
R457.1 Sarcoma of possible germline origin (Small Panel) rare-and-inherited-disease Inherited cancer Small Panel
R458.1 Young onset or familial dementia (WGS) rare-and-inherited-disease Neurology WGS
R459.1 Young onset or complex Parkinson disease (WGS) rare-and-inherited-disease Neurology WGS
R460.1 Amyotrophic lateral sclerosis (WGS) rare-and-inherited-disease Neurology WGS
R461.1 Cerebral amyloid angiopathy (WGS) rare-and-inherited-disease Neurology WGS
R462.1 Childhood interstitial lung disease (Medium Panel) rare-and-inherited-disease Respiratory Medium Panel
R463.1 Cytogenetic characterisation of a genomic abnormality – Karyotype or Targeted Chromosome Analysis (Karyotype) rare-and-inherited-disease Core Karyotype
R464.1 Recurrent miscarriage where products of conception are not available for testing - parental karyotype (Karyotype) rare-and-inherited-disease Core Karyotype
R465.1 Familial cytogenetic rearrangement - Karyotype or Targeted Chromosome Analysis (Karyotype) rare-and-inherited-disease Core Karyotype
R466.1 Unexplained infertility - karyotype (Karyotype) rare-and-inherited-disease Core Karyotype
R467.1 Gamete donors - karyotype (Karyotype) rare-and-inherited-disease Core Karyotype
R468.1 Possible sex chromosome aneuploidy or structural rearrangement – Targeted Chromosome Analysis (Karyotype) rare-and-inherited-disease Core Karyotype
R470.1 T21, T18, and T13 aneuploidy testing - NIPT NHS Fetal Anomaly Screening Programme (FASP) (NIPT) rare-and-inherited-disease Prenatal NIPT
R471.1 Neurodegenerative Disorders, adult onset – Prenatal Exclusion Testing (Linkage analysis) rare-and-inherited-disease Neurology Linkage analysis
R471.2 Neurodegenerative Disorders, adult onset – Prenatal Exclusion Testing (Linkage analysis) rare-and-inherited-disease Neurology Linkage analysis
R471.3 Neurodegenerative Disorders, adult onset – Prenatal Exclusion Testing (Linkage analysis) rare-and-inherited-disease Neurology Linkage analysis
R471.4 Neurodegenerative Disorders, adult onset – Prenatal Exclusion Testing (Linkage analysis) rare-and-inherited-disease Neurology Linkage analysis
M1.1 Colorectal Carcinoma, Multi-target NGS panel - small variant (KRAS, NRAS, BRAF) cancer Panel
M1.2 Colorectal Carcinoma, KRAS hotspot cancer Simple targeted mutation testing
M1.3 Colorectal Carcinoma, NRAS hotspot cancer Simple targeted mutation testing
M1.4 Colorectal Carcinoma, MSI Testing cancer Microsatellite instability
M1.5 Colorectal Carcinoma, MLH1 promoter hypermethylation cancer Targeted mutation testing
M1.6 Colorectal Carcinoma, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M1.7 Colorectal Carcinoma, DPYD hotspot cancer Simple targeted mutation testing
M1.9 Colorectal Carcinoma, Multi-target NGS panel - small variant (MLH1, MSH2, MSH6, PMS2, POLE, POLD1) cancer Panel
M2.1 Ovarian Carcinoma, Multi-target NGS panel - small variant (BRCA1, BRCA2, SMARCA4) cancer Panel
M2.3 Ovarian Carcinoma, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M2.5 Ovarian Carcinoma, HRD status (either positive for BRCA 1 and/or 2, or HRD positive) cancer Panel
M3.5 Breast Cancer, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M3.6 Breast Cancer, Multi-target NGS panel - small variant (PIK3CA, AKT1, PTEN (SNV & CNV)) cancer Panel
M3.7 Breast Cancer, DPYD hotspot cancer Simple targeted mutation testing
M3.9 Breast Cancer, ETV6-NTRK3 FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M3.12 Breast Cancer, Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer cancer Gene expression profilling
M3.13 Breast Cancer, Multi-target ctDNA NGS panel - small variant (ESR1, PIK3CA, AKT1, PTEN (SNV & CNV)) cancer Panel
M4.1 Non-Small Cell Lung Cancer, Multi-target NGS panel - small variant (EGFR, ALK, BRAF, KRAS, MET) cancer Panel
M4.2 Non-Small Cell Lung Cancer, Multi-target NGS panel - structural variant (ROS1, RET, EML4-ALK, NTRK1, NTRK1, NTRK3, MET) cancer Panel
M4.3 Non-Small Cell Lung Cancer, Multi-target NGS panel - copy number variant (MET) cancer Panel
M4.4 Non-Small Cell Lung Cancer, EGFR hotspot tumour cancer Simple targeted mutation testing
M4.5 Non-Small Cell Lung Cancer, EGFR hotspot ctDNA cancer Simple targeted mutation testing
M4.6 Non-Small Cell Lung Cancer, ROS1 rearrangement FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M4.7 Non-Small Cell Lung Cancer, RET rearrangement FISH/RT-PC cancer FISH
M4.8 Non-Small Cell Lung Cancer, MET copy number FISH cancer FISH
M4.10 Non-Small Cell Lung Cancer, EML4-ALK FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M4.11 Non-Small Cell Lung Cancer, ALK hotspot cDNA cancer Simple targeted mutation testing
M4.13 Non-Small Cell Lung Cancer, Combined Multi-target NGS panel - small variant (EGFR, ALK, BRAF, KRAS, MET exon 14 skipping) and structural variant (ROS1, RET, ALK, NTRK1, NTRK2, NTRK3, MET exon 14 skipping) cancer Panel
M4.14 Non-Small Cell Lung Cancer, Multi-target ctDNA combined Multi-target NGS panel - small variant (EGFR, ALK, BRAF, KRAS, MET exon 14 skipping and copy number variations) and structural variant (ROS1, RET, ALK, NTRK1, NTRK2, NTRK3, MET exon 14 skipping) cancer
M5.1 Mesothelioma, CDKN2A copy number FISH cancer FISH
M5.2 Mesothelioma, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M5.3 Mesothelioma, Multi-target NGS panel - copy number variant (CDKN2A) cancer Panel
M6.1 Mucoepidermoid Carcinoma, MAML2 rearrangement FISH cancer FISH
M6.2 Mucoepidermoid Carcinoma, Multi-target NGS panel - structural variant (MAML2, NTRK1, NTRK2, NTRK3) cancer Panel
M6.3 Mucoepidermoid Carcinoma, Multi-target NGS panel - structural variant (MAML2) cancer Panel
M6.5 Mucoepidermoid Carcinoma, DPYD hotspot cancer Simple targeted mutation testing
M7.1 Melanoma - Adult, Multi-target NGS panel - small variant (BRAF, KIT, NRAS) cancer Panel
M7.2 Melanoma - Adult, BRAF hotspot cancer Simple targeted mutation testing
M7.3 Melanoma - Adult, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M7.5 Melanoma - Adult, MYB & 6cen cancer FISH
M7.6 Melanoma - Adult, RREB1 (6p25) cancer FISH
M7.7 Melanoma - Adult, CCND1 (11q13) cancer FISH
M7.8 Melanoma - Adult, MYC & 8cen cancer FISH
M7.9 Melanoma - Adult, CDKN2A & 9cen cancer FISH
M7.10 Melanoma - Adult, Copy number variant detection to genomewide resolution cancer Microarray
M8.1 Gastrointestinal Stromal Tumour, Multi-target NGS panel - small variant (KIT, PDGFRA) cancer Panel
M8.2 Gastrointestinal Stromal Tumour, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M9.1 Thyroid Papillary Carcinoma - Adult, Multi-target NGS panel - small variant (BRAF, KRAS, NRAS, HRAS, TERT promoter) cancer Panel
M9.2 Thyroid Papillary Carcinoma - Adult, Multi-target NGS panel - structural variant (RET, NTRK1, NTRK2, NTRK3) cancer Panel
M9.3 Thyroid Papillary Carcinoma - Adult, RET rearrangement FISH/RT-PC cancer FISH
M9.4 Thyroid Papillary Carcinoma - Adult, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M9.6 Thyroid Papillary Carcinoma - Adult, TERT promoter hotspot cancer Simple targeted mutation testing
M10.1 Thyroid Follicular Carcinoma, Multi-target NGS panel - small variant (KRAS, NRAS, HRAS) cancer Panel
M10.2 Thyroid Follicular Carcinoma, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3, RET) cancer Panel
M11.1 Poorly Differentiated Anaplastic Thyroid Carcinoma, Multi-target NGS panel - small variant (TP53, BRAF) cancer Panel
M11.2 Poorly Differentiated Anaplastic Thyroid Carcinoma, Multi-target NGS panel - copy number variant (TP53) cancer Panel
M11.3 Poorly Differentiated Anaplastic Thyroid Carcinoma, del(17p) TP53 copy number FISH cancer FISH
M11.4 Poorly Differentiated Anaplastic Thyroid Carcinoma, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3, RET, ALK) cancer Panel
M12.1 Thyroid Medullary Carcinoma, Multi-target NGS panel - small variant (RET) cancer Panel
M12.2 Thyroid Medullary Carcinoma, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M13.1 Phaeochromocytoma, Multi-target NGS panel - small variant (RET) cancer Panel
M13.2 Phaeochromocytoma, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M14.1 Adrenal Cortical Carcinoma, Multi-target NGS panel - small variant (TP53) cancer Panel
M14.2 Adrenal Cortical Carcinoma, Multi-target NGS panel - copy number variant (TP53) cancer Panel
M14.3 Adrenal Cortical Carcinoma, del(17p) TP53 copy number FISH cancer FISH
M14.4 Adrenal Cortical Carcinoma, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M14.5 Adrenal Cortical Carcinoma, DPYD hotspot cancer Simple targeted mutation testing
M15.1 Head and Neck Squamous Cell Carcinoma, Multi-target NGS panel - small variant (CDKN2A, EGFR, TP53) cancer Panel
M15.2 Head and Neck Squamous Cell Carcinoma, Multi-target NGS panel - structural variant (RET, NTRK1, NTRK2, NTRK3) cancer Panel
M15.3 Head and Neck Squamous Cell Carcinoma, Multi-target NGS panel - copy number variant (CDKN2A, TP53 cancer Panel
M15.4 Head and Neck Squamous Cell Carcinoma, RET rearrangement FISH/RT-PC cancer FISH
M15.5 Head and Neck Squamous Cell Carcinoma, del(17p) TP53 copy number FISH cancer FISH
M15.6 Head and Neck Squamous Cell Carcinoma, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M15.7 Head and Neck Squamous Cell Carcinoma, DPYD hotspot cancer Simple targeted mutation testing
M16.1 Adenoid Cystic Carcinoma, MYB-NFIB FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M16.2 Adenoid Cystic Carcinoma, Multi-target NGS panel - structural variant (MYB-NFIB, NTRK1, NTRK2, NTRK3) cancer Panel
M16.4 Adenoid Cystic Carcinoma, DPYD hotspot cancer Simple targeted mutation testing
M17.1 Secretory Carcinoma (Salivary Gland), ETV6-NTRK3 FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M17.2 Secretory Carcinoma (Salivary Gland), Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M17.4 Secretory Carcinoma (Salivary Gland), DPYD hotspot cancer Simple targeted mutation testing
M18.1 Renal Cell Carcinoma - Adult, TFE3 rearrangement FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M18.2 Renal Cell Carcinoma - Adult, Multi-target NGS panel small variant (FH, SDHA, SDHB, SDHC, SDHD, VHL, ELOC (TCEB-1), TSC1/2, MET, BRAF) cancer Panel
M18.3 Renal Cell Carcinoma - Adult, Chromosome 3 FISH cancer FISH
M18.4 Renal Cell Carcinoma - Adult, Chromosome 8 FISH cancer FISH
M18.5 Renal Cell Carcinoma - Adult, Chromosome 7 & 17 FISH cancer FISH
M18.6 Renal Cell Carcinoma - Adult, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3, TFE3, TFEB) cancer Panel
M18.7 Renal Cell Carcinoma - Adult, TFEB rearrangement FISH/RT-PCR cancer FISH/RT-PCR
M42.1 Alveolar Rhabdomyosarcoma, FOXO1 rearrangement FISH cancer FISH
M42.2 Alveolar Rhabdomyosarcoma, PAX3-FOXO1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M42.3 Alveolar Rhabdomyosarcoma, PAX7-FOXO1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M42.4 Alveolar Rhabdomyosarcoma, WGS Germline and Tumour cancer WGS
M42.5 Alveolar Rhabdomyosarcoma, Multi-target NGS panel - structural variant (FOXO1, PAX3-FOXO1, PAX7-FOXO1 NTRK1, NTRK2, NTRK3) cancer Panel
M43.1 Alveolar Soft Part Sarcoma, TFE3 rearrangement FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M43.2 Alveolar Soft Part Sarcoma, WGS Germline and Tumour cancer WGS
M43.3 Alveolar Soft Part Sarcoma, Multi-target NGS panel - structural variant (TFE3, NTRK1, NTRK2, NTRK3) cancer Panel
M44.1 Aneurysmal Bone Cyst, USP6 rearrangement FISH cancer FISH
M44.2 Aneurysmal Bone Cyst, Multi-target NGS panel - structural variant (USP6) cancer Panel
M45.1 Angiomatoid Fibrous Histiocytoma, EWSR1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M45.2 Angiomatoid Fibrous Histiocytoma, FUS rearrangement FISH cancer FISH
M45.3 Angiomatoid Fibrous Histiocytoma, WGS Germline and Tumour cancer WGS
M45.4 Angiomatoid Fibrous Histiocytoma, Multi-target NGS panel - structural variant (EWSR1, FUS, NTRK1, NTRK2, NTRK3) cancer Panel
M46.1 Chondrosarcoma Conventional Central, Multi-target NGS panel - small variant (IDH1, IDH2) cancer Panel
M46.2 Chondrosarcoma Conventional Central, WGS Germline and Tumour cancer WGS
M46.3 Chondrosarcoma Conventional Central, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M47.1 Chondroblastoma, SNP Array cancer Karyotype or equivalent
M47.2 Chondroblastoma, WGS Germline and Tumour cancer WGS
M47.3 Chondroblastoma, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M48.1 Clear Cell Sarcoma of Soft Tissue, EWSR1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M48.2 Clear Cell Sarcoma of Soft Tissue, WGS Germline and Tumour cancer WGS
M48.3 Clear Cell Sarcoma of Soft Tissue, Multi-target NGS panel - structural variant (EWSR1, NTRK1, NTRK2, NTRK3) cancer Panel
M49.1 CNS Ewing Sarcoma Family Tumour With CIC Alteration, Multi-target NGS panel - structural variant (CIC, NTRK1, NTRK2, NTRK3) cancer Panel
M49.2 CNS Ewing Sarcoma Family Tumour With CIC Alteration, WGS Germline and Tumour cancer WGS
M50.1 Dermatofibrosarcoma Protuberans, COL1A1-PDGFB rearrangement FISH cancer FISH
M50.2 Dermatofibrosarcoma Protuberans, WGS Germline and Tumour cancer WGS
M50.3 Dermatofibrosarcoma Protuberans, Multi-target NGS panel - structural variant (COL1A1-PDGFB, NTRK1, NTRK2, NTRK3) cancer Panel
M51.1 Desmoid-Type Fibromatosis, Multi-target NGS panel - small variant (APC, CTNNB1) cancer Panel
M52.1 Desmoplastic Small Round Cell Tumour, WT1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M52.2 Desmoplastic Small Round Cell Tumour, WGS Germline and Tumour cancer WGS
M52.3 Desmoplastic Small Round Cell Tumour, Multi-target NGS panel - structural variant (WT1, NTRK1, NTRK2, NTRK3) cancer Panel
M53.1 Endometrial Stromal Sarcoma, EPC1-PHF1 rearrangement FISH cancer FISH
M53.2 Endometrial Stromal Sarcoma, JAZF1-PHF1 rearrangement FISH cancer FISH
M53.3 Endometrial Stromal Sarcoma, JAZF1-SUZ12 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M53.4 Endometrial Stromal Sarcoma, WGS Germline and Tumour cancer WGS
M53.5 Endometrial Stromal Sarcoma, Multi-target NGS panel - structural variant (EPC1-PHF1, JAZF1-PHF1, JAZF1-SUZ12, NTRK1, NTRK2, NTRK3, ZC3H7B-BCOR) cancer Panel
M53.7 Endometrial Stromal Sarcoma, ZC3H7B-BCOR rearrangment FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M54.1 Epithelioid Haemangioendothelioma, WWTR1-CAMTA1 RT-PCR cancer Simple targeted mutation testing
M54.2 Epithelioid Haemangioendothelioma, Multi-target NGS panel - structural variant (WWTR1-CAMTA1) cancer Panel
M55.1 Ewing Like Sarcoma/PNET, Multi-target NGS panel - structural variant (BCOR, BCOR-CCNB3, NTRK1, NTRK2, NTRK3) cancer Panel
M55.2 Ewing Like Sarcoma/PNET, BCOR-CCNB3 RT-PCR cancer Simple targeted mutation testing
M55.3 Ewing Like Sarcoma/PNET, WGS Germline and Tumour cancer WGS
M56.1 Ewing Sarcoma of Bone, EWSR1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M56.2 Ewing Sarcoma of Bone, WGS Germline and Tumour cancer WGS
M56.3 Ewing Sarcoma of Bone, Multi-target NGS panel - structural variant (EWSR1, NTRK1, NTRK2, NTRK3) cancer Panel
M57.1 Ewing-Like Soft-Tissue Sarcoma, Multi-target NGS panel - structural variant (BCOR, BCOR-CCNB3, NTRK1, NTRK2, NTRK3) cancer Panel
M57.2 Ewing-Like Soft-Tissue Sarcoma, BCOR-CCNB3 RT-PCR cancer Simple targeted mutation testing
M57.3 Ewing-Like Soft-Tissue Sarcoma, WGS Germline and Tumour cancer WGS
M58.1 Extraskeletal Myxoid Chondrosarcoma, NR4A3 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M58.2 Extraskeletal Myxoid Chondrosarcoma, WGS Germline and Tumour cancer WGS
M58.3 Extraskeletal Myxoid Chondrosarcoma, Multi-target NGS panel - structural variant (NR4A3, NTRK1, NTRK2, NTRK3) cancer Panel
M59.1 Fibrous Dysplasia/Myxomas (Mazabraud Syndrome), Multi-target NGS panel - small variant (GNAS) cancer Panel
M60.1 Giant Cell Tumour of Bone, H3-3A hotspot cancer Simple targeted mutation testing
M60.2 Giant Cell Tumour of Bone, WGS Germline and Tumour cancer WGS
M60.3 Giant Cell Tumour of Bone, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M61.1 High-Grade Neuroepithelial Tumour-Bcor Group, Multi-target NGS panel - structural variant (BCOR, BCOR-CCNB3, NTRK1, NTRK2, NTRK3) cancer Panel
M61.2 High-Grade Neuroepithelial Tumour-Bcor Group, BCOR-CCNB3 RT-PCR cancer Simple targeted mutation testing
M61.3 High-Grade Neuroepithelial Tumour-Bcor Group, WGS Germline and Tumour cancer WGS
M62.1 Infantile Fibrosarcoma, ETV6-NTRK3 RT-PCR or FISH cancer FISH/Simple targeted mutation testing
M62.2 Infantile Fibrosarcoma, WGS Germline and Tumour cancer WGS
M62.3 Infantile Fibrosarcoma, Multi-target NGS panel - structural variant (ETV6-NTRK3, NTRK1, NTRK2, NTRK3) cancer Panel
M63.1 Inflammatory Myofibroblastic Tumour, TPM4-ALK FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M63.2 Inflammatory Myofibroblastic Tumour, TPM3-ALK FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M63.3 Inflammatory Myofibroblastic Tumour, Multi-target NGS panel - structural variant (ALK, TPM4-ALK, TPM3-ALK, NTRK1, NTRK2, NTRK3) cancer Panel
M63.4 Inflammatory Myofibroblastic Tumour, WGS Germline and Tumour cancer WGS
M64.1 Low Grade Fibromyxoid Sarcoma, FUS rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M64.2 Low Grade Fibromyxoid Sarcoma, WGS Germline and Tumour cancer WGS
M64.3 Low Grade Fibromyxoid Sarcoma, Multi-target NGS panel - structural variant (FUS, NTRK1, NTRK2, NTRK3) cancer Panel
M65.1 Mesenchymal Chondrosarcoma, HEY1-NCOA2 RT-PCR cancer Simple targeted mutation testing
M65.2 Mesenchymal Chondrosarcoma, WGS Germline and Tumour cancer WGS
M65.3 Mesenchymal Chondrosarcoma, Multi-target NGS panel - structural variant (HEY1-NCOA2, NTRK1, NTRK2, NTRK3) cancer Panel
M66.1 Myoepithelial Tumours of Soft Tissue, EWSR1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M66.2 Myoepithelial Tumours of Soft Tissue, WGS Germline and Tumour cancer WGS
M66.3 Myoepithelial Tumours of Soft Tissue, Multi-target NGS panel - structural variant (EWSR1, NTRK1, NTRK2, NTRK3) cancer Panel
M67.1 Myxoid/Round Cell Liposarcoma, DDIT3 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M67.2 Myxoid/Round Cell Liposarcoma, WGS Germline and Tumour cancer WGS
M67.3 Myxoid/Round Cell Liposarcoma, Multi-target NGS panel - structural variant (DDIT3, MDM2, NTRK1, NTRK2, NTRK3) cancer Panel
M67.4 Myxoid/Round Cell Liposarcoma, MDM2 amplification FISH cancer FISH
M68.1 Myxoinflammatory Fibroblastic Sarcoma, TGFBR3-OGA FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M68.2 Myxoinflammatory Fibroblastic Sarcoma, WGS Germline and Tumour cancer WGS
M68.3 Myxoinflammatory Fibroblastic Sarcoma, MDM2 copy number FISH cancer FISH
M68.4 Myxoinflammatory Fibroblastic Sarcoma, Multi-target NGS panel - structural variant (TGFBR3-OGA, NTRK1, NTRK2, NTRK3) cancer Panel
M68.5 Myxoinflammatory Fibroblastic Sarcoma, Multi-target NGS panel - copy number variant (MDM2) cancer Panel
M69.1 Nodular Fasciitis, USP6 rearrangement FISH cancer FISH
M69.2 Nodular Fasciitis, Multi-target NGS panel - structural variant (USP6) cancer Panel
M70.1 Osteosarcoma, MDM2 copy number FISH cancer FISH
M70.2 Osteosarcoma, WGS Germline and Tumour cancer WGS
M70.3 Osteosarcoma, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M70.4 Osteosarcoma, Multi-target NGS panel - copy number variant (MDM2) cancer Panel
M71.1 Phosphaturic Mesenchymal Tumour, FN1 rearrangement FISH cancer FISH
M71.2 Phosphaturic Mesenchymal Tumour, WGS Germline and Tumour cancer WGS
M71.3 Phosphaturic Mesenchymal Tumour, Multi-target NGS panel - structural variant (FN1, NTRK1, NTRK2, NTRK3) cancer Panel
M72.1 Primitive Mesenchymal Myxoid Tumour of Infancy, Multi-target NGS panel - structural variant (BCOR, BCOR-CCNB3, NTRK1, NTRK2, NTRK3) cancer Panel
M72.2 Primitive Mesenchymal Myxoid Tumour of Infancy, BCOR-CCNB3 RT-PCR cancer Simple targeted mutation testing
M72.3 Primitive Mesenchymal Myxoid Tumour of Infancy, WGS Germline and Tumour cancer WGS
M73.1 Pseudomyogenic Haemangioendothelioma, SERPINE1-FOSB FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M73.2 Pseudomyogenic Haemangioendothelioma, WGS Germline and Tumour cancer WGS
M73.3 Pseudomyogenic Haemangioendothelioma, Multi-target NGS panel - structural variant (SERPINE1-FOSB, NTRK1, NTRK2, NTRK3) cancer Panel
M74.1 Radiation Induced Angiosarcoma, MYC copy number FISH cancer FISH
M74.2 Radiation Induced Angiosarcoma, WGS Germline and Tumour cancer WGS
M74.3 Radiation Induced Angiosarcoma, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M74.4 Radiation Induced Angiosarcoma, Multi-target NGS panel - copy number variant (MYC) cancer Panel
M75.1 Round Cell Sarcoma Nos, Multi-target NGS panel - structural variant (BCOR, CIC, BCOR-CCNB3, NTRK1, NTRK2, NTRK3) cancer Panel
M75.2 Round Cell Sarcoma Nos, BCOR-CCNB3 RT-PCR cancer Simple targeted mutation testing
M75.3 Round Cell Sarcoma Nos, WGS Germline and Tumour cancer WGS
M76.1 Sclerosing Epithelioid Fibrosarcoma, FUS rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M76.2 Sclerosing Epithelioid Fibrosarcoma, WGS Germline and Tumour cancer WGS
M76.3 Sclerosing Epithelioid Fibrosarcoma, Multi-target NGS panel - structural variant (FUS, NTRK1, NTRK2, NTRK3) cancer Panel
M77.1 Synovial Sarcoma, SS18 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M77.2 Synovial Sarcoma, WGS Germline and Tumour cancer WGS
M77.3 Synovial Sarcoma, Multi-target NGS panel - structural variant (SS18, NTRK1, NTRK2, NTRK3) cancer Panel
M78.1 Undifferentiated Round Cell Sarcoma of Infancy, Multi-target NGS panel - structural variant (CIC, NTRK1, NTRK2, NTRK3) cancer Panel
M78.2 Undifferentiated Round Cell Sarcoma of Infancy, WGS Germline and Tumour cancer WGS
M79.1 Well Differentiated/Dedifferentiated Liposarcoma, MDM2 amplification FISH cancer FISH
M79.2 Well Differentiated/Dedifferentiated Liposarcoma, WGS Germline and Tumour cancer WGS
M79.3 Well Differentiated/Dedifferentiated Liposarcoma, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M79.4 Well Differentiated/Dedifferentiated Liposarcoma, Multi-target NGS panel - copy number variant (MDM2, DDIT3) cancer Panel
M79.6 Well Differentiated/Dedifferentiated Liposarcoma, DDIT3 copy number FISH cancer FISH
M79.7 Well Differentiated/Dedifferentiated Liposarcoma, DDIT3 copy number RT-PCR/ddPCR cancer RT-PCR/ddPCR
M119.1 Paediatric Tumours, WGS Germline and Tumour cancer WGS
M119.2 Paediatric Tumours, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M119.4 Paediatric Tumours, DPYD hotspot cancer Simple targeted mutation testing
M119.5 Paediatric Tumours, Multi-target NGS-small variant (ABL1, ACVR1, AKT1, ALK, AMER1, APC, ARID1A, ARID1B, ASXL1, ATM, ATR, ATRX, BARD1, BBC3, BCOR, BRAF, BRCA1, BRCA2, BRIP1, CCND1, CCND2, CCNE1, CDK12, CDK4, CDK6, CDKN1A, CDKN2A, CDKN2B, CHEK1, CHEK2, CIC, CREBBP, CTNNB1, DAXX, DDX3X, DICER1, DROSHA, EGFR, EMSY, EPHB2, ERBB2, EZH2, FANCI, FANCL, FBXW7, FGFR1, FGFR2, FGFR3, FGFR4, GPR161, H3F3A, HIST1H3B, HIST1H3C, HIST2H3C, HRAS, IDH1, IDH2, IGF1R, KIAA1549 (CNV), KIT, KMT2A, KRAS, LIN28B, MAP2K1, MAP2K2, MAPK1, MDM2, MDM4, MET, MLH1, MRE11A, MSH2, MSH6, MYC, MYCL, MYCN, MYOD1, NF1, NF2, NRAS, PALB2, PDGFRA, PHOX2B, PIK3CA, PIK3R1, PIN1, PMS1, PMS2, PPM1D, PPP2R2A, PRKAR1A, PTCH1, PTCH2, PTEN, PTPN11, RAD51B, RAD51C, RAD51D, RAD54L, RAF1, RB1, RET, SETD2, SMARCA4, SMARCB1, SMARCE1, SMO, SUFU, TERT, TFE3, TP53, TSC1, TSC2, VHL, WT1, YAP1, YWHAE (CNV)) cancer
M124.1 Clear Cell Kidney Sarcoma - Paediatric, Multi-target NGS panel - small variant (BCOR) cancer Panel
M124.2 Clear Cell Kidney Sarcoma - Paediatric, BCOR seq cancer Single gene sequencing
M124.3 Clear Cell Kidney Sarcoma - Paediatric, BCOR copy number FISH cancer FISH
M124.4 Clear Cell Kidney Sarcoma - Paediatric, BCOR rearrangement FISH cancer FISH
M124.5 Clear Cell Kidney Sarcoma - Paediatric, NUTM2B-YWHAE FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M124.6 Clear Cell Kidney Sarcoma - Paediatric, NUTM2E-YWHAE FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M124.7 Clear Cell Kidney Sarcoma - Paediatric, NUTM1-YWHAE FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M124.8 Clear Cell Kidney Sarcoma - Paediatric, YWHAE copy number FISH cancer FISH
M124.9 Clear Cell Kidney Sarcoma - Paediatric, WGS Germline and Tumour cancer WGS
M124.10 Clear Cell Kidney Sarcoma - Paediatric, Multi-target NGS panel - structural variant (BCOR, NUTM2B-YWHAE, NUTM2E-YWHAE, NUTM1-YWHAE, NTRK1, NTRK2, NTRK3) cancer Panel
M124.11 Clear Cell Kidney Sarcoma - Paediatric, Multi-target NGS panel - copy number variant (BCOR, YWHAE) cancer Panel
M127.1 Congenital Mesoblastic Nephroma - Paediatric, NTRK3-ETV6 FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M127.3 Congenital Mesoblastic Nephroma - Paediatric, WGS Germline and Tumour cancer WGS
M127.4 Congenital Mesoblastic Nephroma - Paediatric, Multi-target NGS panel - structural variant (NTRK3-ETV6, NTRK1, NTRK2, NTRK3) cancer Panel
M131.1 Cystic Nephroma - Paediatric, Multi-target NGS panel - small variant (DICER1) cancer Panel
M131.2 Cystic Nephroma - Paediatric, DICER1 seq cancer Single gene sequencing
M131.3 Cystic Nephroma - Paediatric, DICER1 copy number FISH cancer FISH
M131.4 Cystic Nephroma - Paediatric, WGS Germline and Tumour cancer WGS
M131.5 Cystic Nephroma - Paediatric, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M131.6 Cystic Nephroma - Paediatric, Multi-target NGS panel - copy number variant (DICER1) cancer Panel
M143.1 Lung - Paediatric, Multi-target NGS panel - small variant (H3-3A, H3-3B) cancer Panel
M143.2 Lung - Paediatric, H3-3A seq cancer Single gene sequencing
M143.3 Lung - Paediatric, H3-3B seq cancer Single gene sequencing
M143.4 Lung - Paediatric, WGS Germline and Tumour cancer WGS
M143.5 Lung - Paediatric, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M149.1 Melanotic Tumours - Paediatric, Multi-target NGS panel - small variant (NRAS) cancer Panel
M149.2 Melanotic Tumours - Paediatric, WGS Germline and Tumour cancer WGS
M149.3 Melanotic Tumours - Paediatric, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M151.1 Midline Carcinoma - Paediatric, NUTM1-BRD2 FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M151.2 Midline Carcinoma - Paediatric, NUTM1-BRD3 FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M151.3 Midline Carcinoma - Paediatric, NUTM1-BRD4 FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M151.4 Midline Carcinoma - Paediatric, NUTM1-CIC FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M151.5 Midline Carcinoma - Paediatric, WGS Germline and Tumour cancer WGS
M151.6 Midline Carcinoma - Paediatric, Multi-target NGS panel - structural variant (NUTM1-BRD2, NUTM1-BRD3, NUTM1-BRD4, NUTM1-CIC, NTRK1, NTRK2, NTRK3) cancer Panel
M152.1 Neuroblastoma - Paediatric, SNP Array cancer Karyotype or equivalent
M152.2 Neuroblastoma - Paediatric, Multi-target NGS panel - small variant (ALK, ATRX, FGFR1, MYCN, NRAS, PHOX2B, TP53) cancer Panel
M152.3 Neuroblastoma - Paediatric, ALK seq cancer Single gene sequencing
M152.4 Neuroblastoma - Paediatric, FGFR1 seq cancer Single gene sequencing
M152.5 Neuroblastoma - Paediatric, PHOX2B seq cancer Single gene sequencing
M152.6 Neuroblastoma - Paediatric, TP53 seq cancer Single gene sequencing
M152.7 Neuroblastoma - Paediatric, MYCN copy number FISH cancer FISH
M152.8 Neuroblastoma - Paediatric, ALK copy number FISH cancer FISH
M152.9 Neuroblastoma - Paediatric, 17q copy number FISH cancer FISH
M152.10 Neuroblastoma - Paediatric, 17q rearrangement FISH cancer FISH
M152.11 Neuroblastoma - Paediatric, 11q copy number FISH cancer FISH
M152.12 Neuroblastoma - Paediatric, 1p36 copy number FISH cancer FISH
M152.13 Neuroblastoma - Paediatric, ALK rearrangement FISH cancer FISH
M152.14 Neuroblastoma - Paediatric, WGS Germline and Tumour cancer WGS
M152.15 Neuroblastoma - Paediatric, MYCN seq cancer Single gene sequencing
M152.16 Neuroblastoma - Paediatric, Multi-target NGS panel - structural variant (17q, ALK, NTRK1, NTRK2, NTRK3) cancer Panel
M152.17 Neuroblastoma - Paediatric, Multi-target NGS panel - copy number variant (MYCN, ALK, 17q, 11q, 1p36) cancer Panel
M152.18 Neuroblastoma - Paediatric, DNA Methylation cancer Methylation array (whole genome)
M152.19 Neuroblastoma - Paediatric, TERT promoter rearrangement FISH cancer FISH
M157.1 Thyroid Papillary Carcinoma - Paediatric, Multi-target NGS panel - small variant (RET) cancer Panel
M157.2 Thyroid Papillary Carcinoma - Paediatric, RET seq cancer Single gene sequencing
M157.3 Thyroid Papillary Carcinoma - Paediatric, Multi-target NGS panel - structural variant (RET, NTRK1, NTRK2, NTRK3) cancer Panel
M157.4 Thyroid Papillary Carcinoma - Paediatric, RET rearrangement FISH/RT-PC cancer FISH/Simple targeted mutation testing
M157.5 Thyroid Papillary Carcinoma - Paediatric, WGS Germline and Tumour cancer WGS
M161.1 Pleuropulmonary Blastoma - Paediatric, Multi-target NGS panel - small variant (DICER1) cancer Panel
M161.2 Pleuropulmonary Blastoma - Paediatric, DICER1 seq cancer Single gene sequencing
M161.3 Pleuropulmonary Blastoma - Paediatric, DICER1 copy number FISH cancer FISH
M161.4 Pleuropulmonary Blastoma - Paediatric, WGS Germline and Tumour cancer WGS
M161.5 Pleuropulmonary Blastoma - Paediatric, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M161.6 Pleuropulmonary Blastoma - Paediatric, Multi-target NGS panel - copy number variant (DICER1) cancer Panel
M165.1 Renal Tumours - Paediatric, Multi-target NGS panel - small variant (CTNNB1, DAXX, ATRX) cancer Panel
M165.2 Renal Tumours - Paediatric, ATRX seq cancer Single gene sequencing
M165.3 Renal Tumours - Paediatric, CTNNB1 seq cancer Single gene sequencing
M165.4 Renal Tumours - Paediatric, DAXX seq cancer Single gene sequencing
M165.5 Renal Tumours - Paediatric, ATRX copy number FISH cancer FISH
M165.6 Renal Tumours - Paediatric, WGS Germline and Tumour cancer WGS
M165.7 Renal Tumours - Paediatric, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M165.8 Renal Tumours - Paediatric, Multi-target NGS panel - copy number variant (ATRX) cancer Panel
M166.1 Retinoblastoma - Paediatric, Multi-target NGS panel - small variant (RB1) cancer Panel
M166.2 Retinoblastoma - Paediatric, WGS Germline and Tumour cancer WGS
M166.3 Retinoblastoma - Paediatric, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M166.4 Retinoblastoma - Paediatric, DNA Methylation cancer Methylation array (whole genome)
M167.1 Rhabdoid Tumours - Paediatric, Multi-target NGS panel - small variant (SMARCB1) cancer Panel
M167.2 Rhabdoid Tumours - Paediatric, SMARCB1 seq cancer Single gene sequencing
M167.3 Rhabdoid Tumours - Paediatric, SMARCB1 copy number FISH cancer FISH
M167.4 Rhabdoid Tumours - Paediatric, WGS Germline and Tumour cancer WGS
M167.5 Rhabdoid Tumours - Paediatric, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M167.6 Rhabdoid Tumours - Paediatric, Multi-target NGS panel - copy number variant (SMARCB1) cancer Panel
M173.1 t(6;11) Translocation-Associated Renal Cell Carcinoma - Paediatric, TFEB-MALAT1 FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M173.2 t(6;11) Translocation-Associated Renal Cell Carcinoma - Paediatric, WGS Germline and Tumour cancer WGS
M173.3 t(6;11) Translocation-Associated Renal Cell Carcinoma - Paediatric, Multi-target NGS panel - structural variant (TFEB-MALAT1, NTRK1, NTRK2, NTRK3) cancer Panel
M174.1 Testicular - Paediatric, Multi-target NGS panel - small variant (PRKAR1A) cancer Panel
M174.2 Testicular - Paediatric, PRKAR1A seq cancer Single gene sequencing
M174.3 Testicular - Paediatric, WGS Germline and Tumour cancer WGS
M174.4 Testicular - Paediatric, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M178.1 Wilms Tumours - Paediatric, Multi-target NGS panel - small variant (DROSHA) cancer Panel
M178.2 Wilms Tumours - Paediatric, DROSHA seq cancer Single gene sequencing
M178.3 Wilms Tumours - Paediatric, WGS Germline and Tumour cancer WGS
M178.4 Wilms Tumours - Paediatric, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M180.1 Xp11.2 Translocation-Associated Renal Cell Carcinoma - Paediatric, Multi-target NGS panel - small variant (TFE3) cancer Panel
M180.2 Xp11.2 Translocation-Associated Renal Cell Carcinoma - Paediatric, TFE3 seq cancer Single gene sequencing
M180.3 Xp11.2 Translocation-Associated Renal Cell Carcinoma - Paediatric, TFE3-ASPSCR1 FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M180.4 Xp11.2 Translocation-Associated Renal Cell Carcinoma - Paediatric, TFE3-MITF FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M180.5 Xp11.2 Translocation-Associated Renal Cell Carcinoma - Paediatric, TFE3-PRCC FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M180.6 Xp11.2 Translocation-Associated Renal Cell Carcinoma - Paediatric, WGS Germline and Tumour cancer WGS
M180.7 Xp11.2 Translocation-Associated Renal Cell Carcinoma - Paediatric, Multi-target NGS panel - structural variant (TFE3-ASPSCR1, TFE3-MITF, TFE3-PRCC, NTRK1, NTRK2, NTRK3) cancer Panel
M187.1 Uveal melanoma, 1p, 3, 6, 8 MLPA cancer MLPA or equivalent
M187.2 Uveal melanoma, BRAF hotspot cancer Simple targeted mutation testing
M187.3 Uveal melanoma, Multi-target NGS panel - small variant (BRAF, NRAS, NF1) cancer Panel
M187.4 Uveal melanoma, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M196.1 Bone Forming Soft Tissue Tumour Differential, MDM2 copy number FISH cancer FISH
M196.2 Bone Forming Soft Tissue Tumour Differential, USP6 rearrangement FISH cancer FISH
M196.3 Bone Forming Soft Tissue Tumour Differential, WGS Germline and Tumour cancer WGS
M196.4 Bone Forming Soft Tissue Tumour Differential, Multi-target NGS panel - structural variant (USP6, NTRK1, NTRK2, NTRK3) cancer Panel
M196.5 Bone Forming Soft Tissue Tumour Differential, Multi-target NGS panel - copy number variant (MDM2) cancer Panel
M197.1 Round Cell Sarcoma of Soft Tissue Differential, Multi-target NGS panel - structural variant (BCOR, CIC, DDIT3, EWSR1, FOXO1, WT1, BCOR-CCNB3, HEY1-NCOA2, PAX3-FOXO1, PAX7-FOXO1, NTRK1, NTRK2, NTRK3) cancer Panel
M197.2 Round Cell Sarcoma of Soft Tissue Differential, DDIT3 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M197.3 Round Cell Sarcoma of Soft Tissue Differential, EWSR1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M197.4 Round Cell Sarcoma of Soft Tissue Differential, FOXO1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M197.5 Round Cell Sarcoma of Soft Tissue Differential, WT1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M197.6 Round Cell Sarcoma of Soft Tissue Differential, BCOR-CCNB3 RT-PCR cancer Simple targeted mutation testing
M197.7 Round Cell Sarcoma of Soft Tissue Differential, HEY1-NCOA2 RT-PCR cancer Simple targeted mutation testing
M197.8 Round Cell Sarcoma of Soft Tissue Differential, PAX3-FOXO1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M197.9 Round Cell Sarcoma of Soft Tissue Differential, PAX7-FOXO1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M197.10 Round Cell Sarcoma of Soft Tissue Differential, WGS Germline and Tumour cancer WGS
M198.1 Vascular Soft Tissue Tumour Differential, MYC copy number FISH cancer FISH
M198.2 Vascular Soft Tissue Tumour Differential, SERPINE1-FOSB FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M198.3 Vascular Soft Tissue Tumour Differential, WWTR1-CAMTA1 RT-PCR cancer Simple targeted mutation testing
M198.4 Vascular Soft Tissue Tumour Differential, WGS Germline and Tumour cancer WGS
M198.5 Vascular Soft Tissue Tumour Differential, Multi-target NGS panel - structural variant (SERPINE1-FOSB, WWTR1-CAMTA1, NTRK1, NTRK2, NTRK3) cancer Panel
M198.6 Vascular Soft Tissue Tumour Differential, Multi-target NGS panel - copy number variant (MYC) cancer Panel
M199.1 Spindle Cell Soft Tissue Tumour Differential, Multi-target NGS panel - small variant (APC, CTNNB1) cancer Panel
M199.2 Spindle Cell Soft Tissue Tumour Differential, Multi-target NGS panel - structural variant (ALK, BCOR, CIC, EWSR1, FUS, SS18, USP6, COL1A1-PDGFB, TPM3-ALK, TPM4-ALK, ETV6-NTRK3, NTRK1, NTRK2, NTRK3) cancer Panel
M199.3 Spindle Cell Soft Tissue Tumour Differential, EWSR1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M199.4 Spindle Cell Soft Tissue Tumour Differential, FUS rearrangement FISH cancer FISH
M199.5 Spindle Cell Soft Tissue Tumour Differential, MDM2 copy number FISH cancer FISH
M199.6 Spindle Cell Soft Tissue Tumour Differential, SS18 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M199.7 Spindle Cell Soft Tissue Tumour Differential, USP6 rearrangement FISH cancer FISH
M199.8 Spindle Cell Soft Tissue Tumour Differential, COL1A1-PDGFB rearrangement FISH cancer FISH
M199.9 Spindle Cell Soft Tissue Tumour Differential, TPM3-ALK FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M199.10 Spindle Cell Soft Tissue Tumour Differential, TPM4-ALK FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M199.11 Spindle Cell Soft Tissue Tumour Differential, ETV6-NTRK3 RT-PCR cancer Simple targeted mutation testing
M199.12 Spindle Cell Soft Tissue Tumour Differential, WGS Germline and Tumour cancer WGS
M199.13 Spindle Cell Soft Tissue Tumour Differential, Multi-target NGS panel - copy number variant (MDM2) cancer Panel
M200.1 Myxoid Soft Tissue Tumour Differential, Multi-target NGS panel - structural variant (BCOR, DDIT3, FUS, NR4A3, TGFBR3-OGA, BCOR-CCNB3, NTRK1, NTRK2, NTRK3) cancer Panel
M200.2 Myxoid Soft Tissue Tumour Differential, DDIT3 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M200.3 Myxoid Soft Tissue Tumour Differential, FUS rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M200.4 Myxoid Soft Tissue Tumour Differential, NR4A3 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M200.5 Myxoid Soft Tissue Tumour Differential, TGFBR3-OGA FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M200.6 Myxoid Soft Tissue Tumour Differential, BCOR-CCNB3 RT-PCR cancer Simple targeted mutation testing
M200.7 Myxoid Soft Tissue Tumour Differential, WGS Germline and Tumour cancer WGS
M201.1 Adipocytic Soft Tissue Tumour Differential, DDIT3 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M201.2 Adipocytic Soft Tissue Tumour Differential, MDM2 copy number FISH cancer FISH
M201.3 Adipocytic Soft Tissue Tumour Differential, WGS Germline and Tumour cancer WGS
M201.4 Adipocytic Soft Tissue Tumour Differential, Multi-target NGS panel - structural variant (DDIT3, NTRK1, NTRK2, NTRK3) cancer Panel
M201.5 Adipocytic Soft Tissue Tumour Differential, Multi-target NGS panel - copy number variant (MDM2) cancer Panel
M202.1 Epithelioid Soft Tissue Tumour Differential, EWSR1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M202.2 Epithelioid Soft Tissue Tumour Differential, FUS rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M202.3 Epithelioid Soft Tissue Tumour Differential, SS18 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M202.4 Epithelioid Soft Tissue Tumour Differential, TFE3 rearrangement FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M202.5 Epithelioid Soft Tissue Tumour Differential, WWTR1-CAMTA1 RT-PCR cancer Simple targeted mutation testing
M202.6 Epithelioid Soft Tissue Tumour Differential, WGS Germline and Tumour cancer WGS
M202.7 Epithelioid Soft Tissue Tumour Differential, Multi-target NGS panel - structural variant (EWSR1, FUS, SS18, TFE3, WWTR1-CAMTA1, NTRK1, NTRK2, NTRK3) cancer Panel
M203.1 Uterine Sarcomas (Inc Endometrial), EPC1-PHF1 rearrangement FISH cancer FISH
M203.2 Uterine Sarcomas (Inc Endometrial), JAZF1-PHF1 rearrangement FISH cancer FISH
M203.3 Uterine Sarcomas (Inc Endometrial), JAZF1-SUZ12 rearrangement FISH cancer FISH
M203.4 Uterine Sarcomas (Inc Endometrial), NUTM2B-YWHAE FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M203.5 Uterine Sarcomas (Inc Endometrial), WGS Germline and Tumour cancer WGS
M203.6 Uterine Sarcomas (Inc Endometrial), Multi-target NGS panel - structural variant (EPC1-PHF1, JAZF1-PHF1, JAZF1-SUZ12, NUTM2B-YWHAE, NTRK1, NTRK2, NTRK3) cancer Panel
M204.1 Undifferentiated tumour, WGS Germline and Tumour cancer WGS
M204.2 Undifferentiated tumour, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M205.1 Cartilage Forming Bone Tumour Differential, Multi-target NGS panel - small variant (H3-3A, H3-3B, IDH1, IDH2) cancer Panel
M205.2 Cartilage Forming Bone Tumour Differential, H3-3B hotspot cancer Simple targeted mutation testing
M205.3 Cartilage Forming Bone Tumour Differential, H3-3A seq cancer Single gene sequencing
M205.4 Cartilage Forming Bone Tumour Differential, H3-3B seq cancer Single gene sequencing
M205.5 Cartilage Forming Bone Tumour Differential, HEY1-NCOA2 RT-PCR cancer Simple targeted mutation testing
M205.6 Cartilage Forming Bone Tumour Differential, SNP Array cancer Karyotype or equivalent
M205.7 Cartilage Forming Bone Tumour Differential, WGS Germline and Tumour cancer WGS
M205.8 Cartilage Forming Bone Tumour Differential, Multi-target NGS panel - structural variant (HEY1-NCOA2, NTRK1, NTRK2, NTRK3) cancer Panel
M206.1 Bone Forming Bone Tumour Differential, Multi-target NGS panel - small variant (H3-3A, H3-3B) cancer Panel
M206.2 Bone Forming Bone Tumour Differential, H3-3B hotspot cancer Simple targeted mutation testing
M206.3 Bone Forming Bone Tumour Differential, H3-3A seq cancer Single gene sequencing
M206.4 Bone Forming Bone Tumour Differential, H3-3B seq cancer Single gene sequencing
M206.5 Bone Forming Bone Tumour Differential, MDM2 copy number FISH cancer FISH
M206.6 Bone Forming Bone Tumour Differential, USP6 rearrangement FISH cancer FISH
M206.7 Bone Forming Bone Tumour Differential, WGS Germline and Tumour cancer WGS
M206.8 Bone Forming Bone Tumour Differential, Multi-target NGS panel - structural variant (USP6, NTRK1, NTRK2, NTRK3) cancer Panel
M206.9 Bone Forming Bone Tumour Differential, Multi-target NGS panel - copy number variant (MDM2) cancer Panel
M207.1 Osteoclast-Rich Bone Tumour Differential, Multi-target NGS panel - small variant (H3-3B) cancer Panel
M207.2 Osteoclast-Rich Bone Tumour Differential, H3-3B seq cancer Single gene sequencing
M207.3 Osteoclast-Rich Bone Tumour Differential, H3-3B hotspot cancer Simple targeted mutation testing
M207.4 Osteoclast-Rich Bone Tumour Differential, MDM2 copy number FISH cancer FISH
M207.5 Osteoclast-Rich Bone Tumour Differential, USP6 rearrangement FISH cancer FISH
M207.6 Osteoclast-Rich Bone Tumour Differential, WGS Germline and Tumour cancer WGS
M207.7 Osteoclast-Rich Bone Tumour Differential, Multi-target NGS panel - structural variant (USP6, NTRK1, NTRK2, NTRK3) cancer Panel
M207.8 Osteoclast-Rich Bone Tumour Differential, Multi-target NGS panel - copy number variant (MDM2) cancer Panel
M208.1 Round Cell Sarcoma of Bone Differential, Multi-target NGS panel - structural variant (BCOR, CIC, EWSR1, WT1, BCOR-CCNB3, HEY1-NCOA2, NTRK1, NTRK2, NTRK3) cancer Panel
M208.2 Round Cell Sarcoma of Bone Differential, EWSR1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M208.3 Round Cell Sarcoma of Bone Differential, WT1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M208.4 Round Cell Sarcoma of Bone Differential, BCOR-CCNB3 RT-PCR cancer Simple targeted mutation testing
M208.5 Round Cell Sarcoma of Bone Differential, HEY1-NCOA2 RT-PCR cancer Simple targeted mutation testing
M208.6 Round Cell Sarcoma of Bone Differential, WGS Germline and Tumour cancer WGS
M209.1 Vascular Tumour of Bone Differential, MYC copy number FISH cancer FISH
M209.2 Vascular Tumour of Bone Differential, SERPINE1-FOSB FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M209.3 Vascular Tumour of Bone Differential, WWTR1-CAMTA1 RT-PCR cancer Simple targeted mutation testing
M209.4 Vascular Tumour of Bone Differential, WGS Germline and Tumour cancer WGS
M209.5 Vascular Tumour of Bone Differential, Multi-target NGS panel - structural variant (SERPINE1-FOSB, WWTR1-CAMTA1, NTRK1, NTRK2, NTRK3) cancer Panel
M209.6 Vascular Tumour of Bone Differential, Multi-target NGS panel - copy number variant (MYC) cancer Panel
M210.1 Spindle Cell Tumour of Bone Differential, Multi-target NGS panel - structural variant (ALK, BCOR, CIC, EWSR1, FUS, NTRK1, NTRK2, NTRK3) cancer Panel
M210.2 Spindle Cell Tumour of Bone Differential, EWSR1 rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M210.3 Spindle Cell Tumour of Bone Differential, FUS rearrangement FISH or RT-PCR cancer FISH/Simple targeted mutation testing
M210.4 Spindle Cell Tumour of Bone Differential, MDM2 copy number FISH cancer FISH
M210.5 Spindle Cell Tumour of Bone Differential, WGS Germline and Tumour cancer WGS
M210.6 Spindle Cell Tumour of Bone Differential, Multi-target NGS panel - copy number variant (MDM2) cancer Panel
M211.1 Fibro-Osseous Tumour of Bone Differential, Multi-target NGS panel - small variant (GNAS) cancer Panel
M211.2 Fibro-Osseous Tumour of Bone Differential, MDM2 copy number FISH cancer FISH
M211.3 Fibro-Osseous Tumour of Bone Differential, WGS Germline and Tumour cancer WGS
M211.4 Fibro-Osseous Tumour of Bone Differential, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M211.5 Fibro-Osseous Tumour of Bone Differential, Multi-target NGS panel - copy number variant (MDM2) cancer Panel
M212.1 Renal Tumour Differential - Paediatric, Multi-target NGS panel - small variant (CTNNB1, DAXX, ATRX, TP53, TFE3) cancer Panel
M212.2 Renal Tumour Differential - Paediatric, ATRX seq cancer Single gene sequencing
M212.3 Renal Tumour Differential - Paediatric, CTNNB1 seq cancer Single gene sequencing
M212.4 Renal Tumour Differential - Paediatric, DAXX seq cancer Single gene sequencing
M212.5 Renal Tumour Differential - Paediatric, TFE3 seq cancer Single gene sequencing
M212.6 Renal Tumour Differential - Paediatric, TP53 seq cancer Single gene sequencing
M212.7 Renal Tumour Differential - Paediatric, ATRX copy number FISH cancer FISH
M212.8 Renal Tumour Differential - Paediatric, del(17p) TP53 copy number FISH cancer FISH
M212.9 Renal Tumour Differential - Paediatric, WT1 copy number FISH cancer FISH
M212.10 Renal Tumour Differential - Paediatric, TFEB-MALAT1 FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M212.11 Renal Tumour Differential - Paediatric, TFE3-ASPSCR1 FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M212.12 Renal Tumour Differential - Paediatric, TFE3-MITF FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M212.13 Renal Tumour Differential - Paediatric, TFE3-PRCC FISH/RT-PCR cancer FISH/Simple targeted mutation testing
M212.14 Renal Tumour Differential - Paediatric, WGS Germline and Tumour cancer WGS
M212.15 Renal Tumour Differential - Paediatric, Multi-target NGS panel - structural variant (TFEB-MALAT1, TFE3-ASPSCR1, TFE3-MITF, TFE3-PRCC, NTRK1, NTRK2, NTRK3) cancer Panel
M212.16 Renal Tumour Differential - Paediatric, Multi-target NGS panel - copy number variant (ATRX, TP53, WT1) cancer Panel
M215.1 Endometrial Cancer, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M215.2 Endometrial Cancer, MLH1 promoter hypermethylation cancer Targeted mutation testing
M215.4 Endometrial Cancer, Multi-target NGS panel - small variant (MLH1, MSH2, MSH6, PMS2) cancer Panel
M215.5 Endometrial Cancer, Multi-target NGS panel-small variant detection (POLE) cancer Panel
M217.1 Urothelial Carcinoma, Multi-target NGS panel - small variant (FGFR3, FGFR2) cancer Panel
M217.2 Urothelial Carcinoma, Multi-target NGS panel - copy number variant (FGFR3, FGFR2) cancer Panel
M217.3 Urothelial Carcinoma, Multi-target NGS panel - structural variant (FGFR3, FGFR2, NTRK1, NTRK2, NTRK3) cancer Panel
M218.1 Prostate Cancer, Multi-target NGS panel - small variant (BRCA1, BRCA2) for somatic/tissue testing cancer Panel
M218.2 Prostate Cancer, Multi-target NGS panel - structural variant (TMPRSS2-ERG, NTRK1, NTRK2, NTRK3) cancer Panel
M218.3 Prostate Cancer, TMPRSS2-ERG FISH cancer FISH
M219.1 Pancreatic Cancer, Multi-target NGS panel - small variant (BRCA1, BRCA2) cancer Panel
M219.2 Pancreatic Cancer, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M219.3 Pancreatic Cancer, DPYD hotspot cancer Simple targeted mutation testing
M219.5 Pancreatic Cancer, MSI Testing cancer Microsatellite instability analysis
M220.1 Cholangiocarcinoma, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3, FGFR2) cancer Panel
M220.3 Cholangiocarcinoma, DPYD hotspot cancer Simple targeted mutation testing
M220.5 Cholangiocarcinoma, MSI Testing cancer Microsatellite instability analysis
M220.6 Cholangiocarcinoma, Multi-target NGS panel -small variant (IDH1) cancer Panel
M220.7 Cholangiocarcinoma, FGFR2 rearrangement FISH cancer FISH
M221.1 Spitzoid tumour, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M222.2 Hepatocellular carcinoma, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M222.4 Hepatocellular carcinoma, DPYD hotspot cancer Simple targeted mutation testing
M226.1 Carcinoma of Unknown Primary, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M226.3 Carcinoma of Unknown Primary, DPYD hotspot cancer Simple targeted mutation testing
M226.4 Carcinoma of Unknown Primary, WGS Germline and Tumour cancer WGS
M226.5 Carcinoma of Unknown Primary, Multi-target NGS panel-structural variant (ALK, EML4, FGFR2, FGFR3, MAML2, MET * (including exon 14 skipping), MYB, NFIB, NTRK1, NTRK2, NTRK3, RET,ROS1, TFE3, TMPRSS2, ERG) cancer Panel
M226.6 Carcinoma of Unknown Primary, Multi-target NGS panel -small variant (AKT1, APC, ALK, BRCA1, BRCA2, BRAF, CDKN2A, CTNNB1, DICER1, EGFR, ELOC, ESR1, FGFR2, FGFR3, FH, FOXL2, HRAS, IDH1, KIT, KRAS, MLH1, MSH2, MSH6, MET (including exon 14 skipping), NF1, NRAS, PDGFRA, PIK3CA, POLD1, POLE, PMS2, PTEN, RB1, RET, SDHA, SHDB, SDHC, SDHD, SMARCA4, TP53, TSC1, TSC2, TERT (promoter), VKL, NF2, CDK12) and copy number variant (CDKN2A, FGFR2, FGFR3, MET, PTEN, TP53) cancer Panel
M226.7 Carcinoma of Unknown Primary, Multi-target ctDNA NGS panel - small variant (AKT1, APC, ALK, BRCA1, BRCA2, BRAF, CDKN2A, CTNNB1, EGFR, ESR1, HRAS, IDH1, FGFR2, FGFR3, KIT, KRAS, MLH1, NF1, NRAS, PDGFRA, PIK3CA, PTEN, RB1, RET, TSC1, TP53, TERT (promoter), VHL) , copy number variant (BRCA1, BRCA2, PTEN) , structural variant (ALK, BRAF, EML4, FGFR2, FGFR3, NTRK1, NTRK2, NTRK3, ROS1, MET (including exon 14 skipping), RET) cancer Panel
M227.1 Solid tumour other (i.e. specific histology not listed elsewhere in the test directory), Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M227.3 Solid tumour other (i.e. specific histology not listed elsewhere in the test directory), DPYD hotspot cancer Simple targeted mutation testing
M231.1 Small cell lung cancer, Multi-target NGS panel - copy number variant (RB1) cancer Panel
M231.2 Small cell lung cancer, Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3) cancer Panel
M232.1 Solid Tumour Exhausted all Standards of Care Testing and Treatment- Adult, WGS Germline and Tumour cancer WGS
M233.1 High Grade Ovarian Carcinoma, WGS Germline and Tumour cancer WGS
M234.1 Triple Negative Breast Cancer, WGS Germline and Tumour cancer WGS
M236.1 Oesophageal Cancer, MSI Testing cancer Microsatellite instability analysis
M236.2 Oesophageal Cancer, DPYD hotspot cancer Simple targeted mutation testing
M237.1 Gastric Cancer, MSI Testing cancer Microsatellite instability analysis
M237.2 Gastric Cancer, DPYD hotspot cancer Simple targeted mutation testing
M238.1 Small Bowel Cancer, MSI Testing cancer Microsatellite instability analysis
M238.2 Small Bowel Cancer, DPYD hotspot cancer Simple targeted mutation testing
M239.1 Thyroid Hurtle Cell Carcinoma, Multi-target NGS panel - structural variant (RET) cancer Panel
M240.1 Non-invasive follicular thyroid neoplasm with papillary like nuclei, Multi-target NGS panel - small variant (BRAF,HRAS,NRAS,KRAS) cancer Panel
M241.1 Conjunctival melanoma, MYB & 6cen cancer FISH
M241.2 Conjunctival melanoma, RREB1 (6p25) cancer FISH
M241.3 Conjunctival melanoma, CCND1 (11q13) cancer FISH
M241.4 Conjunctival melanoma, MYC & 8cen cancer FISH
M241.5 Conjunctival melanoma, CDKN2A & 9cen cancer FISH
M242.1 Any patient receiving solid organ transplantation (only in cases where passenger lymphocyte syndrome is suspected), STR Testing cancer Complex targeted mutation testing
M242.2 Any patient receiving solid organ transplantation (only in cases where passenger lymphocyte syndrome is suspected), Sex chromosome FISH cancer FISH
M243.1 Thymic Carcinoma, Multi-target NGS panel (KIT) cancer Panel
M244.1 In all tumours eligible for NTRK1/2/3 testing, FISH cancer FISH
M245.1 Ovarian sex cord stromal tumours, Multi-target NGS panel-small variant (FOXL2, CTNNB1, APC, DICER1) cancer Panel
M20.1 Anaplastic Astrocytoma, Paediatric, Multi-target NGS panel, small variant (BRAF) cancer
M20.2 Anaplastic Astrocytoma, Paediatric, BRAF-KIAA1549 FISH/RT-PCR cancer
M20.3 Anaplastic Astrocytoma, Paediatric, WGS Germline and Tumor cancer
M20.4 Anaplastic Astrocytoma, Paediatric, DNA Methylation cancer
M20.5 Anaplastic Astrocytoma, Paediatric, Multi-target NGS panel, structural variant (BRAF-KIAA1549, NTRK1, NTRK2, NTRK3) cancer
M21.1 Astrocytoma, Adult, Multi-target NGS panel, small variant (IDH1, IDH2, ATRX, H3-3A,H3C2, BRAF, TERT promoter) cancer
M21.2 Astrocytoma, Adult, Multi-target NGS panel, copy number variant (EGFR, CDKN2A, CDKN2B) cancer
M21.3 Astrocytoma, Adult, EGFRvIII RT-PCR cancer
M21.5 Astrocytoma, Adult, EGFR copy number FISH cancer
M21.6 Astrocytoma, Adult, 1p19q codel FISH/RT-PCR cancer
M21.8 Astrocytoma, Adult, IDH1 hotspot cancer
M21.9 Astrocytoma, Adult, IDH2 hotspot cancer
M21.20 Astrocytoma, Adult, DNA Methylation cancer
M21.21 Astrocytoma, Adult, Multi-target NGS panel, structural variant (EGFRvIII, NTRK1, NTRK2, NTRK3) cancer
M21.22 Astrocytoma, Adult, WGS Germline and Tumor cancer
M21.23 Astrocytoma, Adult, CDKN2A copy number FISH cancer
M21.24 Astrocytoma, Adult, CDKN2B copy number FISH cancer
M22.1 Diffuse Astrocytoma, Paediatric, Multi-target NGS panel, small variant (H3C2, H3C14, IDH1, IDH2) cancer
M22.2 Diffuse Astrocytoma, Paediatric, MYC copy number FISH cancer
M22.3 Diffuse Astrocytoma, Paediatric, MYC rearrangement FISH cancer
M22.4 Diffuse Astrocytoma, Paediatric, WGS Germline and Tumor cancer
M22.5 Diffuse Astrocytoma, Paediatric, IDH1 hotspot cancer
M22.6 Diffuse Astrocytoma, Paediatric, IDH2 hotspot cancer
M22.7 Diffuse Astrocytoma, Paediatric, DNA Methylation cancer
M22.8 Diffuse Astrocytoma, Paediatric, Multi-target NGS panel, copy number variant (MYC) cancer
M22.9 Diffuse Astrocytoma, Paediatric, Multi-target NGS panel, structural variant (MYC, NTRK1, NTRK2, NTRK3) cancer
M22.10 Diffuse Astrocytoma, Paediatric, MYB rearrangement FISH/RT-PCR cancer
M22.11 Diffuse Astrocytoma, Paediatric, MYBL1 rearrangement FISH/RT-PCR cancer
M22.12 Diffuse Astrocytoma, Paediatric, MN1 rearrangement FISH/RT-PCR cancer
M23.1 Diffuse Midline Glioma, Adult, Multi-target NGS panel, small variant (IDH1, IDH2, ATRX, TERT promoter, H3-3A) cancer
M23.6 Diffuse Midline Glioma, Adult, IDH1 hotspot cancer
M23.7 Diffuse Midline Glioma, Adult, IDH2 hotspot cancer
M23.8 Diffuse Midline Glioma, Adult, 1p19q codel FISH/RT-PCR cancer
M23.9 Diffuse Midline Glioma, Adult, DNA Methylation cancer
M23.10 Diffuse Midline Glioma, Adult, Multi-target NGS panel, copy number variant (1p, 19q) cancer
M23.11 Diffuse Midline Glioma, Adult, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M23.12 Diffuse Midline Glioma, Adult, WGS Germline and Tumor cancer
M24.1 Embryonal Tumours with Multi-Layered Rosettes, Paediatric, C19MC copy number FISH cancer
M24.2 Embryonal Tumours with Multi-Layered Rosettes, Paediatric, TTYH1-C19MC FISH/RT-PCR cancer
M24.3 Embryonal Tumours with Multi-Layered Rosettes, Paediatric, WGS Germline and Tumor cancer
M24.4 Embryonal Tumours with Multi-Layered Rosettes, Paediatric, DNA Methylation cancer
M24.5 Embryonal Tumours with Multi-Layered Rosettes, Paediatric, Multi-target NGS panel, copy number variant (C19MC) cancer
M24.6 Embryonal Tumours with Multi-Layered Rosettes, Paediatric, Multi-target NGS panel, structural variant (TTYH1-C19MC, NTRK1, NTRK2, NTRK3) cancer
M25.1 Ependymoma, Paediatric, Multi-target NGS panel, small variant (YAP1) cancer
M25.2 Ependymoma, Paediatric, YAP1 copy number FISH cancer
M25.3 Ependymoma, Paediatric, YAP1-C11orf95 FISH/RT-PCR cancer
M25.4 Ependymoma, Paediatric, YAP1-TFE3 FISH/RT-PCR cancer
M25.5 Ependymoma, Paediatric, C11orf95-RELA FISH/RT-PCR cancer
M25.6 Ependymoma, Paediatric, WGS Germline and Tumor cancer
M25.7 Ependymoma, Paediatric, DNA Methylation cancer
M25.8 Ependymoma, Paediatric, Multi-target NGS panel, copy number variant (YAP1, MYCN) cancer
M25.9 Ependymoma, Paediatric, Multi-target NGS panel, structural variant (YAP1-C11orf95, YAP1-TFE3, C11orf95-RELA, NTRK1, NTRK2, NTRK3) cancer
M25.10 Ependymoma, Paediatric, MYCN copy number FISH cancer
M25.11 Ependymoma, Paediatric, ZFTA rearrangements (several fusion partners) cancer
M26.1 Ependymoma Supratentorial, Adult, YAP1 rearrangement FISH/RT-PCR cancer
M26.2 Ependymoma, Adult, RELA rearrangement FISH/RT-PCR cancer
M26.3 Ependymoma, Adult, DNA Methylation cancer
M26.4 Ependymoma, Adult, Multi-target NGS panel, structural variant (YAP1, RELA, NTRK1, NTRK2, NTRK3) cancer
M26.5 Ependymoma, Adult, WGS Germline and Tumor cancer
M26.6 Ependymoma, Adult, ZFTA rearrangements (several fusion partners) cancer
M27.1 Glioblastoma, Adult, Multi-target NGS panel, small variant (IDH1, IDH2, ATRX, H3-3A, H3C2, BRAF, TERT promoter) cancer
M27.2 Glioblastoma, Adult, Multi-target NGS panel, copy number variant (EGFR, PDGFRA, MYC, PTEN, 1p, 19q) cancer
M27.3 Glioblastoma, Adult, EGFRvIII RT-PCR cancer
M27.5 Glioblastoma, Adult, EGFR copy number FISH cancer
M27.6 Glioblastoma, Adult, MGMT promoter hyperMethylation cancer
M27.7 Glioblastoma, Adult, 1p19q codel FISH/RT-PCR cancer
M27.9 Glioblastoma, Adult, PDGFRA copy number FISH/RT-PCR cancer
M27.10 Glioblastoma, Adult, MYC copy number FISH cancer
M27.11 Glioblastoma, Adult, PTEN (10q23) copy number FISH/RT-PCR cancer
M27.12 Glioblastoma, Adult, IDH1 hotspot cancer
M27.13 Glioblastoma, Adult, IDH2 hotspot cancer
M27.14 Glioblastoma, Adult, DNA Methylation cancer
M27.15 Glioblastoma, Adult, Multi-target NGS panel, structural variant (EGFRvIII, NTRK1, NTRK2, NTRK3) cancer
M27.16 Glioblastoma, Adult, WGS Germline and Tumor cancer
M28.1 Glioma, Adult, Multi-target NGS panel, small variant (H3C2, H3C3, H3C14, H3-3A, H3-3B, IDH1, IDH2, TP53, VHL, TERT promoter) cancer
M28.2 Glioma, Adult, Multi-target NGS panel, copy number variant (EGFR, 1p, 19q) cancer
M28.3 Glioma, Adult, EGFR copy number FISH cancer
M28.4 Glioma, Adult, IDH1 hotspot cancer
M28.5 Glioma, Adult, IDH2 hotspot cancer
M28.6 Glioma, Adult, 1p19q codel FISH/RT-PCR cancer
M28.7 Glioma, Adult, DNA Methylation cancer
M28.8 Glioma, Adult, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M28.9 Glioma, Adult, WGS Germline and Tumor cancer
M29.1 High Grade Glioma, Adult, Multi-target NGS panel, small variant (IDH1, IDH2, ATRX, TERT promoter, H3-3A, H3C2) cancer
M29.2 High Grade Glioma, Adult, MGMT promoter hyperMethylation cancer
M29.3 High Grade Glioma, Adult, IDH1 hotspot cancer
M29.4 High Grade Glioma, Adult, IDH2 hotspot cancer
M29.5 High Grade Glioma, Adult, 1p19q codel FISH/RT-PCR cancer
M29.6 High Grade Glioma, Adult, DNA Methylation cancer
M29.7 High Grade Glioma, Adult, Multi-target NGS panel, copy number variant (1p, 19q) cancer
M29.8 High Grade Glioma, Adult, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M29.9 High Grade Glioma, Adult, WGS Germline and Tumor cancer
M30.1 IDH-Wildtype Glioblastoma, Paediatric, Multi-target NGS panel, small variant (RB1, NF1) cancer
M30.2 IDH-Wildtype Glioblastoma, Paediatric, WGS Germline and Tumor cancer
M30.3 IDH-Wildtype Glioblastoma, Paediatric, DNA Methylation cancer
M30.4 IDH-Wildtype Glioblastoma, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M31.1 Low Grade Glioma, Adult, MGMT promoter hyperMethylation cancer
M31.2 Low Grade Glioma, Adult, Multi-target NGS panel, small variant (IDH1, IDH2, TERT promoter, H3-3A, H3C2) cancer
M31.3 Low Grade Glioma, Adult, 1p19q codel FISH/RT-PCR cancer
M31.4 Low Grade Glioma, Adult, DNA Methylation cancer
M31.5 Low Grade Glioma, Adult, Multi-target NGS panel, copy number variant (1p, 19q) cancer
M31.6 Low Grade Glioma, Adult, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M31.7 Low Grade Glioma, Adult, WGS Germline and Tumor cancer
M32.1 Low Grade Glioma/Glioneuronal Tumours, Adult, Multi-target NGS panel, small variant (BRAF, IDH1, IDH2, TERT promoter, H3-3A, H3C2) cancer
M32.2 Low Grade Glioma/Glioneuronal Tumours, Adult, 1p19q codel FISH/RT-PCR cancer
M32.3 Low Grade Glioma/Glioneuronal Tumours, Adult, DNA Methylation cancer
M32.4 Low Grade Glioma/Glioneuronal Tumours, Adult, Multi-target NGS panel, copy number variant (1p, 19q) cancer
M32.5 Low Grade Glioma/Glioneuronal Tumours, Adult, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M32.6 Low Grade Glioma/Glioneuronal Tumours, Adult, WGS Germline and Tumor cancer
M33.3 Meningioma, Adult, Multi-target NGS panel, small variant (TERT promoter) cancer
M33.4 Meningioma, Adult, DNA Methylation cancer
M33.5 Meningioma, Adult, WGS Germline and Tumor cancer
M34.1 Non-Midline Glioma, Adult, Multi-target NGS panel, small variant (IDH1, IDH2, ATRX, TERT promoter, H3-3A, H3C2) cancer
M34.2 Non-Midline Glioma, Adult, IDH1 hotspot cancer
M34.3 Non-Midline Glioma, Adult, IDH2 hotspot cancer
M34.4 Non-Midline Glioma, Adult, 1p19q codel FISH/RT-PCR cancer
M34.5 Non-Midline Glioma, Adult, DNA Methylation cancer
M34.6 Non-Midline Glioma, Adult, Multi-target NGS panel, copy number variant (1p, 19q) cancer
M34.7 Non-Midline Glioma, Adult, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M34.8 Non-Midline Glioma, Adult, WGS Germline and Tumor cancer
M35.1 OligodendroGlioma, Adult, Multi-target NGS panel, small variant (IDH1, IDH2, ATRX, H3-3A, H3C2, BRAF, TERT promoter) cancer
M35.2 OligodendroGlioma, Adult, 1p19q codel FISH/RT-PCR cancer
M35.4 OligodendroGlioma, Adult, IDH1 hotspot cancer
M35.5 OligodendroGlioma, Adult, IDH2 hotspot cancer
M35.6 OligodendroGlioma, Adult, DNA Methylation cancer
M35.7 OligodendroGlioma, Adult, Multi-target NGS panel, copy number variant (1p, 19q) cancer
M35.8 OligodendroGlioma, Adult, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M35.9 OligodendroGlioma, Adult, WGS Germline and Tumor cancer
M36.1 Pilocytic Astrocytoma, Adult, BRAF-KIAA1549 FISH/RT-PCR cancer
M36.2 Pilocytic Astrocytoma, Adult, BRAF-AGK FISH/RT-PCR cancer
M36.3 Pilocytic Astrocytoma, Adult, BRAF-AKAP9 FISH/RT-PCR cancer
M36.4 Pilocytic Astrocytoma, Adult, BRAF-CCDC6 FISH/RT-PCR cancer
M36.5 Pilocytic Astrocytoma, Adult, BRAF-FAM118B FISH/RT-PCR cancer
M36.6 Pilocytic Astrocytoma, Adult, BRAF-FXR1 FISH/RT-PCR cancer
M36.7 Pilocytic Astrocytoma, Adult, BRAF-GNAI1 FISH/RT-PCR cancer
M36.8 Pilocytic Astrocytoma, Adult, BRAF-MACF1 FISH/RT-PCR cancer
M36.9 Pilocytic Astrocytoma, Adult, BRAF rearrangement FISH cancer
M36.10 Pilocytic Astrocytoma, Adult, KIAA1549 copy number FISH cancer
M36.11 Pilocytic Astrocytoma, Adult, CDKN2A copy number FISH cancer
M36.12 Pilocytic Astrocytoma, Adult, Multi-target NGS panel, small variant (BRAF, CDKN2A) cancer
M36.13 Pilocytic Astrocytoma, Adult, DNA Methylation cancer
M36.14 Pilocytic Astrocytoma, Adult, Multi-target NGS panel, structural variant (BRAF-KIAA1549, BRAF-AGK, BRAF-AKAP9, BRAF-CCDC6, BRAF-FAM118B, BRAF-FXR1, BRAF-GNAI1, BRAF-MACF1, other rearrangements of BRAF, NTRK1, NTRK2, NTRK3) cancer
M36.15 Pilocytic Astrocytoma, Adult, Multi-target NGS panel, copy number variant (KIAA1549, CDKN2A) cancer
M36.16 Pilocytic Astrocytoma, Adult, WGS Germline and Tumor cancer
M37.1 Pineoblastoma, Paediatric, Multi-target NGS panel, small variant (DICER1) cancer
M37.2 Pineoblastoma, Paediatric, WGS Germline and Tumor cancer
M37.3 Pineoblastoma, Paediatric, DNA Methylation cancer
M37.4 Pineoblastoma, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M38.1 Pituitary Tumours, MGMT promoter hyperMethylation cancer
M38.2 Pituitary Tumours, Multi-target NGS panel, copy number variant (EGFR) cancer
M38.3 Pituitary Tumours, EGFR copy number FISH cancer
M38.4 Pituitary Tumours, DNA Methylation cancer
M38.5 Pituitary Tumours, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M38.6 Pituitary Tumours, WGS Germline and Tumor cancer
M39.1 Rare Primitive Neuroectodermal Tumours Groups 2/3, Paediatric, Multi-target NGS panel, small variant (CDKN2A) cancer
M39.2 Rare Primitive Neuroectodermal Tumours Groups 2/3, Paediatric, WGS Germline and Tumor cancer
M39.3 Rare Primitive Neuroectodermal Tumours Groups 2/3, Paediatric, DNA Methylation cancer
M39.4 Rare Primitive Neuroectodermal Tumours Groups 2/3, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M80.1 Acute Myeloid Leukaemia, WGS Germline and Tumor haematological-oncology
M80.2 Acute Myeloid Leukaemia, Multi-target NGS panel, small variant (NPM1, CEBPA, RUNX1, FLT3, IDH1, IDH2, KIT, WT1, ASXL1, SRSF2, STAG2, RAD21, TP53, KRAS, NRAS, KMT2A(MLL)-PTD), PPM1D, DDX41, PHF6, CUX1 haematological-oncology
M80.3 Acute Myeloid Leukaemia, Karyotype (To include detection of Complex karyotype, Monosomal karyotype) haematological-oncology
M80.5 Acute Myeloid Leukaemia, Other: See tests M80.25-M80.40 for individual specified FISH targets. haematological-oncology
M80.7 Acute Myeloid Leukaemia, Other RT-PCR: See tests M80.41-80.52 for individual specified RT-PCR targets. haematological-oncology
M80.8 Acute Myeloid Leukaemia, Multi-target NGS panel, structural variant (To include detection of Complex karyotype) haematological-oncology
M80.9 Acute Myeloid Leukaemia, MRD NPM1 RT-qPCR haematological-oncology
M80.10 Acute Myeloid Leukaemia, MRD PML-RARA RT-qPCR haematological-oncology
M80.11 Acute Myeloid Leukaemia, MRD RUNX1-RUNX1T1 RT-qPCR haematological-oncology
M80.12 Acute Myeloid Leukaemia, MRD CBFB-MYH11 RT-qPCR haematological-oncology
M80.13 Acute Myeloid Leukaemia, MRD BCR-ABL1 RT-qPCR haematological-oncology
M80.14 Acute Myeloid Leukaemia, MRD other QF-PCR haematological-oncology
M80.15 Acute Myeloid Leukaemia, BCR-ABL1 TKD NGS haematological-oncology
M80.18 Acute Myeloid Leukaemia, FLT3 ITD haematological-oncology
M80.19 Acute Myeloid Leukaemia, Multi-target NGS panel, small variant (GATA1) haematological-oncology
M80.21 Acute Myeloid Leukaemia, FLT3 TKD hotspot haematological-oncology
M80.22 Acute Myeloid Leukaemia, NPM1 exon 12 hotspot haematological-oncology
M80.23 Acute Myeloid Leukaemia, IDH1 hotspot haematological-oncology
M80.24 Acute Myeloid Leukaemia, IDH2 hotspot haematological-oncology
M80.25 Acute Myeloid Leukaemia, Chr5/Chr5q copy number FISH haematological-oncology
M80.26 Acute Myeloid Leukaemia, Chr7/Chr7q copy number FISH haematological-oncology
M80.27 Acute Myeloid Leukaemia, Chr17/Chr17p copy number FISH haematological-oncology
M80.28 Acute Myeloid Leukaemia, Chr12/Chr12p copy number FISH haematological-oncology
M80.29 Acute Myeloid Leukaemia, t(15;17)(q24;q21) PML-RARA FISH haematological-oncology
M80.30 Acute Myeloid Leukaemia, t(8;21)(q22;q22) RUNX1-RUNX1T1 FISH haematological-oncology
M80.31 Acute Myeloid Leukaemia, inv(16)(p13.1q22) CBFB-MYH11 FISH haematological-oncology
M80.32 Acute Myeloid Leukaemia, t(9;11)(p21;q23) MLLT3-KMT2A & other 11q23.3 ( KMT2A) rearrangements FISH haematological-oncology
M80.33 Acute Myeloid Leukaemia, t(6;9)(p22;q34) DEK-NUP214 FISH haematological-oncology
M80.34 Acute Myeloid Leukaemia, inv(3)(q21q26) GATA2-MECOM FISH haematological-oncology
M80.35 Acute Myeloid Leukaemia, t(1;22)(p13;q13) RBM15-MRTFA FISH haematological-oncology
M80.36 Acute Myeloid Leukaemia, t(9;22)(q34;q11) BCR-ABL1 FISH haematological-oncology
M80.37 Acute Myeloid Leukaemia, t(3;5)(q25;q34) NPM1-MLF1 FISH haematological-oncology
M80.38 Acute Myeloid Leukaemia, t(5;11)(q35;p15.5) NUP98-NSD1 FISH haematological-oncology
M80.39 Acute Myeloid Leukaemia, t(7;12)(q36;p13) MNX1-ETV6 FISH haematological-oncology
M80.40 Acute Myeloid Leukaemia, inv(16)(p13.3q24.3) CBFA2T3-GLIS2 FISH haematological-oncology
M80.41 Acute Myeloid Leukaemia, t(15;17)(q24;q21) PML-RARA RT-PCR haematological-oncology
M80.42 Acute Myeloid Leukaemia, t(8;21)(q22;q22) RUNX1-RUNX1T1 RT-PCR haematological-oncology
M80.43 Acute Myeloid Leukaemia, inv(16)(p13.1q22) CBFB-MYH11 RT-PCR haematological-oncology
M80.44 Acute Myeloid Leukaemia, t(9;11)(p21;q23) MLLT3-KMT2A & other 11q23.3 (KMT2A) rearrangements RT-PCR haematological-oncology
M80.45 Acute Myeloid Leukaemia, t(6;9)(p22;q34) DEK-NUP214 RT-PCR haematological-oncology
M80.46 Acute Myeloid Leukaemia, inv(3)(q21q26) GATA2-MECOM RT-PCR haematological-oncology
M80.47 Acute Myeloid Leukaemia, t(1;22)(p13;q13) RBM15-MRTFA RT-PCR haematological-oncology
M80.48 Acute Myeloid Leukaemia, t(9;22)(q34;q11) BCR-ABL1 RT-PCR haematological-oncology
M80.49 Acute Myeloid Leukaemia, t(3;5)(q25;q34) NPM1-MLF1 RT-PCR haematological-oncology
M80.50 Acute Myeloid Leukaemia, t(5;11)(q35;p15.5) NUP98-NSD1 RT-PCR haematological-oncology
M80.51 Acute Myeloid Leukaemia, t(7;12)(q36;p13) MNX1-ETV6 RT-PCR haematological-oncology
M80.52 Acute Myeloid Leukaemia, inv(16)(p13.3q24.3) CBFA2T3-GLIS2 RT-PCR haematological-oncology
M80.53 Acute Myeloid Leukaemia, Multi-target NGS panel, copy number variant (Monosomal karyotype, del5/del5q, del7/del7q, del17/del17p, del12/del12p) haematological-oncology
M80.54 Acute Myeloid Leukaemia, NUP98 rearrangement FISH haematological-oncology
M80.55 Acute Myeloid Leukaemia, MRD BCR-ABL1 RT-qPCR rare haematological-oncology
M80.56 Acute Myeloid Leukaemia, MRD NPM1 RT-qPCR rare haematological-oncology
M80.57 Acute Myeloid Leukaemia, WGS Tumour First haematological-oncology
M80.58 Acute Myeloid Leukaemia, WGS Follow-up Germline haematological-oncology
M81.1 Transient Abnormal Myelopoiesis, Multi-target NGS panel, small variant (GATA1) haematological-oncology
M82.1 Myelodysplasia, Multi-target NGS panel, small variant (TP53, SF3B1, IDH1, IDH2, NRAS, KRAS, TET2, SRSF2, ASXL1, DNMT3A, RUNX1, U2AF1, EZH2, BCOR, PTPN11, JAK2, SETBP1, PPM1D, DDX41, PHF6, CUX1, UBA1) haematological-oncology
M82.2 Myelodysplasia, Karyotype (To include detection of complex karyotype, -7/del7q, -5/del5q, i(17q)/t(17p), -13/del13q, del11q, del12p/t(12p), del9q, del17/del17p & idic(X)(q13)); -Y; del 20q; +8; +19,(inv(3)/t(3q)/del(3q)) haematological-oncology
M82.4 Myelodysplasia, FISH copy number and rearrangement Other: See tests M82.7 -M82.22 for individual specified FISH targets. haematological-oncology
M82.6 Myelodysplasia, WGS Germline and Tumor haematological-oncology
M82.7 Myelodysplasia, Chr7/Chr7q copy number FISH haematological-oncology
M82.8 Myelodysplasia, Chr5/Chr5q copy number FISH haematological-oncology
M82.9 Myelodysplasia, i(17q)/t(17p) FISH haematological-oncology
M82.10 Myelodysplasia, Chr13/Chr13q copy number FISH haematological-oncology
M82.11 Myelodysplasia, Chr11q copy number FISH haematological-oncology
M82.12 Myelodysplasia, Chr12p copy number FISH, t(12p) rearrangement FISH haematological-oncology
M82.13 Myelodysplasia, Chr9q copy number FISH haematological-oncology
M82.14 Myelodysplasia, Chr17/Chr17p copy number FISH haematological-oncology
M82.15 Myelodysplasia, idic(X)(q13) FISH haematological-oncology
M82.16 Myelodysplasia, Multi-target NGS panel, copy number variant (-7/del7q, -5/del5q, -13/del13q, del11q, del12p, del9q, del17/del17p & idic(X)(q13);-Y; del 20q; +8; +19,del(3q) haematological-oncology
M82.17 Myelodysplasia, Multi-target NGS panel, structural variant (t(12p), t(17p);inv(3)/t(3q)/del(3q) haematological-oncology
M82.18 Myelodysplasia, ChrY copy number FISH haematological-oncology
M82.19 Myelodysplasia, Chr20/20q copy number FISH haematological-oncology
M82.20 Myelodysplasia, Chr8 copy number FISH haematological-oncology
M82.21 Myelodysplasia, Chr19 copy number FISH haematological-oncology
M82.22 Myelodysplasia, inv(3)/t(3q)/del(3q) haematological-oncology
M82.23 Myelodysplasia, WGS Tumour First haematological-oncology
M82.24 Myelodysplasia, WGS Follow-up Germline haematological-oncology
M83.1 Aplastic Anaemia, Karyotype (Genomewide) haematological-oncology
M83.3 Aplastic Anaemia, FISH copy number and rearrangement haematological-oncology
M83.4 Aplastic Anaemia, WGS Germline and Tumor haematological-oncology
M83.5 Aplastic Anaemia, WGS Tumour First haematological-oncology
M83.6 Aplastic Anaemia, WGS Follow-up Germline haematological-oncology
M84.1 Chronic Myeloid Leukaemia, BCR-ABL1 multiplex haematological-oncology
M84.2 Chronic Myeloid Leukaemia, MRD BCR-ABL1 RT-qPCR haematological-oncology
M84.3 Chronic Myeloid Leukaemia, BCR-ABL1 FISH haematological-oncology
M84.4 Chronic Myeloid Leukaemia, Karyotype (To include detection of trisomy 8, trisomy 19, -7/7q, -5/5q, i(17q), 12p-& t(9;22)(q34;q11) BCR-ABL1, 2nd Ph+[+der(22)t(9;22)(q34;q11)], ider(22)(q10)t(9;22)(q34;q11), inv(3), 11q23 rearrangements) haematological-oncology
M84.6 Chronic Myeloid Leukaemia, FISH copy number and rearrangement Other: See tests M84.12 M84.20 for individual specified FISH targets. haematological-oncology
M84.8 Chronic Myeloid Leukaemia, BCR-ABL1 TKD NGS haematological-oncology
M84.11 Chronic Myeloid Leukaemia, WGS Germline and Tumor haematological-oncology
M84.12 Chronic Myeloid Leukaemia, Chr8 copy number FISH haematological-oncology
M84.13 Chronic Myeloid Leukaemia, Chr19 copy number FISH haematological-oncology
M84.14 Chronic Myeloid Leukaemia, Chr7/Chr7q copy number FISH haematological-oncology
M84.15 Chronic Myeloid Leukaemia, Chr5/Chr5q copy number FISH haematological-oncology
M84.16 Chronic Myeloid Leukaemia, i(17q) FISH haematological-oncology
M84.17 Chronic Myeloid Leukaemia, Chr12p copy number FISH haematological-oncology
M84.18 Chronic Myeloid Leukaemia, t(9;22)(q34;q11) BCR-ABL1 FISH and related abnormalities i.e. 2nd Ph+[+der(22)t(9;22)(q34;q11)], Ider(22)(q10)t(9;22)(q34;q11) haematological-oncology
M84.19 Chronic Myeloid Leukaemia, Inv(3) MECOM FISH haematological-oncology
M84.20 Chronic Myeloid Leukaemia, 11q23 (KMT2A) rearrangement FISH haematological-oncology
M84.21 Chronic Myeloid Leukaemia, Multi-target NGS panel, copy number variant (trisomy 8, trisomy 19, -7/7q, -5/5q, i(17q), 12p-) haematological-oncology
M84.22 Chronic Myeloid Leukaemia, Multi-target NGS panel, structural variant (To include detection of t(9;22)(q34;q11) BCR-ABL1, 2nd Ph+[+der(22)t(9;22)(q34;q11)], Ider(22)(q10)t(9;22)(q34;q11), inv(3), 11q23 rearrangements) haematological-oncology
M84.23 Chronic Myeloid Leukaemia, MRD BCR-ABL1 RT-qPCR rare haematological-oncology
M84.24 Chronic Myeloid Leukaemia, WGS Tumour First haematological-oncology
M84.25 Chronic Myeloid Leukaemia, WGS Follow-up Germline haematological-oncology
M85.1 Myeloproliferative Neoplasm, Multi-target NGS limited panel, small variant (JAK2, CALR, MPL) haematological-oncology
M85.2 Myeloproliferative Neoplasm, Multi-target NGS panel, small variant haematological-oncology
M85.3 Myeloproliferative Neoplasm, Karyotype (To include detection of complex karyotype) haematological-oncology
M85.5 Myeloproliferative Neoplasm, FISH copy number and rearrangement Other: See tests M85.18 -M85.34 for individual specified FISH targets. haematological-oncology
M85.7 Myeloproliferative Neoplasm, FIP1L1-PDGFRA (4q12) FISH/RT-PCR haematological-oncology
M85.8 Myeloproliferative Neoplasm, FIP1L1-PDGFRA RT-qPCR haematological-oncology
M85.9 Myeloproliferative Neoplasm, ETV6-PDGFRB FISH/RT-PCR haematological-oncology
M85.10 Myeloproliferative Neoplasm, PCM1-JAK2 FISH/RT-PCR haematological-oncology
M85.11 Myeloproliferative Neoplasm, BCR-ABL1 multiplex haematological-oncology
M85.12 Myeloproliferative Neoplasm, Other RT-PCR haematological-oncology
M85.13 Myeloproliferative Neoplasm, WGS Germline and Tumor haematological-oncology
M85.14 Myeloproliferative Neoplasm, JAK2 V617F hotspot haematological-oncology
M85.15 Myeloproliferative Neoplasm, JAK2 exon 12 hotspot haematological-oncology
M85.16 Myeloproliferative Neoplasm, CALR exon 9 hotspot haematological-oncology
M85.17 Myeloproliferative Neoplasm, MPL exon 10 hotspot haematological-oncology
M85.19 Myeloproliferative Neoplasm, Chr8 copy number FISH haematological-oncology
M85.20 Myeloproliferative Neoplasm, Chr7/Chr7q copy number FISH haematological-oncology
M85.21 Myeloproliferative Neoplasm, Chr5/Chr5q copy number FISH haematological-oncology
M85.22 Myeloproliferative Neoplasm, i(17q) FISH haematological-oncology
M85.23 Myeloproliferative Neoplasm, Chr12p copy number FISH haematological-oncology
M85.24 Myeloproliferative Neoplasm, t(9;22)(q34;q11) BCR-ABL1 FISH haematological-oncology
M85.25 Myeloproliferative Neoplasm, PDGFRA rearrangement FISH (other than FIP1L1-PDGFRA see M85.7) haematological-oncology
M85.26 Myeloproliferative Neoplasm, PDGFRB rearrangement FISH (other than ETV6-PDGFRB see M85.9) haematological-oncology
M85.27 Myeloproliferative Neoplasm, FGFR1 rearrangement FISH haematological-oncology
M85.28 Myeloproliferative Neoplasm, JAK2 rearrangement FISH (other than PCM1-JAK2 see M85.10) haematological-oncology
M85.29 Myeloproliferative Neoplasm, inv(3)/t(3;3) FISH haematological-oncology
M85.30 Myeloproliferative Neoplasm, 11q23 rearrangement FISH haematological-oncology
M85.31 Myeloproliferative Neoplasm, ABL1 rearrangement FISH (other than BCR-ABL1 see M85.24) haematological-oncology
M85.32 Myeloproliferative Neoplasm, FLT3 rearragement FISH haematological-oncology
M85.33 Myeloproliferative Neoplasm, RET rearrangement FISH haematological-oncology
M85.34 Myeloproliferative Neoplasm, NTRK3 rearrangement FISH haematological-oncology
M85.35 Myeloproliferative Neoplasm, Multi-target NGS panel, structural variant haematological-oncology
M85.36 Myeloproliferative Neoplasm, Multi-target NGS panel, copy number variant (cryptic deletion of 4q12, trisomy 8, -7/7q, -5/5q, i(17q), 12p-) haematological-oncology
M85.37 Myeloproliferative Neoplasm, WGS Tumour First haematological-oncology
M85.38 Myeloproliferative Neoplasm, WGS Follow-up Germline haematological-oncology
M86.1 Systemic Mastocytosis, Multi-target NGS panel, small variant (KIT) haematological-oncology
M86.2 Systemic Mastocytosis, KIT D816 QF-PCR haematological-oncology
M86.3 Systemic Mastocytosis, WGS Germline and Tumor haematological-oncology
M86.4 Systemic Mastocytosis, WGS Tumour First haematological-oncology
M86.5 Systemic Mastocytosis, WGS Follow-up Germline haematological-oncology
M87.1 Chronic Neutrophilic Leukaemia, Multi-target NGS panel, small variant (CSF3R) haematological-oncology
M88.1 Juvenile Myelomonocytic Leukaemia, Multi-target NGS panel, small variant (PTPN11, KRAS, NRAS, NF1, CBL) haematological-oncology
M88.2 Juvenile Myelomonocytic Leukaemia, WGS Germline and Tumor haematological-oncology
M88.3 Juvenile Myelomonocytic Leukaemia, Multi-target NGS panel, small variant haematological-oncology
M88.4 Juvenile Myelomonocytic Leukaemia, Karyotype haematological-oncology
M88.5 Juvenile Myelomonocytic Leukaemia, FISH copy number and rearrangement Other: See tests M88.7-M88.9 for individual specified FISH targets. haematological-oncology
M88.7 Juvenile Myelomonocytic Leukaemia, Chr8 copy number FISH haematological-oncology
M88.8 Juvenile Myelomonocytic Leukaemia, Chr7/Chr7q copy number FISH haematological-oncology
M88.9 Juvenile Myelomonocytic Leukaemia, Chr5/Chr5q copy number FISH haematological-oncology
M88.10 Juvenile Myelomonocytic Leukaemia, Multi-target NGS panel, copy number variant (-7/del7q, -5/del5q, trisomy 8) haematological-oncology
M88.11 Juvenile Myelomonocytic Leukaemia, WGS Tumour First haematological-oncology
M88.12 Juvenile Myelomonocytic Leukaemia, WGS Follow-up Germline haematological-oncology
M89.1 Acute Leukaemia Other, WGS Germline and Tumor haematological-oncology
M89.2 Acute Leukaemia Other, Karyotype (To include detection of Complex karyotype, Monosomal karyotype) haematological-oncology
M89.3 Acute Leukaemia Other, FISH copy number and rearrangement other haematological-oncology
M89.4 Acute Leukaemia Other, Multi-target NGS panel, small variant (NPM1, CEBPA, RUNX1, FLT3, IDH1, IDH2, KIT, WT1, ASXL1, SRSF2, STAG2, RAD21, TP53, KRAS, NRAS, KMT2A(MLL)-PTD, PPM1D, ETV6, NOTCH1, FBXW7, PTEN, HRAS) haematological-oncology
M89.5 Acute Leukaemia Other, FLT3 ITD haematological-oncology
M89.6 Acute Leukaemia Other, Other RT-PCR haematological-oncology
M89.7 Acute Leukaemia Other, Multi-target NGS panel, structural variant haematological-oncology
M89.8 Acute Leukaemia Other, BCR-ABL1 multiplex haematological-oncology
M89.9 Acute Leukaemia Other, MRD NPM1 RT-qPCR haematological-oncology
M89.10 Acute Leukaemia Other, MRD PML-RARA RT-qPCR haematological-oncology
M89.11 Acute Leukaemia Other, MRD RUNX1-RUNX1T1 RT-qPCR haematological-oncology
M89.12 Acute Leukaemia Other, MRD CBFB-MYH11 RT-qPCR haematological-oncology
M89.13 Acute Leukaemia Other, MRD BCR-ABL1 RT-qPCR haematological-oncology
M89.14 Acute Leukaemia Other, MRD other QF-PCR haematological-oncology
M89.15 Acute Leukaemia Other, MRD target identification (Ig/TCR gene rearrangement by PCR & sequencing with MRD workup via QF-PCR) haematological-oncology
M89.16 Acute Leukaemia Other, MRD quantification (Ig/TCR gene rearrangement MRD QF-PCR ) haematological-oncology
M89.17 Acute Leukaemia Other, BCR-ABL1 TKD NGS haematological-oncology
M89.20 Acute Leukaemia Other, FLT3 TKD hotspot haematological-oncology
M89.21 Acute Leukaemia Other, NPM1 exon 12 hotspot haematological-oncology
M89.22 Acute Leukaemia Other, IDH1 hotspot haematological-oncology
M89.23 Acute Leukaemia Other, IDH2 hotspot haematological-oncology
M89.24 Acute Leukaemia Other, Chr5/Chr5q copy number FISH haematological-oncology
M89.25 Acute Leukaemia Other, Chr7/Chr7q copy number FISH haematological-oncology
M89.26 Acute Leukaemia Other, Chr17/Chr17p copy number FISH haematological-oncology
M89.27 Acute Leukaemia Other, Chr12/Chr12p copy number FISH haematological-oncology
M89.28 Acute Leukaemia Other, t(15;17)(q24;q21) PML-RARA FISH haematological-oncology
M89.29 Acute Leukaemia Other, t(8;21)(q22;q22) RUNX1-RUNX1T1 FISH haematological-oncology
M89.30 Acute Leukaemia Other, inv(16)(p13.1q22) CBFB-MYH11 FISH haematological-oncology
M89.31 Acute Leukaemia Other, t(9;11)(p21;q23) MLLT3-KMT2A & other 11q23.3 ( KMT2A) rearrangements FISH haematological-oncology
M89.32 Acute Leukaemia Other, t(6;9)(p22;q34) DEK-NUP214 FISH haematological-oncology
M89.33 Acute Leukaemia Other, inv(3)(q21q26) GATA2-MECOM FISH haematological-oncology
M89.34 Acute Leukaemia Other, t(1;22)(p13;q13) RBM15-MRTFA FISH haematological-oncology
M89.35 Acute Leukaemia Other, t(9;22)(q34;q11) BCR-ABL1 FISH haematological-oncology
M89.36 Acute Leukaemia Other, t(3;5)(q25;q34) NPM1-MLF1 FISH haematological-oncology
M89.37 Acute Leukaemia Other, t(5;11)(q35;p15.5) NUP98-NSD1 FISH haematological-oncology
M89.38 Acute Leukaemia Other, t(7;12)(q36;p13) MNX1-ETV6 FISH haematological-oncology
M89.39 Acute Leukaemia Other, inv(16)(p13.3q24.3) CBFA2T3-GLIS2 FISH haematological-oncology
M89.40 Acute Leukaemia Other, Global copy number change FISH (i.e. hyperdiploidy, high hyperdiploidy, near haploidy, low hypodiploidy) haematological-oncology
M89.41 Acute Leukaemia Other, del(1)(p33p33) FISH haematological-oncology
M89.42 Acute Leukaemia Other, iAMP21 FISH haematological-oncology
M89.52 Acute Leukaemia Other, t(12;21)(p13;q22) ETV6-RUNX1 FISH haematological-oncology
M89.53 Acute Leukaemia Other, t(1;19)(q23;p13) TCF3-PBX1 FISH haematological-oncology
M89.54 Acute Leukaemia Other, t(17;19)(q22;p13) TCF3-HLF FISH haematological-oncology
M89.55 Acute Leukaemia Other, t(4;11)(q21;q23) KMT2A-AFF1 FISH haematological-oncology
M89.56 Acute Leukaemia Other, t(11;19)(q23;p13.3) KMT2A-MLLT1 FISH haematological-oncology
M89.57 Acute Leukaemia Other, t(6;11)(q27;q23) KMT2A-AFDN FISH haematological-oncology
M89.58 Acute Leukaemia Other, t(10;11)(p12;q23) KMT2A-MLLT10 FISH haematological-oncology
M89.59 Acute Leukaemia Other, t(11;19)(q23;p13.1) KMT2A-ELL FISH haematological-oncology
M89.60 Acute Leukaemia Other, t(1;7)(p32;q11) TRB-TAL1 FISH haematological-oncology
M89.61 Acute Leukaemia Other, t(11;14)(p15;q11) TRD-LMO1 FISH haematological-oncology
M89.62 Acute Leukaemia Other, t(7;11)(p15;p15) NUP98-HOXA13 FISH haematological-oncology
M89.63 Acute Leukaemia Other, t(10;14)(q24;q11) TLX1-TRD FISH haematological-oncology
M89.64 Acute Leukaemia Other, t(7;10)(q34;q24) TRB-TLX1 FISH haematological-oncology
M89.65 Acute Leukaemia Other, t(5;14)(q35;q32.2) BCL11B-TLX3 FISH haematological-oncology
M89.66 Acute Leukaemia Other, TAL1 rearrangement FISH (other than TRB-TAL1 see M91.45) haematological-oncology
M89.67 Acute Leukaemia Other, TLX1 rearrangement FISH (other than TLX1-TRD & TRB-TLX1 see M91.48 & M91.49) haematological-oncology
M89.68 Acute Leukaemia Other, PDGFRA rearrangement FISH haematological-oncology
M89.69 Acute Leukaemia Other, PDGFRB rearrangement FISH haematological-oncology
M89.70 Acute Leukaemia Other, ABL1 rearrangement FISH (other than BCR-ABL1 see M91.10) haematological-oncology
M89.71 Acute Leukaemia Other, JAK2 rearrangement FISH haematological-oncology
M89.72 Acute Leukaemia Other, KMT2A rearrangement FISH (other than specific rearrangements described in tests M91.30-91,44) haematological-oncology
M89.73 Acute Leukaemia Other, ABL2 rearrangement FISH haematological-oncology
M89.74 Acute Leukaemia Other, CSF1R rearrangement FISH haematological-oncology
M89.75 Acute Leukaemia Other, 14q32 (IGH) rearrangement FISH haematological-oncology
M89.76 Acute Leukaemia Other, CRLF2 rearrangement FISH haematological-oncology
M89.77 Acute Leukaemia Other, EPOR rearrangement FISH haematological-oncology
M89.78 Acute Leukaemia Other, t(15;17)(q24;q21) PML-RARA RT-PCR haematological-oncology
M89.79 Acute Leukaemia Other, t(8;21)(q22;q22) RUNX1-RUNX1T1 RT-PCR haematological-oncology
M89.80 Acute Leukaemia Other, inv(16)(p13.1q22) CBFB-MYH11 RT-PCR haematological-oncology
M89.81 Acute Leukaemia Other, t(9;11)(p21;q23) MLLT3-KMT2A & other 11q23.3 (KMT2A) rearrangements RT-PCR haematological-oncology
M89.82 Acute Leukaemia Other, t(6;9)(p22;q34) DEK-NUP214 RT-PCR haematological-oncology
M89.83 Acute Leukaemia Other, inv(3)(q21q26) GATA2-MECOM RT-PCR haematological-oncology
M89.84 Acute Leukaemia Other, t(1;22)(p13;q13) RBM15-MRTFA RT-PCR haematological-oncology
M89.85 Acute Leukaemia Other, t(9;22)(q34;q11) BCR-ABL1 RT-PCR haematological-oncology
M89.86 Acute Leukaemia Other, t(3;5)(q25;q34) NPM1-MLF1 RT-PCR haematological-oncology
M89.87 Acute Leukaemia Other, t(5;11)(q35;p15.5) NUP98-NSD1 RT-PCR haematological-oncology
M89.88 Acute Leukaemia Other, t(7;12)(q36;p13) MNX1-ETV6 RT-PCR haematological-oncology
M89.89 Acute Leukaemia Other, inv(16)(p13.3q24.3) CBFA2T3-GLIS2 RT-PCR haematological-oncology
M89.90 Acute Leukaemia Other, t(12;21)(p13;q22) ETV6-RUNX1 RT-PCR haematological-oncology
M89.91 Acute Leukaemia Other, t(1;19)(q23;p13) TCF3-PBX1 RT-PCR haematological-oncology
M89.92 Acute Leukaemia Other, t(17;19)(q22;p13) TCF3-HLF RT-PCR haematological-oncology
M89.93 Acute Leukaemia Other, t(4;11)(q21;q23) KMT2A-AFF1 RT-PCR haematological-oncology
M89.94 Acute Leukaemia Other, t(11;19)(q23;p13.3) KMT2A-MLLT1 RT-PCR haematological-oncology
M89.95 Acute Leukaemia Other, t(6;11)(q27;q23) KMT2A-AFDN RT-PCR haematological-oncology
M89.96 Acute Leukaemia Other, t(10;11)(p12;q23) KMT2A-MLLT10 RT-PCR haematological-oncology
M89.97 Acute Leukaemia Other, t(11;19)(q23;p13.1) KMT2A-ELL RT-PCR haematological-oncology
M89.98 Acute Leukaemia Other, t(1;7)(p32;q11) TRB-TAL1 RT-PCR haematological-oncology
M89.99 Acute Leukaemia Other, t(11;14)(p15;q11) TRD-LMO1 RT-PCR haematological-oncology
M89.100 Acute Leukaemia Other, t(7;11)(p15;p15) NUP98-HOXA13 RT-PCR haematological-oncology
M89.101 Acute Leukaemia Other, t(10;14)(q24;q11) TLX1-TRD RT-PCR haematological-oncology
M89.102 Acute Leukaemia Other, t(7;10)(q34;q24) TRB-TLX1 RT-PCR haematological-oncology
M89.103 Acute Leukaemia Other, t(5;14)(q35;q32.2) BCL11B-TLX3 RT-PCR haematological-oncology
M89.104 Acute Leukaemia Other, Multi-target NGS panel, copy number variant haematological-oncology
M89.105 Acute Leukaemia Other, NUP98 rearrangement FISH haematological-oncology
M89.106 Acute Leukaemia Other, MRD BCR-ABL1 RT-qPCR rare haematological-oncology
M89.107 Acute Leukaemia Other, MRD NPM1 RT-qPCR rare haematological-oncology
M89.108 Acute Leukaemia Other, WGS Tumour First haematological-oncology
M89.109 Acute Leukaemia Other, WGS Follow-up Germline haematological-oncology
M90.1 Blastic Plasmacytoid Dendritic Cell Neoplasm, WGS Germline and Tumor haematological-oncology
M90.2 Blastic Plasmacytoid Dendritic Cell Neoplasm, Karyotype (Genomewide) haematological-oncology
M90.3 Blastic Plasmacytoid Dendritic Cell Neoplasm, FISH copy number and rearrangement haematological-oncology
M90.4 Blastic Plasmacytoid Dendritic Cell Neoplasm, Multi-target NGS panel, small variant (NPM1, CEBPA, RUNX1, FLT3, IDH1, IDH2, KIT, WT1, ASXL1, SRSF2, STAG2, RAD21, TP53, KRAS, NRAS, KMT2A(MLL)-PTD) haematological-oncology
M90.5 Blastic Plasmacytoid Dendritic Cell Neoplasm, FLT3 ITD haematological-oncology
M90.6 Blastic Plasmacytoid Dendritic Cell Neoplasm, WGS Tumour First haematological-oncology
M90.7 Blastic Plasmacytoid Dendritic Cell Neoplasm, WGS Follow-up Germline haematological-oncology
M91.1 Acute Lymphoblastic Leukaemia, WGS Germline and Tumor haematological-oncology
M91.2 Acute Lymphoblastic Leukaemia, Karyotype (To include detection of complex karyotype, hyperdiploidy, high hyperdiploidy, near haploidy, low hypodiploidy etc) haematological-oncology
M91.4 Acute Lymphoblastic Leukaemia, FISH copy number and rearrangement other: See tests M91.24-M91.62 for individual specified FISH targets. haematological-oncology
M91.6 Acute Lymphoblastic Leukaemia, Other RT-PCR: See tests M91-63-M91.77 for individual specified RT-PCR targets haematological-oncology
M91.7 Acute Lymphoblastic Leukaemia, Multi-target NGS panel, structural variant haematological-oncology
M91.8 Acute Lymphoblastic Leukaemia, BCR-ABL1 multiplex haematological-oncology
M91.9 Acute Lymphoblastic Leukaemia, MRD BCR-ABL1 RT-qPCR haematological-oncology
M91.10 Acute Lymphoblastic Leukaemia, BCR-ABL1 FISH haematological-oncology
M91.11 Acute Lymphoblastic Leukaemia, BCR-ABL1 TKD NGS haematological-oncology
M91.14 Acute Lymphoblastic Leukaemia, MRD ALL RT-qPCR haematological-oncology
M91.15 Acute Lymphoblastic Leukaemia, Multi-target NGS panel, small variant (ETV6, NOTCH1, FBXW7, TP53, PTEN, KRAS, NRAS, HRAS) haematological-oncology
M91.22 Acute Lymphoblastic Leukaemia, MRD target identification (Ig/TCR gene rearrangement by PCR & sequencing with MRD workup via QF-PCR) haematological-oncology
M91.23 Acute Lymphoblastic Leukaemia, MRD quantification (Ig/TCR gene rearrangement MRD QF-PCR) haematological-oncology
M91.24 Acute Lymphoblastic Leukaemia, Global copy number change FISH (i.e. hyperdiploidy, high hyperdiploidy, near haploidy, low hypodiploidy) haematological-oncology
M91.25 Acute Lymphoblastic Leukaemia, del(1)(p33p33) FISH haematological-oncology
M91.26 Acute Lymphoblastic Leukaemia, iAMP21 FISH haematological-oncology
M91.36 Acute Lymphoblastic Leukaemia, t(12;21)(p13;q22) ETV6-RUNX1 FISH haematological-oncology
M91.37 Acute Lymphoblastic Leukaemia, t(1;19)(q23;p13) TCF3-PBX1 FISH haematological-oncology
M91.38 Acute Lymphoblastic Leukaemia, t(17;19)(q22;p13) TCF3-HLF FISH haematological-oncology
M91.39 Acute Lymphoblastic Leukaemia, t(4;11)(q21;q23) KMT2A-AFF1 FISH haematological-oncology
M91.40 Acute Lymphoblastic Leukaemia, t(11;19)(q23;p13.3) KMT2A-MLLT1 FISH haematological-oncology
M91.41 Acute Lymphoblastic Leukaemia, t(6;11)(q27;q23) KMT2A-AFDN FISH haematological-oncology
M91.42 Acute Lymphoblastic Leukaemia, t(9;11)(p21;q23) KMT2A-MLLT3 FISH haematological-oncology
M91.43 Acute Lymphoblastic Leukaemia, t(10;11)(p12;q23) KMT2A-MLLT10 FISH haematological-oncology
M91.44 Acute Lymphoblastic Leukaemia, t(11;19)(q23;p13.1) KMT2A-ELL FISH haematological-oncology
M91.45 Acute Lymphoblastic Leukaemia, t(1;7)(p32;q11) TRB-TAL1 FISH haematological-oncology
M91.46 Acute Lymphoblastic Leukaemia, t(11;14)(p15;q11) TRD-LMO1 FISH haematological-oncology
M91.47 Acute Lymphoblastic Leukaemia, t(7;11)(p15;p15) NUP98-HOXA13 FISH haematological-oncology
M91.48 Acute Lymphoblastic Leukaemia, t(10;14)(q24;q11) TLX1-TRD FISH haematological-oncology
M91.49 Acute Lymphoblastic Leukaemia, t(7;10)(q34;q24) TRB-TLX1 FISH haematological-oncology
M91.50 Acute Lymphoblastic Leukaemia, t(5;14)(q35;q32.2) BCL11B-TLX3 FISH haematological-oncology
M91.51 Acute Lymphoblastic Leukaemia, TAL1 rearrangement FISH (other than TRB-TAL1 see M91.45) haematological-oncology
M91.52 Acute Lymphoblastic Leukaemia, TLX1 rearrangement FISH (other than TLX1-TRD & TRB-TLX1 see M91.48 & M91.49) haematological-oncology
M91.53 Acute Lymphoblastic Leukaemia, PDGFRA rearrangement FISH haematological-oncology
M91.54 Acute Lymphoblastic Leukaemia, PDGFRB rearrangement FISH haematological-oncology
M91.55 Acute Lymphoblastic Leukaemia, ABL1 rearrangement FISH (other than BCR-ABL1 see M91.10) haematological-oncology
M91.56 Acute Lymphoblastic Leukaemia, JAK2 rearrangement FISH haematological-oncology
M91.57 Acute Lymphoblastic Leukaemia, KMT2A rearrangement FISH (other than specific rearrangements described in tests M91.30-91,44) haematological-oncology
M91.58 Acute Lymphoblastic Leukaemia, ABL2 rearrangement FISH haematological-oncology
M91.59 Acute Lymphoblastic Leukaemia, CSF1R rearrangement FISH haematological-oncology
M91.60 Acute Lymphoblastic Leukaemia, 14q32(IGH) rearrangement FISH haematological-oncology
M91.61 Acute Lymphoblastic Leukaemia, CRLF2 rearrangement FISH haematological-oncology
M91.62 Acute Lymphoblastic Leukaemia, EPOR rearrangement FISH haematological-oncology
M91.63 Acute Lymphoblastic Leukaemia, t(12;21)(p13;q22) ETV6-RUNX1 RT-PCR haematological-oncology
M91.64 Acute Lymphoblastic Leukaemia, t(1;19)(q23;p13) TCF3-PBX1 RT-PCR haematological-oncology
M91.65 Acute Lymphoblastic Leukaemia, t(17;19)(q22;p13) TCF3-HLF RT-PCR haematological-oncology
M91.66 Acute Lymphoblastic Leukaemia, t(4;11)(q21;q23) KMT2A-AFF1 RT-PCR haematological-oncology
M91.67 Acute Lymphoblastic Leukaemia, t(11;19)(q23;p13.3) KMT2A-MLLT1 RT-PCR haematological-oncology
M91.68 Acute Lymphoblastic Leukaemia, t(6;11)(q27;q23) KMT2A-AFDN RT-PCR haematological-oncology
M91.69 Acute Lymphoblastic Leukaemia, t(9;11)(p21;q23) KMT2A-MLLT3 RT-PCR haematological-oncology
M91.70 Acute Lymphoblastic Leukaemia, t(10;11)(p12;q23) KMT2A-MLLT10 RT-PCR haematological-oncology
M91.71 Acute Lymphoblastic Leukaemia, t(11;19)(q23;p13.1) KMT2A-ELL RT-PCR haematological-oncology
M91.72 Acute Lymphoblastic Leukaemia, t(1;7)(p32;q11) TRB-TAL1 RT-PCR haematological-oncology
M91.73 Acute Lymphoblastic Leukaemia, t(11;14)(p15;q11) TRD-LMO1 RT-PCR haematological-oncology
M91.74 Acute Lymphoblastic Leukaemia, t(7;11)(p15;p15) NUP98-HOXA13 RT-PCR haematological-oncology
M91.75 Acute Lymphoblastic Leukaemia, t(10;14)(q24;q11) TLX1-TRD RT-PCR haematological-oncology
M91.76 Acute Lymphoblastic Leukaemia, t(7;10)q34;q24) TRB-TLX1 RT-PCR haematological-oncology
M91.77 Acute Lymphoblastic Leukaemia, t(5;14)(q35;q32.2) BCL11B-TLX3 RT-PCR haematological-oncology
M91.78 Acute Lymphoblastic Leukaemia, Multi-target NGS panel, copy number variant (to include hyperdiploidy, high hyperdiploidy, near haploidy, low hypodiploidy etc.) haematological-oncology
M91.79 Acute Lymphoblastic Leukaemia, MRD BCR-ABL1 RT-qPCR rare haematological-oncology
M91.80 Acute Lymphoblastic Leukaemia, TPMT haematological-oncology
M91.81 Acute Lymphoblastic Leukaemia, NUDT15 haematological-oncology
M91.82 Acute Lymphoblastic Leukaemia, WGS Tumour First haematological-oncology
M91.83 Acute Lymphoblastic Leukaemia, WGS Follow-up Germline haematological-oncology
M91.84 Acute Lymphoblastic Leukaemia, MYC rearrangement FISH haematological-oncology
M91.85 Acute Lymphoblastic Leukaemia, t(8;14)(q34;q32) IGH-MYC FISH haematological-oncology
M91.86 Acute Lymphoblastic Leukaemia, t(2;8)(p12;q24) IGK-MYC FISH haematological-oncology
M91.87 Acute Lymphoblastic Leukaemia, t(8;22)(q24;q11) IGL-MYC FISH haematological-oncology
M91.88 Acute Lymphoblastic Leukaemia, BCL2 rearrangement FISH haematological-oncology
M91.89 Acute Lymphoblastic Leukaemia, BCL6 rearrangement FISH haematological-oncology
M92.1 Plasma Cell Dyscrasia, Multi-target NGS panel, small variant (KRAS, NRAS, BRAF, TP53, DIS3, TENT5C, IRF4) haematological-oncology
M92.2 Plasma Cell Dyscrasia, t(4;14) IGH-FGFR3FISH/RT-PCR haematological-oncology
M92.3 Plasma Cell Dyscrasia, t(6;14) IGH-CCND3 FISH/RT-PCR haematological-oncology
M92.4 Plasma Cell Dyscrasia, t(11;14)(q13;q32) IGH-CCND1 FISH/RT-PCR haematological-oncology
M92.5 Plasma Cell Dyscrasia, t(14;16) IGH-MAF FISH/RT-PCR haematological-oncology
M92.6 Plasma Cell Dyscrasia, t(14;20) IGH-MAFB FISH/RT-PCR haematological-oncology
M92.7 Plasma Cell Dyscrasia, Multi-target NGS panel, structural variant (To include IGH-FGFR3, IGH-CCND3, IGH-CCND1, IGH-MAF, IGH-MAFB, MYC rearrangements) haematological-oncology
M92.8 Plasma Cell Dyscrasia, IGH rearrangement FISH haematological-oncology
M92.9 Plasma Cell Dyscrasia, Hyperdiploidy copy number FISH haematological-oncology
M92.10 Plasma Cell Dyscrasia, del(1p) copy number FISH haematological-oncology
M92.11 Plasma Cell Dyscrasia, gain(1q) copy number FISH haematological-oncology
M92.12 Plasma Cell Dyscrasia, del(17p) TP53 copy number FISH haematological-oncology
M92.13 Plasma Cell Dyscrasia, Multi-target NGS panel (To include hyperdiploidy, del(1p), gain(1q), del17p) haematological-oncology
M92.14 Plasma Cell Dyscrasia, MYC rearrangement FISH haematological-oncology
M93.3 Lymphoma, WGS Germline and Tumor haematological-oncology
M93.4 Lymphoma, WGS Tumour First haematological-oncology
M93.5 Lymphoma, WGS Follow-up Germline haematological-oncology
M93.6 Lymphoma, Multi-target NGS panel-small variant (BTK, PLCG2, RAS, MAP2K1, BCL2) haematological-oncology
M94.1 Chronic Lymphocytic Leukaemia, Multi-target NGS panel, small variant (TP53,BTK, PLCG2, BCL2) haematological-oncology
M94.2 Chronic Lymphocytic Leukaemia, Multi-target NGS panel, copy number variant (TP53,ATM, DLEU2/7, RB1, trisomy 12) haematological-oncology
M94.4 Chronic Lymphocytic Leukaemia, del(17p) TP53 copy number FISH haematological-oncology
M94.5 Chronic Lymphocytic Leukaemia, Ig gene (heavy & light chain) rearrangement & hypermutation detection multiplex seq haematological-oncology
M94.6 Chronic Lymphocytic Leukaemia, Ig gene (heavy & light chain) rearrangement & hypermutation detection NGS haematological-oncology
M94.7 Chronic Lymphocytic Leukaemia, TP53 seq haematological-oncology
M94.8 Chronic Lymphocytic Leukaemia, 11q copy number FISH haematological-oncology
M94.9 Chronic Lymphocytic Leukaemia, 13q copy number FISH haematological-oncology
M94.10 Chronic Lymphocytic Leukaemia, chromosome 12 copy number FISH haematological-oncology
M95.1 B Cell Non-Hodgkin Lymphoma, Ig gene (heavy & light chain) rearrangement & hypermutation detection multiplex seq haematological-oncology
M95.2 B Cell Non-Hodgkin Lymphoma, Ig gene (heavy & light chain) rearrangement & hypermutation detection NGS haematological-oncology
M95.3 B Cell Non-Hodgkin Lymphoma, Ig rearrangement FISH haematological-oncology
M95.4 B Cell Non-Hodgkin Lymphoma, Multi-target NGS panel, small variant (EZH2) haematological-oncology
M95.5 B Cell Non-Hodgkin Lymphoma, EZH2 copy number FISH haematological-oncology
M95.6 B Cell Non-Hodgkin Lymphoma, Multi-target NGS panel, small variant (BTK, PLCG2) haematological-oncology
M95.7 B Cell Non-Hodgkin Lymphoma, WGS Germline and Tumor haematological-oncology
M95.8 B Cell Non-Hodgkin Lymphoma, Multi-target NGS panel, structural variant (Ig) haematological-oncology
M95.9 B Cell Non-Hodgkin Lymphoma, Mutli-target NGS panel, copy number (EZH2) haematological-oncology
M95.10 B Cell Non-Hodgkin Lymphoma, WGS Tumour First haematological-oncology
M95.11 B Cell Non-Hodgkin Lymphoma, WGS Follow-up Germline haematological-oncology
M95.12 B cell Non-Hodgkin Lymphoma, MYD88 (L265P) hotspot haematological-oncology
M96.1 Burkitt Lymphoma, MYC rearrangement FISH haematological-oncology
M96.2 Burkitt Lymphoma, t(8;14)(q34;q32) IGH-MYC FISH/RT-PCR haematological-oncology
M96.3 Burkitt Lymphoma, t(2;8)(p12;q24) IGK-MYC FISH/RT-PCR haematological-oncology
M96.4 Burkitt Lymphoma, t(8;22)(q24;q11) IGL-MYC FISH/RT-PCR haematological-oncology
M96.5 Burkitt Lymphoma, BCL2 rearrangement FISH haematological-oncology
M96.6 Burkitt Lymphoma, BCL6 rearrangement FISH haematological-oncology
M96.7 Burkitt Lymphoma, WGS Germline and Tumor haematological-oncology
M96.8 Burkitt Lymphoma, Multi-target NGS panel, structural variant (IGH-MYC, IGK-MYC, IGL-MYC, other rearrangements of MYC, BCL2, BCL6) haematological-oncology
M96.9 Burkitt Lymphoma, WGS Tumour First haematological-oncology
M96.10 Burkitt Lymphoma, WGS Follow-up Germline haematological-oncology
M97.1 Burkitt Like Lymphoma with 11q Abnormalities, 11q copy number FISH haematological-oncology
M97.2 Burkitt Like Lymphoma with 11q Abnormalities, WGS Germline and Tumor haematological-oncology
M97.3 Burkitt Like Lymphoma with 11q Abnormalities, Multi-target NGS panel, copy number variant (11q) haematological-oncology
M97.4 Burkitt Like Lymphoma with 11q Abnormalities, WGS Tumour First haematological-oncology
M97.5 Burkitt Like Lymphoma with 11q Abnormalities, WGS Follow-up Germline haematological-oncology
M98.1 Large B Cell Like Lymphoma with IRF4 Rearrangement, IRF4 rearrangement FISH haematological-oncology
M98.2 Large B Cell Like Lymphoma with IRF4 Rearrangement, WGS Germline and Tumor haematological-oncology
M98.3 Large B Cell Like Lymphoma with IRF4 Rearrangement, Multi-target NGS panel, structural variant (IRF4) haematological-oncology
M98.4 Large B Cell Like Lymphoma with IRF4 Rearrangement, WGS Tumour First haematological-oncology
M98.5 Large B Cell Like Lymphoma with IRF4 Rearrangement, WGS Follow-up Germline haematological-oncology
M99.1 High Grade Lymphoma, MYC rearrangement FISH haematological-oncology
M99.2 High Grade Lymphoma, t(8;14)(q34;q32) IGH-MYC FISH/RT-PCR haematological-oncology
M99.3 High Grade Lymphoma, t(2;8)(p12;q24) IGK-MYC FISH/RT-PCR haematological-oncology
M99.4 High Grade Lymphoma, t(8;22)(q24;q11) IGL-MYC FISH/RT-PCR haematological-oncology
M99.5 High Grade Lymphoma, BCL2 rearrangement FISH haematological-oncology
M99.6 High Grade Lymphoma, t(14;18)(q32;q21) IGH-BCL2 FISH/RT-PCR haematological-oncology
M99.7 High Grade Lymphoma, BCL6 rearrangement FISH haematological-oncology
M99.8 High Grade Lymphoma, WGS Germline and Tumor haematological-oncology
M99.9 High Grade Lymphoma, Mutli-target NGS panel, structural variant (IGH-MYC, IGK-MYC, IGL-MYC, IGH-BCL2, other rearrangements of MYC, BCL2, BCL6) haematological-oncology
M99.10 High Grade Lymphoma, WGS Tumour First haematological-oncology
M99.11 High Grade Lymphoma, WGS Follow-up Germline haematological-oncology
M100.1 Primary Mediastinal B Cell Lymphoma, CD274, PDCD1LG2 rearrangement FISH haematological-oncology
M100.2 Primary Mediastinal B Cell Lymphoma, CD274, PDCD1LG2 Copy number FISH haematological-oncology
M100.3 Primary Mediastinal B Cell Lymphoma, REL copy number FISH haematological-oncology
M100.4 Primary Mediastinal B Cell Lymphoma, WGS Germline and Tumour haematological-oncology
M100.5 Primary Mediastinal B Cell Lymphoma, Multi-target NGS panel, copy number variant (CD274, PDCD1LG2, REL) haematological-oncology
M100.6 Primary Mediastinal B Cell Lymphoma, Multi-target NGS panel, rearrangement (CD274, PDCD1LG2) haematological-oncology
M100.7 Primary Mediastinal B Cell Lymphoma, WGS Tumour First haematological-oncology
M100.8 Primary Mediastinal B Cell Lymphoma, WGS Follow-up Germline haematological-oncology
M101.1 ALK Positive Large B Cell Lymphoma, ALK rearrangement FISH haematological-oncology
M101.2 ALK Positive Large B Cell Lymphoma, t(2;17)(p23;q23) CLTC-ALK FISH/RT-PCR haematological-oncology
M101.3 ALK Positive Large B Cell Lymphoma, t(2;5)(p23;q35) ALK-NPM1 FISH/RT-PCR haematological-oncology
M101.4 ALK Positive Large B Cell Lymphoma, WGS Germline and Tumour haematological-oncology
M101.5 ALK Positive Large B Cell Lymphoma, Multi-target NGS panel, structural variant (CLTC-ALK, ALK-NPM1, other ALK rearrangements) haematological-oncology
M101.6 ALK Positive Large B Cell Lymphoma, WGS Tumour First haematological-oncology
M101.7 ALK Positive Large B Cell Lymphoma, WGS Follow-up Germline haematological-oncology
M102.1 Mantle Cell Lymphoma, t(11;14)(q13;q32) IGH-CCND1 FISH/RT-PCR haematological-oncology
M102.2 Mantle Cell Lymphoma, CCND1 rearrangement FISH haematological-oncology
M102.3 Mantle Cell Lymphoma, CCND2 rearrangement FISH haematological-oncology
M102.4 Mantle Cell Lymphoma, Multi-target NGS panel, structural variant (IGH-CCND1, other CCND1 rearrangements, CCND2) haematological-oncology
M102.5 Mantle Cell Lymphoma, Multi-target NGS panel, small variant (TP53) haematological-oncology
M103.1 Follicular Lymphoma, t(14;18)(q32;q21) IGH-BCL2 FISH/RT-PCR haematological-oncology
M103.2 Follicular Lymphoma, BCL2 rearrangement FISH haematological-oncology
M103.3 Follicular Lymphoma, BCL6 rearrangement FISH haematological-oncology
M103.4 Follicular Lymphoma, Multi-target NGS panel, small variant (CARD11, CREBBP, EZH2, ARID1A, EP300, MEF2B, FOXO1) haematological-oncology
M103.5 Follicular Lymphoma, Multi-target NGS panel, structural variant (IGH-BCL2, BCL2, BCL6) haematological-oncology
M104.1 Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinaemia, Multi-target NGS panel, small variant (MYD88, CXCR4) haematological-oncology
M104.2 Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinaemia, MYD88 hotspot haematological-oncology
M105.1 Igm Monoclonal Gammopathy of Uncertain Significance, Multi-target NGS panel, small variant (MYD88, CXCR4) haematological-oncology
M105.2 Igm Monoclonal Gammopathy of Uncertain Significance, MYD88 hotspot haematological-oncology
M106.1 Intra-Ocular Lymphoma, MYD88 hotspot haematological-oncology
M107.1 Malt-Lymphoma, t(11;18)(q21;q21) BIRC3-MALT1 FISH/RT-PCR haematological-oncology
M107.2 Malt-Lymphoma, t(1;14)(p22;q32) IGH-BCL10 FISH/RT-PCR haematological-oncology
M107.3 Malt-Lymphoma, t(14;18)(q32;q21) IGH-MALT1 FISH/RT-PCR haematological-oncology
M107.4 Malt-Lymphoma, MALT1 rearrangement FISH haematological-oncology
M107.5 Malt-Lymphoma, BCL10 rearrangement FISH haematological-oncology
M107.6 Malt-Lymphoma, FOXP1 rearrangement FISH haematological-oncology
M107.7 Malt-Lymphoma, WGS Germline and Tumour haematological-oncology
M107.8 Malt-Lymphoma, Multi-target NGS panel, structural variant (BIRC3-MALT1, IGH-BCL10, IGH-MALT1, other MALT rearrangements, other BCL10 rearrangements, FOXP1) haematological-oncology
M107.9 Malt-Lymphoma, WGS Tumour First haematological-oncology
M107.10 Malt-Lymphoma, WGS Follow-up Germline haematological-oncology
M108.1 Hairy Cell Leukaemia, Multi-target NGS panel, small variant (BRAF) haematological-oncology
M108.2 Hairy Cell Leukaemia, BRAF V600 hotspot haematological-oncology
M108.5 Hairy Cell Leukaemia, Ig gene hypermutation detection multiplex seq haematological-oncology
M108.6 Hairy Cell Leukaemia, Ig gene hypermutation detection NGS haematological-oncology
M109.1 Hairy Cell Leukaemia, Vh4-34 Variant, Ig gene (heavy chain) rearrangement detection multiplex seq haematological-oncology
M109.2 Hairy Cell Leukaemia, Vh4-34 Variant, Ig gene (heavy chain) rearrangement detection NGS haematological-oncology
M110.1 Paediatric Type Follicular Lymphoma, Multi-target NGS panel, small variant (MAP2K1) haematological-oncology
M110.2 Paediatric Type Follicular Lymphoma, WGS Germline and Tumour haematological-oncology
M110.3 Paediatric Type Follicular Lymphoma, WGS Tumour First haematological-oncology
M110.4 Paediatric Type Follicular Lymphoma, WGS Follow-up Germline haematological-oncology
M111.1 T Cell Non-Hodgkin Lymphoma, Multi-target NGS panel, small variant (RHOA, DNMT3A, IDH2, TET2) haematological-oncology
M111.2 T Cell Non-Hodgkin Lymphoma, TCR gene rearrangement detection multiplex seq haematological-oncology
M111.3 T Cell Non-Hodgkin Lymphoma, TCR gene rearrangement detection NGS haematological-oncology
M111.4 T Cell Non-Hodgkin Lymphoma, TCR rearrangement FISH haematological-oncology
M111.5 T Cell Non-Hodgkin Lymphoma, WGS Germline and Tumour haematological-oncology
M111.6 T Cell Non-Hodgkin Lymphoma, Multi-target NGS panel, structural variant (TCR rearrangement) haematological-oncology
M111.7 T Cell Non-Hodgkin Lymphoma, WGS Tumour First haematological-oncology
M111.8 T Cell Non-Hodgkin Lymphoma, WGS Follow-up Germline haematological-oncology
M112.3 ALK Negative Anaplastic Large Cell Lymphoma (Including Primary Cutaneous Subtypes), IRF4/DUSP22 rearrangement FISH/RT-PCR haematological-oncology
M112.4 ALK Negative Anaplastic Large Cell Lymphoma (Including Primary Cutaneous Subtypes), TP63 rearrangement FISH/RT-PCR haematological-oncology
M112.5 ALK Negative Anaplastic Large Cell Lymphoma (Including Primary Cutaneous Subtypes), WGS Germline and Tumour haematological-oncology
M112.6 ALK Negative Anaplastic Large Cell Lymphoma (Including Primary Cutaneous Subtypes), Multi-target NGS panel, structural variant (IRF4/DUSP22, TP63) haematological-oncology
M112.7 ALK Negative Anaplastic Large Cell Lymphoma (Including Primary Cutaneous Subtypes), WGS Tumour First haematological-oncology
M112.8 ALK Negative Anaplastic Large Cell Lymphoma (Including Primary Cutaneous Subtypes), WGS Follow-up Germline haematological-oncology
M113.1 T Prolymphocytic Leukaemia, TCL1A rearrangement FISH haematological-oncology
M113.2 T Prolymphocytic Leukaemia, Chr8 rearrangement FISH haematological-oncology
M113.3 T Prolymphocytic Leukaemia, Multi-target NGS panel, structural variant (TCL1A, Chr8) haematological-oncology
M113.6 T Prolymphocytic Leukaemia, Karyotype (to include TCL1 rearrangements t(X;14)) haematological-oncology
M114.1 Large Granular Lymphocyte Leukaemia, Multi-target NGS panel, small variant (STAT3, STAT5B) haematological-oncology
M115.1 NK Cell/Gamma-Delta T Cell Lymphoma, Multi-target NGS panel, small variant (STAT3, STAT5B) haematological-oncology
M115.2 NK Cell/Gamma-Delta T Cell Lymphoma, WGS Germline and Tumour haematological-oncology
M115.3 NK Cell/Gamma-Delta T Cell Lymphoma, WGS Tumour First haematological-oncology
M115.4 NK Cell/Gamma-Delta T Cell Lymphoma, WGS Follow-up Germline haematological-oncology
M116.1 Hepatosplenic T Cell Lymphoma, Multi-target NGS panel, small variant (STAT3, STAT5B) haematological-oncology
M116.2 Hepatosplenic T Cell Lymphoma, i7q rearrangement FISH haematological-oncology
M116.3 Hepatosplenic T Cell Lymphoma, WGS Germline and Tumour haematological-oncology
M116.4 Hepatosplenic T Cell Lymphoma, Multi-target NGS panel, structural variant (i17q) haematological-oncology
M116.5 Hepatosplenic T Cell Lymphoma, WGS Tumour First haematological-oncology
M116.6 Hepatosplenic T Cell Lymphoma, WGS Follow-up Germline haematological-oncology
M117.1 Histiocytosis, Multi-target NGS panel, small variant (BRAF, MAP2K1, NRAS, KRAS, HRAS, ERBB3, ARAF, MAP3K1, PIK3CA, PIK3CD) haematological-oncology
M117.2 Histiocytosis, Multi-target NGS panel, structural variant haematological-oncology
M117.3 Histiocytosis, ALK rearrangement FISH haematological-oncology
M117.7 Histiocytosis, BRAF rearrangement FISH haematological-oncology
M117.12 Histiocytosis, NTRK1 rearrangement FISH haematological-oncology
M117.16 Histiocytosis, WGS Germline and Tumour haematological-oncology
M117.17 Histiocytosis, WGS Tumour First haematological-oncology
M117.18 Histiocytosis, WGS Follow-up Germline haematological-oncology
M117.19 Histiocytosis, High Sensitivity BRAF haematological-oncology
M118.1 Any patient undergoing Allogeneic Haematopoietic Stem Cell transplantation, STR Testing haematological-oncology
M118.2 Any patient undergoing Allogeneic Haematopoietic Stem Cell transplantation, Sex chromosome FISH haematological-oncology
M120.1 Atypical Teratoid/Rhabdoid Tumour, Paediatric, Multi-target NGS panel, small variant (SMARCA4, SMARCB1) cancer
M120.2 Atypical Teratoid/Rhabdoid Tumour, Paediatric, SMARCA4 seq cancer
M120.3 Atypical Teratoid/Rhabdoid Tumour, Paediatric, SMARCB1 seq cancer
M120.4 Atypical Teratoid/Rhabdoid Tumour, Paediatric, SMARCA4 copy number FISH cancer
M120.5 Atypical Teratoid/Rhabdoid Tumour, Paediatric, SMARCB1 copy number FISH cancer
M120.6 Atypical Teratoid/Rhabdoid Tumour, Paediatric, Multi-target NGS panel, structural variant cancer
M120.7 Atypical Teratoid/Rhabdoid Tumour, Paediatric, BRAF-KIAA1549 FISH/RT-PCR cancer
M120.8 Atypical Teratoid/Rhabdoid Tumour, Paediatric, BRAF-FXR1 FISH/RT-PCR cancer
M120.9 Atypical Teratoid/Rhabdoid Tumour, Paediatric, BRAF-AGK FISH/RT-PCR cancer
M120.10 Atypical Teratoid/Rhabdoid Tumour, Paediatric, BRAF-AKAP9 FISH/RT-PCR cancer
M120.11 Atypical Teratoid/Rhabdoid Tumour, Paediatric, BRAF-CCDC6 FISH/RT-PCR cancer
M120.12 Atypical Teratoid/Rhabdoid Tumour, Paediatric, BRAF-FAM118B FISH/RT-PCR cancer
M120.13 Atypical Teratoid/Rhabdoid Tumour, Paediatric, BRAF-GNAI1 FISH/RT-PCR cancer
M120.14 Atypical Teratoid/Rhabdoid Tumour, Paediatric, BRAF-MACF1 FISH/RT-PCR cancer
M120.15 Atypical Teratoid/Rhabdoid Tumour, Paediatric, BRAF rearrangement FISH cancer
M120.16 Atypical Teratoid/Rhabdoid Tumour, Paediatric, WGS Germline and Tumour cancer
M120.17 Atypical Teratoid/Rhabdoid Tumour, Paediatric, Multi-target NGS panel, copy number variant (SMARCA4, SMARCB1) cancer
M120.18 Atypical Teratoid/Rhabdoid Tumour, Paediatric, DNA Methylation cancer
M126.1 CNS High-Grade Neuroepithelial Tumour with MN1 Alteration, Paediatric, MN1 rearrangement FISH cancer
M126.2 CNS High-Grade Neuroepithelial Tumour with MN1 Alteration, Paediatric, WGS Germline and Tumour cancer
M126.3 CNS High-Grade Neuroepithelial Tumour with MN1 Alteration, Paediatric, Multi-target NGS panel, structural variant (MN1, NTRK1, NTRK2, NTRK3) cancer
M126.4 CNS High-Grade Neuroepithelial Tumour with MN1 Alteration, Paediatric, DNA Methylation cancer
M130.1 Cribriform Neuroepithelial Tumour, Paediatric, Multi-target NGS panel, small variant (SMARCB1) cancer
M130.2 Cribriform Neuroepithelial Tumour, Paediatric, SMARCB1 seq cancer
M130.3 Cribriform Neuroepithelial Tumour, Paediatric, SMARCB1 copy number FISH cancer
M130.4 Cribriform Neuroepithelial Tumour, Paediatric, WGS Germline and Tumour cancer
M130.5 Cribriform Neuroepithelial Tumour, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M130.6 Cribriform Neuroepithelial Tumour, Paediatric, Multi-target NGS panel, copy number variant (SMARCB1) cancer
M130.7 Cribriform Neuroepithelial Tumour, Paediatric, DNA Methylation cancer
M132.1 Desmoplastic Infantile Gangliogliomas, Paediatric, Multi-target NGS panel, small variant (BRAF) cancer
M132.2 Desmoplastic Infantile Gangliogliomas, Paediatric, Multi-target NGS panel, structural variant cancer
M132.3 Desmoplastic Infantile Gangliogliomas, Paediatric, BRAF-KIAA1549 FISH/RT-PCR cancer
M132.4 Desmoplastic Infantile Gangliogliomas, Paediatric, BRAF-FXR1 FISH/RT-PCR cancer
M132.5 Desmoplastic Infantile Gangliogliomas, Paediatric, BRAF-AGK FISH/RT-PCR cancer
M132.6 Desmoplastic Infantile Gangliogliomas, Paediatric, BRAF-AKAP9 FISH/RT-PCR cancer
M132.7 Desmoplastic Infantile Gangliogliomas, Paediatric, BRAF-CCDC6 FISH/RT-PCR cancer
M132.8 Desmoplastic Infantile Gangliogliomas, Paediatric, BRAF-FAM118B FISH/RT-PCR cancer
M132.9 Desmoplastic Infantile Gangliogliomas, Paediatric, BRAF-GNAI1 FISH/RT-PCR cancer
M132.10 Desmoplastic Infantile Gangliogliomas, Paediatric, BRAF-MACF1 FISH/RT-PCR cancer
M132.11 Desmoplastic Infantile Gangliogliomas, Paediatric, BRAF rearrangement FISH cancer
M132.12 Desmoplastic Infantile Gangliogliomas, Paediatric, WGS Germline and Tumour cancer
M132.13 Desmoplastic Infantile Gangliogliomas, Paediatric, DNA Methylation cancer
M133.1 Desmoplastic Medulloblastoma, Paediatric, Multi-target NGS panel, small variant (SUFU) cancer
M133.2 Desmoplastic Medulloblastoma, Paediatric, SUFU seq cancer
M133.3 Desmoplastic Medulloblastoma, Paediatric, WGS Germline and Tumour cancer
M133.4 Desmoplastic Medulloblastoma, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M133.5 Desmoplastic Medulloblastoma, Paediatric, DNA Methylation cancer
M136.1 Fibrolamellar Hepatocellular Carcinoma, Paediatric, DNAJB1-PRKACA FISH/RT-PCR cancer
M136.2 Fibrolamellar Hepatocellular Carcinoma, Paediatric, WGS Germline and Tumour cancer
M136.3 Fibrolamellar Hepatocellular Carcinoma, Paediatric, Multi-target NGS panel, structural variant (DNAJB1-PRKACA, NTRK1, NTRK2, NTRK3) cancer
M136.5 Fibrolamellar Hepatocellular Carcinoma, Paediatric, DPYD hotspot cancer
M137.1 Ganglioglioma, Paediatric, Multi-target NGS panel, small variant (BRAF) cancer
M137.2 Ganglioglioma, Paediatric, Multi-target NGS panel, structural variant (BRAF-KIAA1549, BRAF-FXR1, BRAF-AGK, BRAF-AKAP9, BRAF-CCDC6, BRAF-FAM118B, BRAF-GNAI1, BRAF-MACF1, other rearrangements of BRAF, NTRK1, NTRK2, NTRK3) cancer
M137.3 Ganglioglioma, Paediatric, BRAF-KIAA1549 FISH/RT-PCR cancer
M137.4 Ganglioglioma, Paediatric, BRAF-FXR1 FISH/RT-PCR cancer
M137.5 Ganglioglioma, Paediatric, BRAF-AGK FISH/RT-PCR cancer
M137.6 Ganglioglioma, Paediatric, BRAF-AKAP9 FISH/RT-PCR cancer
M137.7 Ganglioglioma, Paediatric, BRAF-CCDC6 FISH/RT-PCR cancer
M137.8 Ganglioglioma, Paediatric, BRAF-FAM118B FISH/RT-PCR cancer
M137.9 Ganglioglioma, Paediatric, BRAF-GNAI1 FISH/RT-PCR cancer
M137.10 Ganglioglioma, Paediatric, BRAF-MACF1 FISH/RT-PCR cancer
M137.11 Ganglioglioma, Paediatric, KIAA1549 copy number FISH cancer
M137.12 Ganglioglioma, Paediatric, BRAF rearrangement FISH cancer
M137.13 Ganglioglioma, Paediatric, WGS Germline and Tumour cancer
M137.14 Ganglioglioma, Paediatric, Multi-target NGS panel, copy number variant (KIAA1549) cancer
M137.15 Ganglioglioma, Paediatric, DNA Methylation cancer
M138.1 Glial Tumours, Paediatric, Multi-target NGS panel, small variant (ATRX) cancer
M138.2 Glial Tumours, Paediatric, WGS Germline and Tumour cancer
M138.3 Glial Tumours, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M138.4 Glial Tumours, Paediatric, DNA Methylation cancer
M139.1 Glioblastoma, Paediatric, Multi-target NGS panel, small variant (BRAF, CDKN2A, FGFR4) cancer
M139.2 Glioblastoma, Paediatric, Multi-target NGS panel, structural variant (BRAF-KIAA1549, BRAF-FXR1, BRAF-AGK, BRAF-AKAP9, BRAF-CCDC6, BRAF-FAM118B, BRAF-GNAI1, BRAF-MACF1, other rearrangements of BRAF, NTRK1, NTRK2, NTRK3) cancer
M139.3 Glioblastoma, Paediatric, BRAF-KIAA1549 FISH/RT-PCR cancer
M139.4 Glioblastoma, Paediatric, BRAF-FXR1 FISH/RT-PCR cancer
M139.5 Glioblastoma, Paediatric, BRAF-AGK FISH/RT-PCR cancer
M139.6 Glioblastoma, Paediatric, BRAF-AKAP9 FISH/RT-PCR cancer
M139.7 Glioblastoma, Paediatric, BRAF-CCDC6 FISH/RT-PCR cancer
M139.8 Glioblastoma, Paediatric, BRAF-FAM118B FISH/RT-PCR cancer
M139.9 Glioblastoma, Paediatric, BRAF-GNAI1 FISH/RT-PCR cancer
M139.10 Glioblastoma, Paediatric, BRAF-MACF1 FISH/RT-PCR cancer
M139.12 Glioblastoma, Paediatric, CDKN2A seq cancer
M139.13 Glioblastoma, Paediatric, FGFR4 seq cancer
M139.14 Glioblastoma, Paediatric, CDKN2A copy number FISH cancer
M139.15 Glioblastoma, Paediatric, BRAF rearrangement FISH cancer
M139.16 Glioblastoma, Paediatric, WGS Germline and Tumour cancer
M139.17 Glioblastoma, Paediatric, Multi-target NGS panel, copy number variant (CDKN2A) cancer
M139.18 Glioblastoma, Paediatric, DNA Methylation cancer
M145.1 Medulloblastoma, Paediatric, Multi-target NGS panel, small variant (ALK, BCOR, PTCH1, PTCH2, PTEN, TERT promoter) cancer
M145.2 Medulloblastoma, Paediatric, ALK seq cancer
M145.3 Medulloblastoma, Paediatric, BCOR seq cancer
M145.4 Medulloblastoma, Paediatric, PTCH1 seq cancer
M145.5 Medulloblastoma, Paediatric, PTCH2 seq cancer
M145.6 Medulloblastoma, Paediatric, TERT promoter seq cancer
M145.7 Medulloblastoma, Paediatric, ALK copy number FISH cancer
M145.8 Medulloblastoma, Paediatric, ALK rearrangement FISH cancer
M145.9 Medulloblastoma, Paediatric, BCOR copy number FISH cancer
M145.10 Medulloblastoma, Paediatric, BCOR rearrangement FISH cancer
M145.11 Medulloblastoma, Paediatric, C19MC copy number FISH cancer
M145.12 Medulloblastoma, Paediatric, PTEN copy number FISH cancer
M145.13 Medulloblastoma, Paediatric, WGS Germline and Tumour cancer
M145.14 Medulloblastoma, Paediatric, Multi-target NGS panel, structural variant (ALK, BCOR, NTRK1, NTRK2, NTRK3) cancer
M145.15 Medulloblastoma, Paediatric, Multi-target NGS panel, copy number variant (ALK, BCOR, C19MC, PTEN) cancer
M145.16 Medulloblastoma, Paediatric, DNA Methylation cancer
M146.1 Medulloblastoma Group 3, Paediatric, Multi-target NGS panel, small variant (SMARCA4, DDX3X) cancer
M146.2 Medulloblastoma Group 3, Paediatric, SMARCA4 seq cancer
M146.3 Medulloblastoma Group 3, Paediatric, DDX3X seq cancer
M146.4 Medulloblastoma Group 3, Paediatric, SMARCA4 copy number FISH cancer
M146.5 Medulloblastoma Group 3, Paediatric, PVT1-MYC FISH/RT-PCR cancer
M146.6 Medulloblastoma Group 3, Paediatric, WGS Germline and Tumour cancer
M146.7 Medulloblastoma Group 3, Paediatric, Multi-target NGS panel, structural variant (PVT1-MYC, NTRK1, NTRK2, NTRK3) cancer
M146.8 Medulloblastoma Group 3, Paediatric, Multi-target NGS panel, copy number variant (SMARCA4) cancer
M146.9 Medulloblastoma Group 3, Paediatric, DNA Methylation cancer
M147.1 Medulloblastoma Group 3/4, Paediatric, Multi-target NGS panel, small variant (MYCN, EZH2) cancer
M147.2 Medulloblastoma Group 3/4, Paediatric, MYCN seq cancer
M147.3 Medulloblastoma Group 3/4, Paediatric, EZH2 seq cancer
M147.4 Medulloblastoma Group 3/4, Paediatric, MYCN copy number FISH cancer
M147.5 Medulloblastoma Group 3/4, Paediatric, MYC copy number FISH cancer
M147.6 Medulloblastoma Group 3/4, Paediatric, MYC rearrangement FISH cancer
M147.7 Medulloblastoma Group 3/4, Paediatric, WGS Germline and Tumour cancer
M147.8 Medulloblastoma Group 3/4, Paediatric, Multi-target NGS panel, structural variant (MYC, NTRK1, NTRK2, NTRK3) cancer
M147.9 Medulloblastoma Group 3/4, Paediatric, Multi-target NGS panel, copy number variant (MYCN, MYC) cancer
M147.10 Medulloblastoma Group 3/4, Paediatric, DNA Methylation cancer
M148.1 Medulloblastoma TP53 WT, Paediatric, Multi-target NGS panel, small variant (YAP1, PTCH1) cancer
M148.2 Medulloblastoma TP53 WT, Paediatric, YAP1 seq cancer
M148.3 Medulloblastoma TP53 WT, Paediatric, PTCH1 seq cancer
M148.4 Medulloblastoma TP53 WT, Paediatric, YAP1-C11orf95 FISH/RT-PCR cancer
M148.5 Medulloblastoma TP53 WT, Paediatric, YAP1-TFE3 FISH/RT-PCR cancer
M148.6 Medulloblastoma TP53 WT, Paediatric, YAP1 copy number FISH cancer
M148.7 Medulloblastoma TP53 WT, Paediatric, PTCH1 copy number FISH cancer
M148.8 Medulloblastoma TP53 WT, Paediatric, WGS Germline and Tumour cancer
M148.9 Medulloblastoma TP53 WT, Paediatric, Multi-target NGS panel, structural variant (YAP1-C11orf95, YAP1-TFE3, NTRK1, NTRK2, NTRK3) cancer
M148.10 Medulloblastoma TP53 WT, Paediatric, Multi-target NGS panel, copy number variant (YAP1, PTCH1) cancer
M148.11 Medulloblastoma TP53 WT, Paediatric, DNA Methylation cancer
M150.1 Meningioma, Paediatric, Multi-target NGS panel, small variant (SMARCE1, AKT1, NF2, TERT promoter) cancer
M150.2 Meningioma, Paediatric, SMARCE1 seq cancer
M150.3 Meningioma, Paediatric, AKT1 seq cancer
M150.4 Meningioma, Paediatric, NF2 seq cancer
M150.5 Meningioma, Paediatric, TERT promoter seq cancer
M150.6 Meningioma, Paediatric, WGS Germline and Tumour cancer
M150.7 Meningioma, Paediatric, DNA Methylation cancer
M150.8 Meningioma, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M153.1 Nodular Brain Tumour, Paediatric, Multi-target NGS panel, small variant (SMO) cancer
M153.2 Nodular Brain Tumour, Paediatric, SMO seq cancer
M153.3 Nodular Brain Tumour, Paediatric, SMO copy number FISH cancer
M153.4 Nodular Brain Tumour, Paediatric, WGS Germline and Tumor cancer
M153.5 Nodular Brain Tumour, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M153.6 Nodular Brain Tumour, Paediatric, Multi-target NGS panel, copy number variant (SMO) cancer
M153.7 Nodular Brain Tumour, Paediatric, DNA Methylation cancer
M155.1 Oligoastrocytoma, Paediatric, Multi-target NGS panel, small variant (KIT) cancer
M155.2 Oligoastrocytoma, Paediatric, KIT copy number FISH cancer
M155.3 Oligoastrocytoma, Paediatric, WGS Germline and Tumor cancer
M155.4 Oligoastrocytoma, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M155.5 Oligoastrocytoma, Paediatric, Multi-target NGS panel, copy number variant (KIT) cancer
M155.6 Oligoastrocytoma, Paediatric, DNA Methylation cancer
M156.1 Oligodendroglioma, Paediatric, Multi-target NGS panel, small variant (RB1, ATRX) cancer
M156.2 Oligodendroglioma, Paediatric, ATRX seq cancer
M156.3 Oligodendroglioma, Paediatric, RB1 seq cancer
M156.4 Oligodendroglioma, Paediatric, Multi-target NGS panel, copy number variant (1p19q, RB1, ATRX) cancer
M156.5 Oligodendroglioma, Paediatric, 1p19q codel FISH cancer
M156.6 Oligodendroglioma, Paediatric, RB1 copy number FISH cancer
M156.7 Oligodendroglioma, Paediatric, ATRX copy number FISH cancer
M156.8 Oligodendroglioma, Paediatric, WGS Germline and Tumor cancer
M156.9 Oligodendroglioma, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M156.10 Oligodendroglioma, Paediatric, DNA Methylation cancer
M158.1 Pilocytic Astrocytoma, Paediatric, Multi-target NGS panel, small variant (RAF1) cancer
M158.2 Pilocytic Astrocytoma, Paediatric, RAF1 seq cancer
M158.3 Pilocytic Astrocytoma, Paediatric, RAF1-SRGAP3 FISH/RT-PCR cancer
M158.4 Pilocytic Astrocytoma, Paediatric, RAF1-NF1A FISH/RT-PCR cancer
M158.5 Pilocytic Astrocytoma, Paediatric, WGS Germline and Tumor cancer
M158.6 Pilocytic Astrocytoma, Paediatric, Multi-target NGS panel, structural variant (RAF1-SRGAP3, RAF1-NF1A, NTRK1, NTRK2, NTRK3) cancer
M158.7 Pilocytic Astrocytoma, Paediatric, DNA Methylation cancer
M159.1 Pituitary Blastoma, Paediatric, Multi-target NGS panel, small variant (DICER1) cancer
M159.2 Pituitary Blastoma, Paediatric, DICER1 seq cancer
M159.3 Pituitary Blastoma, Paediatric, DICER1 copy number FISH cancer
M159.4 Pituitary Blastoma, Paediatric, WGS Germline and Tumour cancer
M159.5 Pituitary Blastoma, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M159.6 Pituitary Blastoma, Paediatric, Multi-target NGS panel, copy number variant (DICER1) cancer
M159.7 Pituitary Blastoma, Paediatric, DNA Methylation cancer
M160.1 Pleomorphic Xanthoastrocytoma, Paediatric, Multi-target NGS panel, small variant (BRAF, H3-3A) cancer
M160.2 Pleomorphic Xanthoastrocytoma, Paediatric, Multi-target NGS panel, structural variant cancer
M160.3 Pleomorphic Xanthoastrocytoma, Paediatric, BRAF-KIAA1549 FISH/RT-PCR cancer
M160.4 Pleomorphic Xanthoastrocytoma, Paediatric, BRAF-FXR1 FISH/RT-PCR cancer
M160.5 Pleomorphic Xanthoastrocytoma, Paediatric, BRAF-AGK FISH/RT-PCR cancer
M160.6 Pleomorphic Xanthoastrocytoma, Paediatric, BRAF-AKAP9 FISH/RT-PCR cancer
M160.7 Pleomorphic Xanthoastrocytoma, Paediatric, BRAF-CCDC6 FISH/RT-PCR cancer
M160.8 Pleomorphic Xanthoastrocytoma, Paediatric, BRAF-FAM118B FISH/RT-PCR cancer
M160.9 Pleomorphic Xanthoastrocytoma, Paediatric, BRAF-GNAI1 FISH/RT-PCR cancer
M160.10 Pleomorphic Xanthoastrocytoma, Paediatric, BRAF-MACF1 FISH/RT-PCR cancer
M160.11 Pleomorphic Xanthoastrocytoma, Paediatric, H3-3A seq cancer
M160.12 Pleomorphic Xanthoastrocytoma, Paediatric, KIAA1549 copy number FISH cancer
M160.13 Pleomorphic Xanthoastrocytoma, Paediatric, BRAF rearrangement FISH cancer
M160.14 Pleomorphic Xanthoastrocytoma, Paediatric, WGS Germline and Tumour cancer
M160.15 Pleomorphic Xanthoastrocytoma, Paediatric, Multi-target NGS panel, copy number variant (KIAA1549) cancer
M160.16 Pleomorphic Xanthoastrocytoma, Paediatric, DNA Methylation cancer
M162.1 Primitive Neuroectodermal Tumours, Paediatric, Multi-target NGS panel, small variant (MSH6, PMS2, PTEN) cancer
M162.2 Primitive Neuroectodermal Tumours, Paediatric, MSH6 seq cancer
M162.3 Primitive Neuroectodermal Tumours, Paediatric, PMS2 seq cancer
M162.4 Primitive Neuroectodermal Tumours, Paediatric, MYC copy number FISH cancer
M162.5 Primitive Neuroectodermal Tumours, Paediatric, MYC rearrangement FISH cancer
M162.6 Primitive Neuroectodermal Tumours, Paediatric, MSH6 copy number FISH cancer
M162.7 Primitive Neuroectodermal Tumours, Paediatric, PTEN copy number FISH cancer
M162.8 Primitive Neuroectodermal Tumours, Paediatric, WGS Germline and Tumor cancer
M162.9 Primitive Neuroectodermal Tumours, Paediatric, Multi-target NGS panel, structural variant (MYC, NTRK1, NTRK2, NTRK3) cancer
M162.10 Primitive Neuroectodermal Tumours, Paediatric, Multi-target NGS panel, copy number variant (MYC, MSH6, PTEN) cancer
M162.11 Primitive Neuroectodermal Tumours, Paediatric, DNA Methylation cancer
M168.1 Rosette-Forming Glioneuronal Tumour, Paediatric, Multi-target NGS panel, small variant (PIK3CA, FGFR1) cancer
M168.2 Rosette-Forming Glioneuronal Tumour, Paediatric, FGFR1 seq cancer
M168.3 Rosette-Forming Glioneuronal Tumour, Paediatric, FGFR1 rearrangement FISH cancer
M168.4 Rosette-Forming Glioneuronal Tumour, Paediatric, FGFR1 ITD FISH cancer
M168.5 Rosette-Forming Glioneuronal Tumour, Paediatric, WGS Germline and Tumor cancer
M168.6 Rosette-Forming Glioneuronal Tumour, Paediatric, Multi-target NGS panel, structural variant (FGFR1, NTRK1, NTRK2, NTRK3) cancer
M168.7 Rosette-Forming Glioneuronal Tumour, Paediatric, Multi-target NGS panel, copy number variant (FGFR1 ITD) cancer
M168.8 Rosette-Forming Glioneuronal Tumour, Paediatric, DNA Methylation cancer
M169.1 Secondary Glioblastoma, Paediatric, Multi-target NGS panel, small variant (IDH1, IDH2) cancer
M169.2 Secondary Glioblastoma, Paediatric, IDH1 seq cancer
M169.3 Secondary Glioblastoma, Paediatric, IDH2 seq cancer
M169.4 Secondary Glioblastoma, Paediatric, WGS Germline and Tumor cancer
M169.5 Secondary Glioblastoma, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M169.6 Secondary Glioblastoma, Paediatric, DNA Methylation cancer
M170.1 SHH Medulloblastoma, Paediatric, Multi-target NGS panel, small variant (SMO, DDX3X) cancer
M170.2 SHH Medulloblastoma, Paediatric, SMO seq cancer
M170.3 SHH Medulloblastoma, Paediatric, DDX3X seq cancer
M170.4 SHH Medulloblastoma, Paediatric, SMO copy number FISH cancer
M170.5 SHH Medulloblastoma, Paediatric, DDX3X copy number FISH cancer
M170.6 SHH Medulloblastoma, Paediatric, WGS Germline and Tumor cancer
M170.7 SHH Medulloblastoma, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M170.8 SHH Medulloblastoma, Paediatric, Multi-target NGS panel, copy number variant (SMO, DDX3X) cancer
M170.9 SHH Medulloblastoma, Paediatric, DNA Methylation cancer
M171.1 SHH Medulloblastoma, TP53 WT, Paediatric, Multi-target NGS panel, small variant (SUFU, TERT promoter, PTCH1) cancer
M171.2 SHH Medulloblastoma, TP53 WT, Paediatric, PTCH1 seq cancer
M171.3 SHH Medulloblastoma, TP53 WT, Paediatric, SUFU seq cancer
M171.4 SHH Medulloblastoma, TP53 WT, Paediatric, TERT promoter seq cancer
M171.5 SHH Medulloblastoma, TP53 WT, Paediatric, PTCH1 copy number FISH cancer
M171.6 SHH Medulloblastoma, TP53 WT, Paediatric, TERT copy number FISH cancer
M171.7 SHH Medulloblastoma, TP53 WT, Paediatric, WGS Germline and Tumor cancer
M171.8 SHH Medulloblastoma, TP53 WT, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M171.9 SHH Medulloblastoma, TP53 WT, Paediatric, Multi-target NGS panel, copy number variant (PTCH1, TERT) cancer
M171.10 SHH Medulloblastoma, TP53 WT, Paediatric, DNA Methylation cancer
M172.1 SHH Medulloblastoma, TP53 MUTANT, Paediatric, Multi-target NGS panel, small variant (TP53, MYCN) cancer
M172.2 SHH Medulloblastoma, TP53 MUTANT, Paediatric, TP53 seq cancer
M172.3 SHH Medulloblastoma, TP53 MUTANT, Paediatric, MYCN seq cancer
M172.4 SHH Medulloblastoma, TP53 MUTANT, Paediatric, del(17p) TP53 copy number FISH cancer
M172.5 SHH Medulloblastoma, TP53 MUTANT, Paediatric, MYCN copy number FISH cancer
M172.6 SHH Medulloblastoma, TP53 MUTANT, Paediatric, WGS Germline and Tumor cancer
M172.7 SHH Medulloblastoma, TP53 MUTANT, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M172.8 SHH Medulloblastoma, TP53 MUTANT, Paediatric, Multi-target NGS panel, copy number variant (TP53, MYCN) cancer
M172.9 SHH Medulloblastoma, TP53 MUTANT, Paediatric, DNA Methylation cancer
M179.1 WNT Medulloblastoma, Paediatric, Multi-target NGS panel, small variant (DDX3X, CTNNB1, SMARCA4, TP53) cancer
M179.2 WNT Medulloblastoma, Paediatric, DDX3X seq cancer
M179.3 WNT Medulloblastoma, Paediatric, CTNNB1 seq cancer
M179.4 WNT Medulloblastoma, Paediatric, SMARCA4 seq cancer
M179.5 WNT Medulloblastoma, Paediatric, TP53 seq cancer
M179.6 WNT Medulloblastoma, Paediatric, SMARCA4 copy number FISH cancer
M179.7 WNT Medulloblastoma, Paediatric, del(17p) TP53 copy number FISH cancer
M179.8 WNT Medulloblastoma, Paediatric, WGS Germline and Tumor cancer
M179.9 WNT Medulloblastoma, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M179.10 WNT Medulloblastoma, Paediatric, Multi-target NGS panel, copy number variant (SMARCA4, TP53) cancer
M179.11 WNT Medulloblastoma, Paediatric, DNA Methylation cancer
M181.1 Hairy Cell Leukaemia, Non-Classical Variant, Multi-target NGS panel, small variant (MAP2K1) haematological-oncology
M181.4 Hairy Cell Leukaemia, Non-Classical Variant, Ig gene hypermutation detection multiplex seq haematological-oncology
M181.5 Hairy Cell Leukaemia, Non-Classical Variant, Ig gene hypermutation detection NGS haematological-oncology
M182.1 ALK Positive Anaplastic Large Cell Lymphoma, t(2;5)(p23;q35) ALK-NPM1 FISH/RT-PCR haematological-oncology
M182.2 ALK Positive Anaplastic Large Cell Lymphoma, ALK rearrangement FISH haematological-oncology
M182.3 ALK Positive Anaplastic Large Cell Lymphoma, WGS Germline and Tumor haematological-oncology
M182.4 ALK Positive Anaplastic Large Cell Lymphoma, Multi-target NGS panel, structural variant (ALK-NPM1, other ALK rearrangements) haematological-oncology
M182.5 ALK Positive Anaplastic Large Cell Lymphoma, WGS Tumour First haematological-oncology
M182.6 ALK Positive Anaplastic Large Cell Lymphoma, WGS Follow-up Germline haematological-oncology
M183.1 Diffuse Midline Glioma, Paediatric, Multi-target NGS panel, small variant (H3-3A, NF1, TERT promoter) cancer
M183.2 Diffuse Midline Glioma, Paediatric, MYCN copy number FISH cancer
M183.3 Diffuse Midline Glioma, Paediatric, MYC copy number FISH cancer
M183.4 Diffuse Midline Glioma, Paediatric, MYC rearrangement FISH cancer
M183.5 Diffuse Midline Glioma, Paediatric, WGS Germline and Tumor cancer
M183.6 Diffuse Midline Glioma, Paediatric, 1p19q codel FISH/RT-PCR cancer
M183.7 Diffuse Midline Glioma, Paediatric, DNA Methylation cancer
M183.8 Diffuse Midline Glioma, Paediatric, Multi-target NGS panel, copy number variant (1p, 19q, MYC, MYCN) cancer
M183.9 Diffuse Midline Glioma, Paediatric, Multi-target NGS panel, structural variant (MYC, NTRK1, NTRK2, NTRK3) cancer
M184.1 Glioma, Paediatric, Multi-target NGS panel, small variant (H3-3B, H3C2, H3C3, H3C14, IDH1, IDH2, TP53, VHL) cancer
M184.2 Glioma, Paediatric, WGS Germline and Tumor cancer
M184.3 Glioma, Paediatric, IDH1 hotspot cancer
M184.4 Glioma, Paediatric, IDH2 hotspot cancer
M184.5 Glioma, Paediatric, 1p19q codel FISH/RT-PCR cancer
M184.6 Glioma, Paediatric, DNA Methylation cancer
M184.7 Glioma, Paediatric, Multi-target NGS panel, copy number variant (1p, 19q) cancer
M184.8 Glioma, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M185.1 High Grade Glioma, Paediatric, Multi-target NGS panel, small variant (CDKN2B) cancer
M185.2 High Grade Glioma, Paediatric, WGS Germline and Tumor cancer
M185.3 High Grade Glioma, Paediatric, 1p19q codel FISH/RT-PCR cancer
M185.4 High Grade Glioma, Paediatric, DNA Methylation cancer
M185.5 High Grade Glioma, Paediatric, Multi-target NGS panel, copy number variant (1p, 19q) cancer
M186.1 Low Grade Glioma, Paediatric, Multi-target NGS panel, small variant (TSC1, TSC2, IDH1, IDH2, FGFR1) cancer
M186.2 Low Grade Glioma, Paediatric, WGS Germline and Tumor cancer
M186.3 Low Grade Glioma, Paediatric, IDH1 hotspot cancer
M186.4 Low Grade Glioma, Paediatric, IDH2 hotspot cancer
M186.5 Low Grade Glioma, Paediatric, 1p19q codel FISH/RT-PCR cancer
M186.6 Low Grade Glioma, Paediatric, DNA Methylation cancer
M186.7 Low Grade Glioma, Paediatric, Multi-target NGS panel, copy number variant (1p, 19q) cancer
M186.8 Low Grade Glioma, Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M189.1 Brain Tumour, No Further Morphological Classification, Paediatric, Multi-target NGS panel, small variant (IDH1, IDH2, BRAF, H3C2, H3C3, H3C14, H3-3A, H3-3B, TERT promoter, TP53, VHL, YAP1, SMARCA4, SMARCB1, DDX3X, CTNNB1) cancer
M189.2 Brain Tumour, No Further Morphological Classification, Paediatric, Multi-target NGS panel, structural variant (CIC, BCOR, BCOR-CCNB3, C11orf95-RELA, YAP1-C11orf95, YAP1-TFE3, EWSR1, MN1, RELA, YAP1, NTRK1, NTRK2, NTRK3) cancer
M189.3 Brain Tumour, No Further Morphological Classification, Paediatric, BCOR-CCNB3 RT-PCR cancer
M189.4 Brain Tumour, No Further Morphological Classification, Paediatric, C11orf95-RELA FISH/RT-PCR cancer
M189.5 Brain Tumour, No Further Morphological Classification, Paediatric, YAP1-C11orf95 FISH/RT-PCR cancer
M189.6 Brain Tumour, No Further Morphological Classification, Paediatric, YAP1-TFE3 FISH/RT-PCR cancer
M189.7 Brain Tumour, No Further Morphological Classification, Paediatric, EWSR1 rearrangement FISH cancer
M189.8 Brain Tumour, No Further Morphological Classification, Paediatric, MN1 rearrangement FISH cancer
M189.9 Brain Tumour, No Further Morphological Classification, Paediatric, RELA rearrangement FISH/RT-PCR cancer
M189.10 Brain Tumour, No Further Morphological Classification, Paediatric, YAP1 rearrangement FISH/RT-PCR cancer
M189.11 Brain Tumour, No Further Morphological Classification, Paediatric, SNP Array cancer
M189.12 Brain Tumour, No Further Morphological Classification, Paediatric, C19MC copy number FISH cancer
M189.13 Brain Tumour, No Further Morphological Classification, Paediatric, SMARCA4 copy number FISH cancer
M189.14 Brain Tumour, No Further Morphological Classification, Paediatric, SMARCB1 copy number FISH cancer
M189.15 Brain Tumour, No Further Morphological Classification, Paediatric, YAP1 copy number FISH cancer
M189.16 Brain Tumour, No Further Morphological Classification, Paediatric, MGMT promoter hyperMethylation cancer
M189.17 Brain Tumour, No Further Morphological Classification, Paediatric, WGS Germline and Tumor cancer
M189.18 Brain Tumour, No Further Morphological Classification, Paediatric, IDH1 hotspot cancer
M189.19 Brain Tumour, No Further Morphological Classification, Paediatric, IDH2 hotspot cancer
M189.20 Brain Tumour, No Further Morphological Classification, Paediatric, DNA Methylation cancer
M189.21 Brain Tumour, No Further Morphological Classification, Paediatric, Multi-target NGS panel, copy number variant (C19MC, SMARCA4, SMARCB1, YAP1) cancer
M190.1 Embryonal Tumour Differential, Adult and Paediatric, Multi-target NGS panel, small variant (CDKN2A, DICER1, RB1, YAP1, SMARCA4, SMARCB1, MSH6, PMS2, PTEN, ATRX) cancer
M190.2 Embryonal Tumour Differential, Adult and Paediatric, Multi-target NGS panel, structural variant cancer
M190.3 Embryonal Tumour Differential, Adult and Paediatric, BCOR-CCNB3 RT-PCR cancer
M190.4 Embryonal Tumour Differential, Adult and Paediatric, BRAF-AGK FISH/RT-PCR cancer
M190.5 Embryonal Tumour Differential, Adult and Paediatric, BRAF-AKAP9 FISH/RT-PCR cancer
M190.6 Embryonal Tumour Differential, Adult and Paediatric, BRAF-CCDC6 FISH/RT-PCR cancer
M190.7 Embryonal Tumour Differential, Adult and Paediatric, BRAF-FAM118B FISH/RT-PCR cancer
M190.8 Embryonal Tumour Differential, Adult and Paediatric, BRAF-FRX1 FISH/RT-PCR cancer
M190.9 Embryonal Tumour Differential, Adult and Paediatric, BRAF-GNAI1 FISH/RT-PCR cancer
M190.10 Embryonal Tumour Differential, Adult and Paediatric, BRAF-KIAA1549 FISH/RT-PCR cancer
M190.11 Embryonal Tumour Differential, Adult and Paediatric, BRAF-MACF1 FISH/RT-PCR cancer
M190.12 Embryonal Tumour Differential, Adult and Paediatric, BRAF rearrangement FISH cancer
M190.13 Embryonal Tumour Differential, Adult and Paediatric, C11orf95-RELA FISH/RT-PCR cancer
M190.14 Embryonal Tumour Differential, Adult and Paediatric, RELA rearrangement FISH/RT-PCR cancer
M190.15 Embryonal Tumour Differential, Adult and Paediatric, TTYH1-C19MC FISH/RT-PCR cancer
M190.16 Embryonal Tumour Differential, Adult and Paediatric, YAP1 rearrangement FISH/RT-PCR cancer
M190.17 Embryonal Tumour Differential, Adult and Paediatric, YAP1-C11orf95 FISH/RT-PCR cancer
M190.18 Embryonal Tumour Differential, Adult and Paediatric, YAP1-TFE3 FISH/RT-PCR cancer
M190.19 Embryonal Tumour Differential, Adult and Paediatric, MYC rearrangement FISH cancer
M190.20 Embryonal Tumour Differential, Adult and Paediatric, MN1 rearrangement FISH cancer
M190.21 Embryonal Tumour Differential, Adult and Paediatric, SNP Array cancer
M190.22 Embryonal Tumour Differential, Adult and Paediatric, C19MC copy number FISH cancer
M190.23 Embryonal Tumour Differential, Adult and Paediatric, DICER1 copy number FISH cancer
M190.24 Embryonal Tumour Differential, Adult and Paediatric, MSH6 copy number FISH cancer
M190.25 Embryonal Tumour Differential, Adult and Paediatric, MYC copy number FISH cancer
M190.26 Embryonal Tumour Differential, Adult and Paediatric, PTEN (10q23) copy number FISH/RT-PCR cancer
M190.27 Embryonal Tumour Differential, Adult and Paediatric, SMARCA4 copy number FISH cancer
M190.28 Embryonal Tumour Differential, Adult and Paediatric, SMARCB1 copy number FISH cancer
M190.30 Embryonal Tumour Differential, Adult and Paediatric, WGS Germline and Tumor cancer
M190.31 Embryonal Tumour Differential, Adult and Paediatric, DNA Methylation cancer
M190.32 Embryonal Tumour Differential, Adult and Paediatric, Multi-target NGS panel, copy number variant (C19MC, DICER1, MSH6, MYC, PTEN, SMARCA4, SMARCB1) cancer
M191.1 Low Grade Intrinsic Brain Tumour Differential, Adult, Multi-target NGS panel, small variant (IDH1, IDH2, ATRX, H3-3A, H3-3B, H3C2, H3C3, H3C14, BRAF, TERT promoter, CDKN2B, TP53, VHL, NF1) cancer
M191.2 Low Grade Intrinsic Brain Tumour Differential, Adult, BRAF-AGK FISH/RT-PCR cancer
M191.3 Low Grade Intrinsic Brain Tumour Differential, Adult, BRAF-AKAP9 FISH/RT-PCR cancer
M191.4 Low Grade Intrinsic Brain Tumour Differential, Adult, BRAF-CCDC6 FISH/RT-PCR cancer
M191.5 Low Grade Intrinsic Brain Tumour Differential, Adult, BRAF-FAM118B FISH/RT-PCR cancer
M191.6 Low Grade Intrinsic Brain Tumour Differential, Adult, BRAF-FXR1 FISH/RT-PCR cancer
M191.7 Low Grade Intrinsic Brain Tumour Differential, Adult, BRAF-GNAI1 FISH/RT-PCR cancer
M191.8 Low Grade Intrinsic Brain Tumour Differential, Adult, BRAF-KIAA1549 FISH/RT-PCR cancer
M191.9 Low Grade Intrinsic Brain Tumour Differential, Adult, BRAF-MACF1 FISH/RT-PCR cancer
M191.10 Low Grade Intrinsic Brain Tumour Differential, Adult, BRAF rearrangement FISH cancer
M191.11 Low Grade Intrinsic Brain Tumour Differential, Adult, Multi-target NGS panel, copy number variant (1p, 19q, EGFR, CDKN2A, PTEN) cancer
M191.12 Low Grade Intrinsic Brain Tumour Differential, Adult, 1p19q codel FISH/RT-PCR cancer
M191.13 Low Grade Intrinsic Brain Tumour Differential, Adult, CDKN2A copy number FISH cancer
M191.14 Low Grade Intrinsic Brain Tumour Differential, Adult, EGFR copy number FISH cancer
M191.15 Low Grade Intrinsic Brain Tumour Differential, Adult, EGFRvIII RT-PCR cancer
M191.16 Low Grade Intrinsic Brain Tumour Differential, Adult, PTEN (10q23) copy number FISH/RT-PCR cancer
M191.17 Low Grade Intrinsic Brain Tumour Differential, Adult, MGMT promoter hyperMethylation cancer
M191.18 Low Grade Intrinsic Brain Tumour Differential, Adult, IDH1 hotspot cancer
M191.19 Low Grade Intrinsic Brain Tumour Differential, Adult, IDH2 hotspot cancer
M191.20 Low Grade Intrinsic Brain Tumour Differential, Adult, DNA Methylation cancer
M191.21 Low Grade Intrinsic Brain Tumour Differential, Adult, Multi-target NGS panel, structural variant cancer
M191.22 Low Grade Intrinsic Brain Tumour Differential, Adult, WGS Germline and Tumor cancer
M192.1 High Grade Intrinsic Brain Tumour Differential, Adult, Multi-target NGS panel, small variant (IDH1, IDH2, ATRX, H3-3A, H3-3B, H3C2, H3C3, H3C14, BRAF, TERT promoter, CDKN2B, TP53, VHL, NF1) cancer
M192.2 High Grade Intrinsic Brain Tumour Differential, Adult, BRAF-AGK FISH/RT-PCR cancer
M192.3 High Grade Intrinsic Brain Tumour Differential, Adult, BRAF-AKAP9 FISH/RT-PCR cancer
M192.4 High Grade Intrinsic Brain Tumour Differential, Adult, BRAF-CCDC6 FISH/RT-PCR cancer
M192.5 High Grade Intrinsic Brain Tumour Differential, Adult, BRAF-FAM118B FISH/RT-PCR cancer
M192.6 High Grade Intrinsic Brain Tumour Differential, Adult, BRAF-FXR1 FISH/RT-PCR cancer
M192.7 High Grade Intrinsic Brain Tumour Differential, Adult, BRAF-GNAI1 FISH/RT-PCR cancer
M192.8 High Grade Intrinsic Brain Tumour Differential, Adult, BRAF-KIAA1549 FISH/RT-PCR cancer
M192.9 High Grade Intrinsic Brain Tumour Differential, Adult, BRAF-MACF1 FISH/RT-PCR cancer
M192.10 High Grade Intrinsic Brain Tumour Differential, Adult, BRAF rearrangement FISH cancer
M192.11 High Grade Intrinsic Brain Tumour Differential, Adult, Multi-target NGS panel, copy number variant (EGFR) cancer
M192.12 High Grade Intrinsic Brain Tumour Differential, Adult, 1p19q codel FISH/RT-PCR cancer
M192.13 High Grade Intrinsic Brain Tumour Differential, Adult, CDKN2A copy number FISH cancer
M192.14 High Grade Intrinsic Brain Tumour Differential, Adult, EGFR copy number FISH cancer
M192.15 High Grade Intrinsic Brain Tumour Differential, Adult, EGFRvIII RT-PCR cancer
M192.16 High Grade Intrinsic Brain Tumour Differential, Adult, PTEN (10q23) copy number FISH/RT-PCR cancer
M192.17 High Grade Intrinsic Brain Tumour Differential, Adult, MGMT promoter hyperMethylation cancer
M192.18 High Grade Intrinsic Brain Tumour Differential, Adult, IDH1 hotspot cancer
M192.19 High Grade Intrinsic Brain Tumour Differential, Adult, IDH2 hotspot cancer
M192.20 High Grade Intrinsic Brain Tumour Differential, Adult, DNA Methylation cancer
M192.21 High Grade Intrinsic Brain Tumour Differential, Adult, Multi-target NGS panel, structural variant cancer
M192.22 High Grade Intrinsic Brain Tumour Differential, Adult, Multi-target NGS panel, copy number variant (1p, 19q, EGFR, CDKN2A, PTEN) cancer
M192.23 High Grade Intrinsic Brain Tumour Differential, Adult, WGS Germline and Tumor cancer
M193.1 Unable To Grade Intrinsic Brain Tumour, Adult, Multi-target NGS panel, small variant (IDH1, IDH2, ATRX, H3-3A, H3-3B, H3C2, H3C3, H3C14, BRAF, TERT promoter, CDKN2B, TP53, VHL, NF1) cancer
M193.2 Unable To Grade Intrinsic Brain Tumour, Adult, BRAF-AGK FISH/RT-PCR cancer
M193.3 Unable To Grade Intrinsic Brain Tumour, Adult, BRAF-AKAP9 FISH/RT-PCR cancer
M193.4 Unable To Grade Intrinsic Brain Tumour, Adult, BRAF-CCDC6 FISH/RT-PCR cancer
M193.5 Unable To Grade Intrinsic Brain Tumour, Adult, BRAF-FAM118B FISH/RT-PCR cancer
M193.6 Unable To Grade Intrinsic Brain Tumour, Adult, BRAF-FXR1 FISH/RT-PCR cancer
M193.7 Unable To Grade Intrinsic Brain Tumour, Adult, BRAF-GNAI1 FISH/RT-PCR cancer
M193.8 Unable To Grade Intrinsic Brain Tumour, Adult, BRAF-KIAA1549 FISH/RT-PCR cancer
M193.9 Unable To Grade Intrinsic Brain Tumour, Adult, BRAF-MACF1 FISH/RT-PCR cancer
M193.10 Unable To Grade Intrinsic Brain Tumour, Adult, BRAF rearrangement FISH cancer
M193.11 Unable To Grade Intrinsic Brain Tumour, Adult, Multi-target NGS panel, copy number variant (EGFR) cancer
M193.12 Unable To Grade Intrinsic Brain Tumour, Adult, 1p19q codel FISH/RT-PCR cancer
M193.13 Unable To Grade Intrinsic Brain Tumour, Adult, CDKN2A copy number FISH cancer
M193.14 Unable To Grade Intrinsic Brain Tumour, Adult, EGFR copy number FISH cancer
M193.15 Unable To Grade Intrinsic Brain Tumour, Adult, EGFRvIII RT-PCR cancer
M193.16 Unable To Grade Intrinsic Brain Tumour, Adult, PTEN (10q23) copy number FISH/RT-PCR cancer
M193.17 Unable To Grade Intrinsic Brain Tumour, Adult, MGMT promoter hyperMethylation cancer
M193.18 Unable To Grade Intrinsic Brain Tumour, Adult, IDH1 hotspot cancer
M193.19 Unable To Grade Intrinsic Brain Tumour, Adult, IDH2 hotspot cancer
M193.20 Unable To Grade Intrinsic Brain Tumour, Adult, DNA Methylation cancer
M193.21 Unable To Grade Intrinsic Brain Tumour, Adult, Multi-target NGS panel, structural variant cancer
M193.22 Unable To Grade Intrinsic Brain Tumour, Adult, Multi-target NGS panel, copy number variant (1p, 19q, EGFR, CDKN2A, PTEN) cancer
M193.23 Unable To Grade Intrinsic Brain Tumour, Adult, WGS Germline and Tumor cancer
M194.1 Medulloblastoma all Subtypes, Multi-target NGS panel, small variant (ALK, BCOR, CTNNB1, DDX3X, DDX3X, EZH2, MYCN, PTCH1, PTCH2, PTEN, SMARCA4, SMO, SUFU, TERT promoter, TP53, YAP1) cancer
M194.2 Medulloblastoma all Subtypes, ALK rearrangement FISH cancer
M194.3 Medulloblastoma all Subtypes, BCOR rearrangement FISH cancer
M194.4 Medulloblastoma all Subtypes, MYC rearrangement FISH cancer
M194.5 Medulloblastoma all Subtypes, PVT1-MYC FISH/RT-PCR cancer
M194.6 Medulloblastoma all Subtypes, YAP1-C11orf95 FISH/RT-PCR cancer
M194.7 Medulloblastoma all Subtypes, YAP1-TFE3 FISH/RT-PCR cancer
M194.8 Medulloblastoma all Subtypes, SNP Array cancer
M194.9 Medulloblastoma all Subtypes, ALK copy number FISH cancer
M194.10 Medulloblastoma all Subtypes, BCOR copy number FISH cancer
M194.11 Medulloblastoma all Subtypes, C19MC copy number FISH cancer
M194.12 Medulloblastoma all Subtypes, DDX3X copy number FISH cancer
M194.13 Medulloblastoma all Subtypes, MYC copy number FISH cancer
M194.14 Medulloblastoma all Subtypes, MYCN copy number FISH cancer
M194.15 Medulloblastoma all Subtypes, PTCH1 copy number FISH cancer
M194.16 Medulloblastoma all Subtypes, PTEN (10q23) copy number FISH/RT-PCR cancer
M194.17 Medulloblastoma all Subtypes, SMARCA4 copy number FISH cancer
M194.18 Medulloblastoma all Subtypes, SMO copy number FISH cancer
M194.19 Medulloblastoma all Subtypes, TERT copy number FISH cancer
M194.20 Medulloblastoma all Subtypes, del(17p) TP53 copy number FISH cancer
M194.21 Medulloblastoma all Subtypes, YAP1 copy number FISH cancer
M194.22 Medulloblastoma all Subtypes, WGS Germline and Tumor cancer
M194.23 Medulloblastoma all Subtypes, DNA Methylation cancer
M194.24 Medulloblastoma all Subtypes, Multi-target NGS panel, structural variant (ALK, BCOR, MYC, PVT1-MYC, YAP1-C11orf95, YAP1-TFE3, NTRK1, NTRK2, NTRK3) cancer
M194.25 Medulloblastoma all Subtypes, Multi-target NGS panel, copy number variant (ALK, BCOR, C19MC, DDX3X, MYC, MYCN, PTCH1, PTEN, SMARCA4, SMO, TERT, TP53, YAP1) cancer
M195.1 Craniopharyngioma, Adult and Paediatric, Multi-target NGS panel, small variant (BRAF, CTNNB1) cancer
M195.2 Craniopharyngioma, Adult and Paediatric, MGMT promoter hyperMethylation cancer
M195.3 Craniopharyngioma, Adult and Paediatric, WGS Germline and Tumor cancer
M195.4 Craniopharyngioma, Adult and Paediatric, Multi-target NGS panel, structural variant (NTRK1, NTRK2, NTRK3) cancer
M195.5 Craniopharyngioma, Adult and Paediatric, DNA Methylation cancer
M213.1 Glial and Glioneuronal Tumour Differential, Paediatric, Multi-target NGS panel, small variant (SMARCA4, SMARCB1, DDX3X, CTNNB1, CDKN2A, TP53, RAF1, PIK3CA, FGFR1, FGFR4, KIT, BRAF, H3-3A, ALK, ATRX, NRAS, PHOX2B) cancer
M213.2 Glial and Glioneuronal Tumour Differential, Paediatric, Multi-target NGS panel, structural variant (BRAF-KIAA1549, BRAF-AGK, BRAF-AKAP9, BRAF-CCDC6, BRAF-FAM118B, BRAF-FXR1, BRAF-GNAI1, BRAF-MACF1, other rearrangements of BRAF, ALK, C1 cancer
M213.3 Glial and Glioneuronal Tumour Differential, Paediatric, BRAF rearrangement FISH cancer
M213.4 Glial and Glioneuronal Tumour Differential, Paediatric, BRAF-AGK FISH/RT-PCR cancer
M213.5 Glial and Glioneuronal Tumour Differential, Paediatric, BRAF-AKAP9 FISH/RT-PCR cancer
M213.6 Glial and Glioneuronal Tumour Differential, Paediatric, BRAF-CCDC6 FISH/RT-PCR cancer
M213.7 Glial and Glioneuronal Tumour Differential, Paediatric, BRAF-FAM118B FISH/RT-PCR cancer
M213.8 Glial and Glioneuronal Tumour Differential, Paediatric, BRAF-FRX1 FISH/RT-PCR cancer
M213.9 Glial and Glioneuronal Tumour Differential, Paediatric, BRAF-GNAI1 FISH/RT-PCR cancer
M213.10 Glial and Glioneuronal Tumour Differential, Paediatric, BRAF-KIAA1549 FISH/RT-PCR cancer
M213.11 Glial and Glioneuronal Tumour Differential, Paediatric, BRAF-MACF1 FISH/RT-PCR cancer
M213.12 Glial and Glioneuronal Tumour Differential, Paediatric, ALK-NPM1 rearrangement FISH cancer
M213.13 Glial and Glioneuronal Tumour Differential, Paediatric, C11orf95-RELA FISH/RT-PCR cancer
M213.14 Glial and Glioneuronal Tumour Differential, Paediatric, EWSR1 rearrangement FISH cancer
M213.15 Glial and Glioneuronal Tumour Differential, Paediatric, FGFR1 rearrangement FISH cancer
M213.16 Glial and Glioneuronal Tumour Differential, Paediatric, RAF1-NF1A FISH/RT-PCR cancer
M213.17 Glial and Glioneuronal Tumour Differential, Paediatric, RAF1-SRGAP3 FISH/RT-PCR cancer
M213.18 Glial and Glioneuronal Tumour Differential, Paediatric, RELA rearrangement FISH/RT-PCR cancer
M213.19 Glial and Glioneuronal Tumour Differential, Paediatric, YAP1 rearrangement FISH/RT-PCR cancer
M213.20 Glial and Glioneuronal Tumour Differential, Paediatric, YAP1-C11orf95 FISH/RT-PCR cancer
M213.21 Glial and Glioneuronal Tumour Differential, Paediatric, YAP1-TFE3 FISH/RT-PCR cancer
M213.22 Glial and Glioneuronal Tumour Differential, Paediatric, Multi-target NGS panel, copy number variant (1p, 19q, EGFR, ALK, C19MC, CDKN2A, FGFR1, KIAA1549, KIT, MYCN, PDGFRA, SMARCA4, SMARCB1, YAP1) cancer
M213.23 Glial and Glioneuronal Tumour Differential, Paediatric, 1p19q codel FISH/RT-PCR cancer
M213.24 Glial and Glioneuronal Tumour Differential, Paediatric, ALK copy number FISH cancer
M213.25 Glial and Glioneuronal Tumour Differential, Paediatric, C19MC copy number FISH cancer
M213.26 Glial and Glioneuronal Tumour Differential, Paediatric, CDKN2A copy number FISH cancer
M213.27 Glial and Glioneuronal Tumour Differential, Paediatric, EGFR copy number FISH cancer
M213.28 Glial and Glioneuronal Tumour Differential, Paediatric, FGFR1 ITD FISH cancer
M213.29 Glial and Glioneuronal Tumour Differential, Paediatric, KIAA1549 copy number FISH cancer
M213.30 Glial and Glioneuronal Tumour Differential, Paediatric, KIT copy number FISH cancer
M213.31 Glial and Glioneuronal Tumour Differential, Paediatric, MYCN copy number FISH cancer
M213.32 Glial and Glioneuronal Tumour Differential, Paediatric, PDGFRA FISH/RT-PCR cancer
M213.33 Glial and Glioneuronal Tumour Differential, Paediatric, SMARCA4 copy number FISH cancer
M213.34 Glial and Glioneuronal Tumour Differential, Paediatric, SMARCB1 copy number FISH cancer
M213.35 Glial and Glioneuronal Tumour Differential, Paediatric, YAP1 copy number FISH cancer
M213.36 Glial and Glioneuronal Tumour Differential, Paediatric, EGFRvIII RT-PCR cancer
M213.37 Glial and Glioneuronal Tumour Differential, Paediatric, WGS Germline and Tumor cancer
M213.38 Glial and Glioneuronal Tumour Differential, Paediatric, DNA Methylation cancer
M224.1 MDS/MPN, Multi-target NGS panel, small variant haematological-oncology
M224.2 MDS/MPN, Karyotype (To include detection of complex karyotype) haematological-oncology
M224.3 MDS/MPN, FISH copy number and rearrangement Other: See tests M224. -M224. for individual specified FISH targets. haematological-oncology
M224.4 MDS/MPN, WGS Germline and Tumor haematological-oncology
M224.5 MDS/MPN, Multi-target NGS limited panel, small variant (JAK2, CALR, MPL) haematological-oncology
M224.6 MDS/MPN, FIP1L1-PDGFRA FISH/RT-PCR haematological-oncology
M224.7 MDS/MPN, FIP1L1-PDGFRA RT-qPCR haematological-oncology
M224.8 MDS/MPN, ETV6-PDGFRB FISH/RT-PCR haematological-oncology
M224.9 MDS/MPN, PCM1-JAK2 FISH/RT-PCR haematological-oncology
M224.10 MDS/MPN, BCR-ABL1 multiplex haematological-oncology
M224.11 MDS/MPN, Other RT-PCR haematological-oncology
M224.13 MDS/MPN, JAK2 V617F hotspot haematological-oncology
M224.14 MDS/MPN, JAK2 exon 12 hotspot haematological-oncology
M224.15 MDS/MPN, CALR exon 9 hotspot haematological-oncology
M224.16 MDS/MPN, MPL exon 10 hotspot haematological-oncology
M224.18 MDS/MPN, Chr8 copy number FISH haematological-oncology
M224.19 MDS/MPN, Chr7/Chr7q copy number FISH haematological-oncology
M224.20 MDS/MPN, Chr5/Chr5q copy number FISH haematological-oncology
M224.21 MDS/MPN, i(17q)/t(17p) FISH haematological-oncology
M224.22 MDS/MPN, Chr12p copy number FISH, t(12p) rearrangement FISH haematological-oncology
M224.23 MDS/MPN, t(9;22)(q34;q11) BCR-ABL1 FISH haematological-oncology
M224.24 MDS/MPN, PDGFRA rearrangement FISH (other than FIP1L1-PDGFRA see M85.7) haematological-oncology
M224.25 MDS/MPN, PDGFRB rearrangement FISH (other than ETV6-PDGFRB see M85.9) haematological-oncology
M224.26 MDS/MPN, FGFR1 rearrangement FISH haematological-oncology
M224.27 MDS/MPN, JAK2 rearrangement FISH (other than PCM1-JAK2 see M85.10) haematological-oncology
M224.28 MDS/MPN, inv(3)/t(3;3) FISH haematological-oncology
M224.29 MDS/MPN, 11q23 (KMT2A) rearrangement FISH haematological-oncology
M224.30 MDS/MPN, ABL1 rearrangement FISH (other than BCR-ABL1 see M85.24) haematological-oncology
M224.31 MDS/MPN, FLT3 rearragement FISH haematological-oncology
M224.32 MDS/MPN, RET rearrangement FISH haematological-oncology
M224.33 MDS/MPN, NTRK3 rearrangement FISH haematological-oncology
M224.34 MDS/MPN, Chr13/Chr13q copy number FISH haematological-oncology
M224.35 MDS/MPN, Chr11q copy number FISH haematological-oncology
M224.36 MDS/MPN, Chr9q copy number FISH haematological-oncology
M224.37 MDS/MPN, Chr17/Chr17p copy number FISH haematological-oncology
M224.38 MDS/MPN, idic(X)(q13) FISH haematological-oncology
M224.39 MDS/MPN, Multi-target NGS panel, copy number variant (-7/del7q, -5/del5q, -13/del13q, del11q, del12p, del9q, del17/del17p/i(17q) & idic(X)(q13), cryptic deletion of 4q12, trisomy 8) haematological-oncology
M224.40 MDS/MPN, Multi-target NGS panel, structural variant haematological-oncology
M224.41 MDS/MPN, WGS Tumour First haematological-oncology
M224.42 MDS/MPN, WGS Follow-up Germline haematological-oncology
M225.1 Suspected Lymphoma, Ig gene (heavy & light chain) rearrangement detection multiplex seq haematological-oncology
M225.2 Suspected Lymphoma, Ig gene (heavy & light chain) rearrangement detection NGS haematological-oncology
M225.3 Suspected Lymphoma, TCR gene rearrangement detection multiplex seq haematological-oncology
M225.4 Suspected Lymphoma, TCR gene rearrangement detection NGS haematological-oncology
M225.5 Suspected Lymphoma, Karyotype haematological-oncology
M235.1 Proven or Suspected Haematological Tumours Exhausted all Standard of Care Testing and Treatment, WGS Germline and Tumor haematological-oncology
M235.2 Proven or Suspected Haematological Tumours Exhausted all Standard of Care Testing and Treatment, WGS Tumour First haematological-oncology
M235.3 Proven or Suspected Haematological Tumours Exhausted all Standard of Care Testing and Treatment, WGS Follow-up Germline haematological-oncology

Description of the above table(s).